OMED COMMITTEES

STANDING COMMITTEES

 

Education Committee:
Chairman: Jerome D Waye
650 Park Avenue
New York, NY 10021, USA
Fax: 1-212-2495349
Members: Daldiyono (Indonesia), R Fujita (Japan), Yesus Y Perez (Philippines), A Martin (Italy), L.A. Simon (Hungary), C.B. Williams (UK), N Chopita (Argentina), H Espejo Romeo (Peru), G Machado (Brazil)

Research Committee:
Chairman: Eamonn MM Quigley
University of Nebraska - Medical Ctr
Section of Gastroenterology & Hepatology
600 South 42nd Street
Box 982000
Omaha, NE 68198-2000, USA
Fax: 1-402-559 9004
Members: H.J. Choi (Korea), S Nakazawa (Japan), K Huibregtse (NL), R Lambert (France), J.F. Riemann (Germany), T.H. Wang (ROC), Villa-Gomez (Bolivia), R.A. Kozarek, (USA), A Abrao Neto, (Brazil)

Nominating Committee:
Chairman: T. Sakita (Japan)
Members: G Machado (Brazil), R Llanio (Cuba), H Niwa (Japan), M Crespi (Italy)

Financial Committee:
Chairman: A. Montori (Italy)

"AD HOC" COMMITTEES

Information Committee:
Chairman: Friedrich Hagenmüller
A.K. Altona
Paul-Ehrlich Str. 1
D-22763 Hamburg, GERMANY
Fax: 49-40-88224902
Members: B Krishna Rau (India), Y Oguro (Japan), J St. John (Australia), D Colin- Jones (UK), A Nowak (Poland), W Roesch (Germany), A Celestino (Peru), M Paniagua (Cuba), A Penaloza-Rosas (Colombia)

Terminology and Data Processing Committee:
Chairman: Zdenek Maratka
U5 baterie 40
16200 Praha 6, CZECH REPUBLIC
Fax: 4202-24314574
Members: WSC Chao (Hong Kong), MA Fujino (Japan), S Wilairatana (Thailand), S Brunati (Italy), W Swobodnik (Germany), CW Venables (UK), LAG Juruena Mattos (Brazil), JE Segal (Argentina), M Schapiro (USA)

Minimal Invasive Surgery Committee:
Chairman: Alberto Montori
III Dept. of Surgery
University La Sapienza
00161 Roma, ITALY
Fax: 39-06-44702412
Members: SC Sydney Chung (Hong Kong), Dayasiri Fernando (Sri Lanka), T Yamakawa (Japan), J Perissat (France), A Cuschieri ( UK), G Buess (Germany), AL de Paula (Brazil), P Briceno (Venezuela), J Ruiz (Cuba)

Electronic Communications Committee:
Chairman: J.R. Armengol-Mirò
Secretary: A. Grassi
National Cancer Institute Regina Elena
Viale Regina Elena 291 – 00161 Roma, ITALY
Fax: +39.06.44 57 086 e-mail: mc6512@mclink.it
Members: H.D. Allescher, M. Delvaux, M. Fujino, V. Tejedo Grafia, Cheng-Yi Wang

Ethics Committee (joint with the OMGE Ethics Committee):
Chairman: Jean Escourrou
Service de Gastroenterologie
Hopital de Rangueil
Avenue Jean Poulhes 1
31054 Toulouse Cedex, FRANCE
Fax:33-56132-2176

REPORTS OF STANDING COMMITTEE CHAIRMEN
Education Committee

Education Committee and Research Committee:" Survey on Endoscopic Practice and Priorities throughout the world" Eamonn M.M. Quigley, M.D.

Research Committee

Terminology and Data Processing Committee

Minimally Invasive Surgery Committee

Ethics Committee

Ethics Committee "Medical Ethics in Gastroenterology and Digestive Endoscopy: changing concepts in a changing world" Editor J. Escourrou.

Education Committee
Jerome D. Waye, Chairman (1994-1998)

OUTLINE OF THE ACTIVITIES OF THE OMED
EDUCATION COMMITTEE, MAY 1995

 This Committee has set broad goals for the next four years:
1. A set of teaching video tapes will be made available in each of the major endoscopic specialties. OMED will maintain an up-to-date video library, and copies of tapes will be presented to endoscopy societies, hospitals and chiefs of endoscopy training centers throughout the world.
2. An attempt will be made to establish true "hands on" training programs for beginner endoscopists and for learning advanced techniques. Intensive, short courses have been successfully structured in upper intestinal endoscopy and colonoscopy by Dr. Charles Swan in England. Although these provide only rudimentary entry-level knowledge and are not acceptable in countries where full training programs exist, they will provide the concepts of indications, contraindications and techniques to ensure a safe start in endoscopy.
3. OMED will collect from each national endoscopic society a copy of their constitution, by-laws and guidelines to serve as an international reference source. Information can be shared, and societies that are in the formative stages will no longer need to reinvent the structure of their group anew, nor rewrite guidelines which have already been labored over by other endoscopic societies.
All of these endeavors will need funding to be able to provide the services that are necessary to introduce endoscopy to countries where it is undeveloped and underutilized, to assist in continuing education and to ensure our patients of the safety of the procedure.

ACTIONS BY THE OMED EDUCATION COMMITTEE, MAY 1997

Omed is embarking upon a two-part approach to teaching endoscopy in under developed countries. The overall plan is to present videotape demonstrations of endoscopic procedures to a national meeting at which all people who are interested in gastrointestinal endoscopy and gastroenterology will be invited. The group of people who express an interest in forming endoscopic centers will subsequently (within one year) be invited to attend a practical workshop on endoscopy in that country. Cases will be provided and experts will demonstrate various techniques of basic endoscopic procedures. Lectures and written material will be developed for those basic workshops. The first area contacted for this approach is Africa. Communication has been established with professor Simjee, president of the newly-formed African Federation of Gastroenterology. He has expressed an interest in this program and is currently contacting physicians who may be interested in this approach.

A cadre of teachers in endoscopy is being developed for purposes of teaching endoscopy in underdeveloped countries. If anyone would like to be nominated as a member of the Omed teaching faculty, please contact me with a brief resume detailing your endoscopic experience, the hospitals in which you were trained, a description of the level of expertise, and the types of endoscopy in which you are interested in teaching.

The education committee is attempting to act as a repository for the collection of constitution and by-laws of endoscopic societies throughout the world. This will allow us to know which organizations have established by-laws, and the languages in which they are written. Upon request from any group which is considering formation of an endoscopic society, or which would like further information on patterns which have been developed by other organizations, the names of the endoscopic societies and a specific contact person will be sent so that communications can be established between various endoscopic societies for the exchange of this information. At the present time, the education committee has received twelve responses. The committee has also requested information concerning teaching videotapes and guidelines which have been established for endoscopy. The American Society for Gastrointestinal Endoscopy, seems to have the best-developed set of guidelines. The British Society of Gastroenterology also has several endoscopic guidelines available.

In order to facilitate communication between endoscopic societies and endoscopists worldwide concerning items of interest, Omed is currently on the internet at: www.uni. net/omed. The E-mail address is OMED@uni.net.

Videotapes of the Post-graduate Courses of the last two World Congresses of Gastroenterology, held in Sydney and Los Angeles, are currently available at no cost for national organizations who request them from the Omed General Secretariat. The stipulation is that they will be shown at a National Congress of Gastroenterology within a year after their having been received by the national Society.

They will be also available to individual physicians by request. They are in two formats, Pal and Ntsc. The price for the complete package of 13 videotapes is $ 100 US. This is to defray the cost of videotapes and mailing. The requests should be addressed to Prof. Massimo Crespi, National Cancer Institute "Regina Elena", Viale Regina Elena 291 - 00161 Roma, Italy
Fax: +39.06.4457086 E-mail: as stated above.

OMED EDUCATION COMMITTEE, OCTOBER 1997

The World Organization of Digestive Endoscopy represents organized gastrointestinal endoscopy throughout the world. Many areas of the world are well-served by endoscopic societies, endoscopic organizations, and gastroenterology associations which have active endoscopic components. Each of the many endoscopic organizations throughout the world are autonomous, and most endoscopic organizations or groups of endoscopists develop their own rules, regulations, and organizational structures to suit their particular needs, constituents, and geographic areas. For the most part, rules, regulations, endoscopic guidelines, and organizational structures are developed independently from any other endoscopic organizations. Associations which are well established and have multitudes of members are the groups that characteristically take the lead in the development of practice parameters, practice guidelines, and in the defining of indications, techniques and contraindications for gastrointestinal endocopy. omed has taken upon itself the collation of information from various sources throughout the world and has redefined itself as being the stucture which scan knit the various worldwide organizations into a cohesive array of societies. OMED is the link across all of endoscopy and will disseminate knowledge and education to all of our members, from the highly organized societies to te less-well-developed groups of endoscopists throughout the world.
In an attempt to transmit specific knowledge about endoscopy, OMED has made available the endoscopy videotapes from the last two World Congress of Gastroenterology to any member-constituent GI organization throughout the world. These are available in both PAL and NTSC format, and merely have to be requested by the constituent societies. The intent of OMED is to have these shown at any endoscopic congress held by the individual society, or available to be loaned to any individual or group in that society. Any individual may purchase the entire twelve-videotape packet of World Congress videotapes from the endoscopy courses of the Australia World Congress of Gastroenterology (1990) as well as from the Los Angeles World Congress of Gastroenterology (1994) for US$100 plus mailing. These can be obtained by sending a check directly to: Massimo Crespi, MD - OMED acting president.
The Education Committee has also requested information on constitutions and by-laws from all of the constituent endoscopic organizations. Only a few of the many constituent societies have submitted copies of their constitutions and by-laws, but a list of countries which have sent printed by-laws, will be made available to any organizations who request them.
Some of the larger and more advanced endoscopic societies have multiple guidelines and practice parameters which are "state of the art" position papers. A list will be sent upon request.

The education committee has made initiatives for the "hands-on" teaching of endoscopy in areas in which endoscopy is underdeveloped or under-served. A cadre of teachers is currently available for teaching endoscopy in underdeveloped countries. If any member would like to add their names to the list of available endoscopists who may be requested to travel to foreign countries to begin endoscopic instructions, please contact me with names, addresses, and a curriculum vitae listing hospital affiliations, endoscopic training, current affiliations, and an outline of the endoscopic teaching that you have performed.
All the members of the Education Committee have committed to submitting to the OMED bulletin articles concerning endoscopy in their particular countries. Other endoscopists are encouraged to send in their own experiences in individual countries, unusual endoscopic situations, et cetera. Please send manuscripts directly to: Alberto Montori, MD - OMED News Letter Editor.
OMED is currently on the worldwide web, and can be reached at: "uni.net/omed". This website will be further developed in the future, and is intended to be a bulletin board of worldwide interest in endoscopy. It is hoped that a "chat page" can be formulated to allow interchange between endoscopists throughout the world.
The OMED bulletin will be published twice yearly, and an attempt will be made to disseminate these at all major endoscopic meetings throughout the world; OMED is committed to disseminating knowledge about endoscopy and being the leader in worldwide endoscopy education. Please send in suggestions and comments concerning educational endeavours in the field of gastrointestinal endoscopy.

REPORT OF THE EDUCATION COMMITTEE OMED, APRIL 1998

The Education Committee consists of the following members:
Nestor A. Chopita, MD
Daldiyono, MD
Rikiya Fujita, MD
Glaciomar Machado, MD
Alessandro Martin, MD
Jesus Y. Perez, MD
Herman Espejo Romeo, MD
Laszlo A. Simon, MD
Jerome D. Waye, MD (Chairman)
Christopher B. Williams, MD.
The Education Committee has applied itself over the past four years to several areas with the purpose of bringing information concerning various aspects of endoscopy to endoscopists throughout the world. The major thrust of the Education Committee is not in the training of endoscopists in a formal fellowship program, but rather is focused on bringing information to physicians who already perform endoscopy and educating doctors about endoscopy in countries where there is a need for further endoscopic expertise.
Videotapes from the past two World Congresses of Gastroenterology (Australia, 1990 and USA, 1994) are now available as a package. The price for the entire package is US$100. This is available in either PAL or NTSC format, and is available upon request form Prof. Massimo Crespi, President of OMED. Constituent member societies of OMED may acquire a copy of these videotapes free of charge providing that they agree to show these videotapes at national meetings of their endoscopic societies.
The Education Committee has arranged for a live demonstration endoscopy course to be held in Moscow on April 23-24, 1998. This course will be presented in conjunction with the Olympus Corporation, who will supply equipment and arrange for video transmission.
The Education Committee currently has a list of constitutions and by-laws which is available on request. These constitutions and by-laws had been submitted by member endoscopic societies of OMED three years ago. The Education Committee is currently seeking information from every constituent endoscopic society as to the availability of educational aids for gastrointestinal endoscopy. The aids would include slide series, brochures, written material, and videotapes. A letter has been sent to every president of each constituent endoscopic society throughout the world seeking such information.If any individual members have knowledge of educational material which contain information concerning gastrointestinal endoscopy, please contact Dr. Waye with a listing of this information.
The Education Committee is currently working on developing a brochure for the performance of live courses in endoscopy. Live tele-endoscopic courses are of great benefit in the education of large numbers of physicians in the performance of endoscopic procedures. A section of this brochure will address small, focused endoscopy courses. OMED desires to establish standards for patient safety, patient selection, the performance of such live courses, and patient privacy. The Education Committee is also concerned with the selection of "experts" in endoscopic procedures, and desires to eliminate any risk to the patient from being a subject in a "live" endoscopic course. Most physicians who agree to produce such a course, are, in general, not knowledgeable about the various forms of transmission to a nearby or remote location, and would benefit by having a "primer" on the conduct of these courses. Anybody with a special expertise in the development or production of live courses or is knowledgeable about the video requirements should contact Dr. Waye with such information.
Stimulated by an excellent response from the Research Committee on a previous questionnaire, the Education Committee is collaborating with the Research Committee to distribute a questionnaire worldwide to collect further information on endoscopic practices. The questionnaire is currently in the development phase, and will be distributed during 1998.

MINUTES OF THE MEETING OF THE OMED EDUCATION, MAY 1998

OMED conducted a live endoscopy demonstration in Moscow on April 23-24, 1998. The meeting was sponsored by Olympus and Wilson-Cook. The local organizers were Drs. Poddubny and Fedorov. Approximately 400 Russian physicians attended the two-day workshop, where they saw a wide range of endoscopic procedures including ERCP, stone extraction, endoscopic ultrasound, endoscopic mucosal resection and colonoscopic polypectomy. Several lectures were also given by the faculty members, which consisted of Dr. Massimo Crespi, MD (President, OMED), Dr. Alberto Montori, MD (Treasurer, OMED), Dr. Melvin Schapiro, MD (Vice President, OMED), Dr. Aksel Kruse, MD (Denmark), Dr. Paul Fockens, MD (Amsterdam), Dr. J.R. Armengol Mirò, MD (Barcelona) and Dr. Jerome Waye, MD (New York).
The meeting was a great success and was considered a great benefit to all of the registrants who had traveled from all different parts of Russia to attend the workshop. At the present time various locations are being explored for future workshops.
The committee has developed a list of all the guidelines and brochures concerning endoscopy, as well as the video-educational material available throughout the world. The United States, Japan and Australia have the largest number of published guidelines and instructional videotape material concerning endoscopy. The Education Committee will try to adapt currently published guidelines in English for use by the international fraternity of endoscopy. Permission must be obtained from countries which already have developed guidelines. Once the guidelines have been reformulated for their international applicability, the will be published in the OMED bulletin and on the internet site. We thank the individual societies who responded to our request for information.
OMED had made available a 12-pack packet of videotapes from the Sidney World Congress of Gastroenterology and the Los Angeles World Congresses of Gastroenterology.
These videotapes are available without charge upon request by any of the constituent endoscopic societies, and are available for $100 for anyone else who is interested. If interested, contact Dr. Massimo Crespi and specify whether the video format desired il PAL or NTSC.
The Research Committee, in conjunction with the Education Committee, has distributed a questionnaire about "endoscopic practice and priorities throughout the world".
We urge all of the constituent societies to answer the survey promptly so that information can be gathered on several topics, including the availability of endoscopy in various parts of the world, the types of endoscopy which are considered to be of greatest benefit throughout the world, and the degree of training required for performing endoscopy. The information from this survey will serve to focus the future thrusts of endoscopy for both educational purposes and research needs.
The Education Committee is currently developing a brochure on the requirements for live courses in endoscopy. This will consist of two parts, a technical portion concerning types of transmission, number of cameras, and the adequacy of facilities. The second part will consist of patient selection, patients safeguards, and the role of the nurse/assistant during live demonstration.

OMED has its own web page, which is found at www.uni.net/omed.

The E-mail address is OMED@uni.net.

TEACHING ENDOSCOPY BY INTERACTIVE VIDEOTAPES, MAY 1997
(Melvin Schapiro, MD)

Teaching endoscopy has evolved from artist’s reproduction of endoscopic findings, through the direct capture of high quality still and video images. The limitations of teaching were primarily related to the need for a one on one or very small group experience. The electronic endoscope brought large screen T-V to the teaching environment and a large number of remote transmissions from international centers soon evolved via satellite or telephone lines. The two most important limiting factors to the remote, live transmission technology are the down time during complicated cases, and the costs involved for a one time use.
A radically different approach has been developed by Advance Medical Ventures, a Hollywood based company that utilizes professional motion picture production and editing crews as well as state-of-the-art presentations designed to capture the "live atmosphere".
The format is the presentation of a wide range of pretaped video sequences of procedures actually performed by experts in their individual endoscopy units. In addition to large screen projection, a high quality sound reproduction system and multiple high resolution video monitors are spaced through out the presentation center allowing close-up demonstrations of the technical aspects of complicated therapeutic endoscopic techniques that were performed under real practice situations.
The direct video reproductions are enhanced by split screen technology allowing the audience to focus on many aspects of the procedures with simultaneous visualization of the high resolution endoscopic images. The use of stop-start and rapid rewind methods have been combined with both recorded and live voice-over explanations by the on-site faculty presenters who were filmed in their own units
The audience is further involved in the sessions through the use of interactive "touch-pad" questions and the presence of an expert endoscopic "facilitator" who anticipates questions and the need to review special technical aspects of the presentations. The facilitator is as well scripted with time code associated material so that by watching a special monitor he can amplify certain teaching points agreed with by the faculty in pre-presentation rehearsal sessions.
A special teaching technique is further provided by "telestrator" technology that allows the expert presenter to draw over or provide diagramming to emphasize particular concepts.
This teaching concept was developed over five years ago and has been utilized at the World Congresses of Gastroenterology Post-graduate Endoscopy course in Los Angeles in 1994 and at the American Society for Gastrointestinal Endoscopy’s annual Post -graduate teaching course in San Francisco in 1996. Parts of the program have been reproduced internationally at the UEGW, and at regional society meetings. New endoscopic material is provided every two years so that the latest in technology is provided as well as the opportunity for individuals who have attended previous presentations to return for new material. The attendance evaluations have universally indicated that the program is extremely well received.
The high quality video material has been reproduced on video cassettes for international distribution, and lends itself to the new electronic formats such as DVD and CD-ROM. This enables continued study outside of the presentation environment.
The teaching format has been used by small groups such as a hospital that invites 50 physicians to a meeting, or by large groups with attendance exceeding 2000. Further information concerning presentations and materials are available on the AMV home page: http:/www.amv.com.

" SURVEY ON ENDOSCOPIC PRACTICE AND PRIORITIES THROUGHOUT THE WORLD"
All the member Societies already received the questionnaire.

Those which did not yet reply are invited to do so as soon as possible.

SURVEY ON ENDOSCOPIC PRACTICE AND PRIORITIES THROUGHOUT THE WORLD DEVELOPED BY RESEARCH AND EDUCATION COMMITTEES OF OMED: CHAIRS EAMONN M.M. QUIGLEY, M.D.,JEROME D. WAYE, M.D.
Please Submit Responses to: Eamonn M.M. Quigley, M.D. Gastroenterology and Hepatology University of Nebraska Medical Center Omaha, NE 68198-2000, USA, FAX.+001.402-559-9004, E-MAIL: equigley@mail.unmc.edu

1. Who performs endoscopy in your country? For each type of practitioner, please estimate the percentage of all endoscopy that is performed by these individuals.

A. Upper Gastrointestinal Endoscopy

------- % Family Practitioner
------- % General Internist/General Physician
------- % Gastroenterologist
------- % Surgeon
------- % Other (Please clarify)

B. Colonoscopy

------- % Family Practitioner
------- % General Internist/General Physician
------- % Gastroenterologist
------- % Surgeon
------- % Other (Please clarify)

C. ERCP and Other Interventional Procedures

------- % Family Practitioner
------- % General Internist/General Physician
------- % Gastroenterologist
--------% Surgeon
--------% Other (Please clarify)

2. In your country, please estimate the proportion (as %) of endoscopic examinations that are performed at the following sites:

% hospital inpatient
% hospital outpatient (ambulatory)
% private clinic, attached to a hospital
% free-standing private clinic, not associated with a hospital

Surgical Residency
Gastroenterology Fellowship
Fellowship training in endoscopy other than that provided in
Gastroenterology.

3. Which of the following endoscopic procedures are available in your country? For each, state whether they are

A. Not available
B. Available only at a few center
C. Available only at major referral hospitals or
D. Available widely in community-type hospitals or physician's offices.

A B C D

Esophago- gastroduodenoscopy/upper gastrointestinal endoscopy
Endoscopic therapy of gastrointestinal hemorrhage
Endoscopic therapy of esophageal/gastric varices
Endoscopic placement of gastrostomy/jejunostomy tubes
Colonoscopy
Colonoscopic Polypectomy
ERCP
ERCP with Sphincterotomy
ERCP with Sphincterotomy and placement of stents
Esophageal dilatation and placement of prosthesis
Enteroscopy
Endoscopic Ultrasound
Endoscopic laser therapy of tumors

4. What are the most common indications for the major endoscopic procedures in your country? For each procedure, list the top 3 indications:

A. Upper Gastrointestinal Endoscopy (diagnostic)
B. Upper Gastrointestinal Endoscopy (therapeutic)
C. ERCP
D. Colonoscopy (diagnostic)
E. Colonoscopy (therapeutic)

5. What is the prevailing practice of patient preparation/sedation/anesthesia in your country for:

A. Upper Gastrointestinal Endoscopy

No sedation
Conscious Sedation with Benzodizapine/Opiate/Other (please specify)
General Anesthesia

B. Colonoscopy

No sedation
Conscious Sedation with Benzodizapine/Opiate/Other (please specify)
General Anesthesia

If conscious sedation or anesthesia are employed, who administers these?

The endoscopist
An anesthesiologist
Other (please specify)

6. What are the guidelines for disinfection of endoscopes and accessories in your country?

No generally accepted guidelines - each institution has its own
National guidelines developed by national GI/endoscopic societies
National guidelines mandated by governmental agency

7. In general, would you regard the approach to the disinfection of endoscopes and accessories in your country as...

Adequate
Inadequate

8. What are the major problems in terms of the disinfection of endoscopes in your country?

A. Are there particular or unique infections or infectious agents that cause problems with disinfection in your country" Please specify
B. Do cost concerns limit the performance of disinfection of endoscopes and accessories? If so, please specify.
C. Is there access to adequately trained personnel for the disinfection of endoscopes and accessories?

9. What is the average time taken to clean and disinfect an instrument between uses in your country?

--------------- minutes.

10. What is the disinfectant most commonly used in your country?

11. What do you perceive to be the greatest unmet need in the area of endoscopy in your country? Please list

A. Clinical problems that you feel would benefit from additional endoscopic expertise or technology:
B.    The endoscopic procedures that you would most like to see developed in
your country.

Research Committee
Eamonn M.M. Quigley, Chairman (1994-1996)

OMED RESEARCH COMMITTEE, SAPRIL 1997

Following the resignation of Dr. Stiel, it was my great honor to be nominated to succeed him as Chair of the Research Committee, which became effective in May 1996. I now have the pleasure of updating you on current and planned activities of the Research Committee. Several activities are currently in hand.
A major priority for the Research Committee is the development of an international database on endoscopic priorities. If the Research Committee is to serve as a voice for endoscopic research in the future it is clear that we need data to indicate the important priorities for the development of endoscopy in various parts of the world. Each member of the Research Committee has, therefore, been charged with compiling a list of the most important diagnostic and therapeutic uses of endoscopy in their part of the world. This data will be collated and should be of considerable assistance in the development of research and educational strategies appropriate to different parts of the world. It is my impression that, contrary to popular belief, endoscopy may, in fact, be a very important and almost basic medical tool in many parts of the world, including the developing world, yet priorities may be quite different.
In the past, the Research Committee, Omed and the World Congress have addressed the issue of endoscopic disinfection. I am pleased to announce that the Organizing Committee of the Vienna World Congress have asked me to chair a working party on minimal standards for endoscopic disinfection. While this will be performed within the auspices of a separate working party, the results of this group should be of considerable value to Omed and its Research Committee. Along similar lines, the Omed Research Committee is also working to develop a consensus document on minimal standards for the performance of endoscopy. Our goal here is to establish, through data generated by members of the Research Committee, what are, indeed, the basic requirements for the performance of diagnostic and/or therapeutic endoscopy in various parts of the world. This information should, again, help to provide an appreciation of variations in endoscopic priorities throughout the world, help delineate areas of mutual interest and also assist in developing specific protocols for different parts of the world. Building on this, we also hope to address the standardization of accessory equipment.
A proposal for a multicenter study of Barrett’s esophagus, intestinal metaplasia and adenocarcinoma is under review and proposal in the area of endoscopic hemostasis and laparoscopy will be considered.
The Research Committee will meet in Washington DC, at the time of Digestive Diseases Week – we anticipate lively discussion, and I look forward to updating you of the continuing activities of the Omed Research Committee.

ACTIVITIES OF RESEARCH COMMITTEE OF OMED, APRIL 1998

In association with Dr. Jerome Waye, Chair of the Education Committee of OMED, the Research Committee has been working over the past several months to develop a comprehensive questionnaire on endoscopic priorities throughout the world. This has now been finalized and is about to be distributed to the constituent national societies of OMED. This questionnaire will address several areas, including what endoscopic procedures are performed, who performs them and what has been their training. The purpose is to develop a database on endoscopic practice, training and facilities throughout the world, to provide a basis for further education, training and research initiative in this area. We look forward to the active participation of the constituent national societies in this process and we hope that all of you will complete this questionnaire and, also, that you will communicate with either Dr. Waye or Dr. Quigley regarding any comments or criticisms on the questionnaire. We believe that this is a vital prerequisite to developing short- and long-term strategies for OMED throughout the world.

SUMMARY OF THE SURVEY CONDUCTED BY THE RESEARCH COMMITTEE OF THE S.I.E.D.

During 1997, the Research Committee of the Interamerican Society of Gastrointestinal Endoscopy (SIED), conducted a survey directed to all the Societies of Gastrointestinal Endoscopy within the Latin-American area on "Endoscopic equipment, Accessories, Disinfection and Endoscopy training". As illustrated by the response rate, the survey was well received among constituent societies. A total of 58 endoscopy centers completed the survey: 19 from Brazil, 18 from Argentina, 9 from Colombia, 5 from Uruguay, 4 from Bolivia, 2 from the Dominican Republic and 1 from Peru.
Endoscopic Examinations:
Regarding the frequency of the various endoscopic studies, there was only minor variation between centers: the most frequent studies being esophagogastroduodenoscopy (comprising 65% to 70% of all studies), colonoscopy (20% to 23%) and duodenoscopy (10% to 15%).
Endoscopic Equipment:
Only four of the centers used videoendoscopes exclusively. Most (30) used both videoendoscopes and fiberscopes; a significant number (20), also utilized videocameras, i.e., an adaptor connection to transform a fiberoptic image into a video image. Only 3 centers did no possess video equipment. Fiberscopes are, therefore, still widely used in Latin American countries, even though videoendoscopes are increasing in popularity.
Of those centers that use fiberscopes, 80% use immersible equipment. Of importance in relation to disinfection, 13% of all centers continue to use non-immersible endoscopes and 7% use both immersible and non-immersible. Given the fact that non-immersible equipment has not been manufactured for several years, it can be concluded that a significant number of centers still use this outdated equipment. Of all videoendoscope systems, 60% were housed in endoscopy centers and 40% in public hospitals. This distribuction was similar in all countries with the exception of Argentina where 75% of videoendoscopes were in private and 25% in public centers. This difference in distribution may be explained by the fact that, in Argentina, videoendoscopy is frequently reimbursed at a higher rate than fiberoscopy. In 75% of responses from centers in all other countries, it was stated that both types of endoscopy were reimbursed at a similar rate. It should be noted that 28% of centers responding to the questionnaire did not answer this question; these conclusions are, therefore, drawn from an incomplete sample.
Costs of Endoscopy:
Inquiries regarding fees charged for endoscopic studies provided widely variable responses: charges for diagnostic videoesophagogastro-duodenoscopy ranged from U.S.$ 150 to 600, in various countries. In those countries where there was a difference in fees between video and fiberoscopy (notably Argentina), fiberoscopy was reimbursed at half, or even less, of the rate for videoendoscopy. In general, the fee quoted included the use of the equipment and accessories, as well as, nursing support and other ancillary services. The fee for therapeutic endoscopy varied widely and it was very difficult to draw any conclusions.
Cleaning and Disinfection:
All centers performed manual cleasing of endoscopes and accessories with a neutral detergent or an enzymatic soap and then disinfected with 2% glutataldehyde. Six centers used ethylene oxide for accessories and only 4 used automated "washing machines". Seventy-five percent disinfected equipment after each examination; 25% performed this, only at the end of the day or following cases with known infectious diseases.
With regard to who performs cleaning and disinfection, 41 centers stated that disinfection is performed by trained paramedical personnel; 28 stated that disinfection is carried out by the physician (in several centers both of those options were operative) and only 3 centers use operating room personnel who do not have specific training in endoscopic cleaning and disinfection.
With regard to protection of staff: 100% of responders use gloves, 53,5% protective goggles, 48,3% chin straps, 39,6% disposable aprons and 15,5% boots. Some centers took precautions only in those cases where they knew that the patient was HIV (+).
Accessories:
With regard to access to accessories, 40 centers responded that accessories can be easily obtained in their own countries; 15 experienced some difficulties and 3 did not answer this question. The reasons for such difficulties included the following: high price, absence of hospital budget, lack of stock in the country and a bureaucracy that hinders purchase of accessories. When asked about what accessories are used in the different centers, most (50) use well-known international brands; 12 (from Argentina and Brazil), use national brands (domestically manufactured) and 9 (in Argentina, Bolivia and Brazil) use self-manufactured accessories. Accessory prices vary widely. For example, the price of a papillotomy knife ranged from U.S. $200 to 700 and a polypectomy snare from U.S. $65 to 500. In Argentina and Brazil, domestic brands are, on average, half the price. In Latin America, accessories are, onaverage, twice or three times more expensive than in USA or Europe and this is a major problem for endoscopy centers. All centers stated that they re-use accessories that have previously been disinfected with 2% glutaraldehyde or ethylene oxide.
Endoscopy Training and Certification:
With regard to gastrointestinal endoscopy training, all countries responded that their gastroenterology residencies include training in gastrointestinal endoscopy; both diagnostic and therapeutic. The location of such gastroenterology training is as follows: University Center 51, Private Institution 19, Public Hospital 18. Thirty-five centers responded that specialized, concentrated, endoscopic training experiences were available in their country; in addition to a standard gastroenterology residency. The duration of this additional endoscopy training is variable, but they generally last between one years and two. With regard to the administration of these specialized endoscopic training portions, 27 responses stated that these were administered by Universities, 12 by Scientific Societies, 10 by private and 5 by other hospitals. When asked about wherether a higher qualification in gastroenterology enables a physician to perform endoscopies, all countries answered affirmatively except for Brazil where 14 Centers answered positively an 5 negatively.

With regard to the granting of certification in gastroenterology and endoscopy, 25 answered that such certification is granted by Scientific Societies, 20 by Universities, 16 by Medical Colleges and 9 by a giverment Ministry. In some countries more that one mechanism was operative. In Peru, the Dominican Republic and Uruguay, certification does not require a practival demonstration of endoscopic skills. In other countries requirements appeared to vary. In Brazil 18 Centers stated that a practical demonstration is required; one stated that it is not. In Colombia, 4 answered positively and 5 negatively; in Argentina, 2 answered positively and 16 negatively and in Bolivia, 2 answered positively and 2 negatively.
The last question was whether centers were prepared to receive foreign doctors for endoscopy training. To this, 45 answered affirmatively, 6 negatively and 7 did not answer.
Nevertheless, in all countries that responded to the survey there is at least one center willing to receive foreign trainees.

COMMENTARY BY EAMONN M.M. QUINGLEY, CHAIRMAN RESEARCH COMMITTEE OMED

Dr. Rainoldi and his colleagues are to be congratulated on this important survey. This report illustrates that meaningful surveys are feasible an worthwhile. Several important findings deserve emphasis. These include the persistence of non-immersible endoscopes in a minority of centers and significant variations in policies for cleaning, disinfection ,and staff protection.
Reflecting high costs and difficulties with accessory cleaning, re-use of accessories following disinfection seems universal and should be contrasted with emerging policies regarding single-use in Europe an North America. While the basic components of gastroenterology training appear similar, the details of endoscopic training and certification, in particular, vary considerably both between and within various countries. Surveys such as this provide "real" data on endoscopic practive and should serve as the basis for future projects in endoscopic research, training and education.

WORLD CONGRESS OF GASTOENTEREOLOGY, WORKING PARTY
ON "MINIMAL STANDARD FOR ENDOSCOPIC DISINFECTION", May 1998
Intermediate Report

Present: Eamonn Quigley, MD (USA-Chair), Habib Ben Khelifa, MD (Tunisia), Nestor Chopita, MD (Argentina), Axel Kruse, MD (Denmark), Kazuei Ogoshi, MD (Japan), Rakesh Tandon, MD, PhD (India)
Excused Absence: Walter Bond, MS (USA), Alistair Cowen, MD, FRACP (Australia), Richard Kozarek, MD (USA)
 I)The following interns were distributed:

A. Monograph "Clinical Risks of Infection Associated with Endoscopy" by Dr. Cowen
B. Correspondence to Dr. Quigley from Dr. Bond, draft monograph, "Standard practice for the reprocessing of reusable, heat-stable endoscopic accessory instruments (EAI) used with flexible fiberoptic and video gastrointestinal endoscopes, Correspondence to Dr. Cowen from Dr. Bond regarding his monograph, monograph on "Disinfection, Sterilization and Antisepsis in Health Care", published by the Association for Professionals Infection Control in Epidemiology and draft from CDC on "Creutzfeldt-Jakob disease. Current epidemiology, risk factors and decontamination.
C. Comments on the draft proposal by Dr. Ben Khelifa
D. Comments on the experience in Latin America with endoscopic disinfection from Dr. Chopita

II) Dr. Quigley summarized the format and the order of presentation for the Working Party in Vienna. The presentation for the Working Party is scheduled between 4-6 pm on Monday afternoon September 7, 1998. Following a brief introduction by Dr. Quigley, three-20-minute presentations will follow as follows:

A. Walter W. Bond, MS "Microbiological Considerations in Disinfection and Endoscopy.
B. Alistai Cowen, MD "Clinical Risk of Infection Associated with Endoscop
C. Rakesh Tandon, MD "Endoscopic Disinfection – Practices and Recommendations for Endoscopes and Accessories"

1. This will be followed by a discussion within the panel with particular emphasis on experience in different parts of the world and on controversial issues, in particular, the reuse of accessories.
2. This will be followed by an open discussion and concluding remarks by Dr. Quigley.

III) The remainder of the meeting was taken up with a detailed discussion of Prof. Tandon’s presentation on "Endoscopic Disinfection – Practices and Recommendations for Endoscopes and Accessories". The details of this presentation will be circulated to the members of the committee following receipt of the complete document from Prof. Tandon. The most extensive discussion has surrounded a number of areas which remain controversial.
These are as follows:

A. The issue of reuse of accessories. While it was agreed that some accessories such as sclerotherapy needles should never be reused, there was some divergence of opinion with regard to the reuse of some common accessories such as biopsy forceps and sphinctertomes, The problems here appears to be in relation to the cleaning of these accessories rather than their disinfection.
B. The other contentious issue related to the "soaking time" in disinfectant. This is clearly a major issue which has enormous impact, particularly in the developing world. Again, there was divergence of opinion varying from the 10 minutes recommended by the Gastroenterological Nurses Society of Australia and Gastroenterological Nurses Society of Australia to the 20 minutes recommended in Britain and Europe. Indeed, times of up to two hours had been recommended in some reports.
C. The issued of cleaning, manual vs. machine was discussed in some detail. With regard to manual cleaning, the importance of adequate training of personnel, adequate protection and adequate ventilation were emphasized. Some discussion took place with regard to automated systems, their potential benefits an limitations.
D. There was consensus that non-immersible instruments should not be recommended.
E. While most data relates to 2% glutaraldahyde, there are problems with its use, in particular, with the issue of sensitivity in personnel, which apparently has led to its prohibition in Germany and Denmark. What should the Working Party recommended as an alternative? Should this be paracetic acid or are there other possibilities?
F. Are there some infectious agents that we cannot protect against, in particular, prions and MAI? What should be our statement with regard to these?
G. What should be our position on alternative methods of disinfection such as thermal, superoxide water, etc? Should these be mentioned if there is insufficient data or availability?

IV) Dr. Quigley undertook to distribute the three draft documents to all of the Working Party once these have been received.
There being no further business, the meeting was adjourned.

REPORT OF "AD HOC" COMMITTEES CHAIRMEN

Terminology and Data Processing Committee
Zdnek Maratka, Chairman (1994-1998)

TERMINOLOGY COMMITTEE REPORT, July 1993

The Committee of Terminology in Digestive Endoscopy was founded in 1976 by the European Scociety for Gastrointestinal Endoscopy (ESGE) and was raised to a Committee of the World Society (OMED) in 1978. Its activity has included regular meetings at the European and World Congresses of ESGE and OMED and elaboration of a standard endoscopic terminology suitable for daily practice and computer-aided endoscopic reports. The collaboration within the Committees in the three zones of OMED as well as continuing discussions have resulted in a series of publications, especially the manual of standard endoscopic terminology: Terminology, Definitions and Diagnostic Criteria in Digestive Endoscopy, 1st ed. [Scan J Gastroenterol 1984, 19 (suppl 103): 1–74]. The 2nd revised edition appeared in English (1989), German (1989), Italian (1989), Czech (1989), French (1990); all published by Normed Verlag, Bod Homburg, Germany. The Spanish, Portuguese and Norwegian editions are in preparation as well as the 3rd English edition. This book has been complemented by an atlas of endoscopic pictures presenting the most common findings with a standard description and interpretation (by the same publisher). Five video films have been produced by F. Costentino) documenting standard terminology in upper and lower digestive endoscopy (so far published in English, Italian and German). The publications and video films have been included in the educational programmes of endoscopic and gastroenterological societies.

TWENTY YEAR ANNIVERSARY OF THE OMED
TERMINOLOGY COMMITTEE, April 1998

The evolution of endoscopic terminology and nomenclature has been mentioned in previcus reports (1) but a 20 years anniversary of the committee gives the opportunity to recall the story shortly.

In the seventies the need for a standardized endoscopic terminology became more and more apparent and with the advent of computers was urgent. One of the first innovations which I introduced after being elected President of the European Society for Gastrointestinal Endoscopy (ESGE) in 1976 was founding the Terminology Committee. A round table conference was organized at the IV World Congress of Digestive Endoscopy in Madrid (1978) which aroused unexpected interest and incited inviting representatives of the other zones to participate in future activities. Thus the ESGE Committee was raised to an OMED Committee and since then bore the name Committee for Terminology and Computerization in Digestive Fndoscopy of the World Society of Digestive Endoscopy (OMED).The achievements of this committee during its 20 years existence can be summarized as follows.

First it was necessary to establish basic rules for endoscopic terminology. Three essential requirements were put forward:

1) Endoscopic terminology must be based on visual perception and denomination of macroscopic features as seen through the scope.
2) Accepted terms must be classified and arranged in a system according to the character of the finding; OMED’s classification distinguished nine categories of findings referring to lumen, contents, wall, peristalsis, mucosa, hemorrhage, flat changes, protrusions and depressed/excavated lesions. The list of all terms belonging to the discipline represents a comprehensive database: the OMED nomenclature.
3) The endoscope findings designated by appropriate terms specific for the endoscopic method are interpreted in terms of clinical diagnosis by means of accessory methods like biopsy, if necessary.

Developing a consistent endoscopic terminology was considered to be the primary goal of endeavor. A draft was prepared and repeatedly circulated to the members of the Committee and relevant experts to insure the greatest possible consensus. At all international Congresses symposia and round table conferences were held and the present state of the document was discussed and comments respected.
In 1984 the first publication appeared and gained wide acceptance; it was quickly translated in other languages and updated in further editions (2). At present the forth English edition is ready-to-print. In addition to the book, an atlas (3) and videos (4) were published. A CD-ROM in 5 languages presenting gastroenterology as a discipline viewed by the eyes of the endoscopist and using the OMED nomenclature was published under the name Normedia-Gastro (5). All this work was accomplished thanks to sponsoring by pharmaceutical and endoscopic industry companies as well as by perfect collaboration with Normed Verlag, Bad Homburg.
The OMED nomenclature aims at being a possibly complete list of terms used in digestive endoscopy organized in a hierarchical system and provided by definitions and diagnostic criteria. Being such it should represent a fundamental database. For practical purposes this exhaustive list can be tailored to suit different computer programs, e.g. Minimal Standards for a computerized endoscopic database (6) facilitating a correct formulation of endoscopic records. Customized databases of this kind, however, should use the standardized nomenclature and should not depart from agreed categorization and terminology.

It has been a privilege to chair the OMED Terminology Committee for these 20 years and to see its achievements being accepted by the endoscopic community and further developed by the ESGE Committee for Minimal Standards for Tenninology and Documentation in Digestive Endoscopy.

REFERENCES

  1. ESGE News Letter No.11 (1978) p.7; No.15 (1989) p. 1,5; No. 17 (1983) p. 8; ESGE News- Acta Endoscop. 15 (1987) p. 5; 20 (1988) p. VI; Bulletin OMED III. (1986) p.13; V. (1994) p. 25; OMED News Letter No. 1 (1993) p. 21.
  2. Maratka Z. et al. Terminology, Definitions and Diagnostic Criteria in Digistive Endoscopy, Scandinavian Journal Gastroenterology 19 (1984) Suppl. 103, Normed Verlag, Bad Homburg. English 1984, 1989, 1994; German 1984, 1989; Italian 1986, 1989; Spanish 1986, 1994; Portuguese 1986, 1994; Czech 1989, French 1990; Russian 1996; Norwegian 1996; Brazilian 1995.
  3. Maratka Z. et al. Illustrated Terminology, Definitions and Diagnostic Criteria in Digestive Endoscopy, Normed Verlag, Bad Homburg, English 1992, French 1992, German 1993.
  4. Cosentino F. et al. 5 Videos OMED nomenclature. Normed Verlag, Bad Homburg. English; Italian; German; 1991.
  5. Maratka M., Armengol Mirò J.R. et al. Normedia-Gastro CD-ROM, Normed Verlag, Bad Homburg, 1996.
  6. Crespi M., Delvaux M., Schapiro M. et al. Minimal Standards for a Computerized Endoscopic Database, Am J Gastroenterol 89 (1994) p. 144-153, ESGE Committee for Minimal Standards for Terminology and Documentation in Digestive Endoscopy: Minimal Standard Terminology for Databases in Digestive Endoscopy, Normed Verlag, Bad Homburg, English 1995, Italian 1998.

Minimally Invasive Surgery Committee
Alberto Montori, Chairman (1994-1998)

THE IMPACT OF ENDOSCOPY
ON DIGESTIVE SURGERY

Having been trained as a surgeon in the so-called pre-endoscopic era, I have no doubt that the impact of endoscopy on digestive surgery has been tremendous. In an attempt to identify and analyse the key points of such tremendous impact, I draw my readers’ attention to three different aspects.
The importance of endoscopy in obtaining early diagnosis, its influence on clinical judgement and its role in surgery, by suggesting the most      appropriate surgical approach and technique through a correct diagnosis of the lesion.
 The contribution of digestive endoscopy to a better knowledge of the pathophysiology of several gastrointestinal diseases with enormous consequent benefit in the surgical decision-making process.
The host of therapeutic applications which have become more and more widespread and sophisticated and which have arisen because of the direct visual inspection that endoscopy allows.
Therapeutic endoscopy has perhaps had the most visible impact in terms of reducing morbidity and mortality in the emergency as well as in the high-risk patient. Its application and the consequent refinement of indications for surgery has also produced a reduction in the number of surgical operations performed and has shortened hospitalization periods, thus producing a reduction in the cost of management of surgical patients.
In my opinion, endoscopy has also had an impact on the evolution of digestive surgery. In fact, the same principles of flexible endoscopy have inspired the diffusion of "minimal access surgery" via laparoscopy, which represents a great progress in gastrointestinal surgery.
On the basis of these brief observations, I recommend that gastrointestinal endoscopy be considered a complementary aid to surgery and not a contrasting technique. It has led to a multidisciplinary approach to the gastroenterological patient and to a better co-operation between physicians and surgeons.

FIRST CLINICAL APPLICATIONS IN TELESURGERY
PRESENTED AT 6TH WORLD CONGRESS OF ENDOSCOPIC
SURGERY IN ROME, JUNE 1998

Based on recent scientific and clinical experience of the first applications in telesurgery, the 6th World Congress of Endoscopic Surgery in Rome added two special sessions to include presentations by Professor Guy-Bernard Cadiere, of St. Pierre Hospital in Belgium, and Doctor Anno Diegeler, of the Leipzig Heart Center in Germany. These two surgeons were invited to present their initial results and experience using the Intuitive computer-enhanced surgery system.
Professor Cadiere performed the world’s first computer-enhanced Nissen Fundoplication procedure and Doctor Diegeler and his team performed the world’s first videoscopic coronary artery bypass surgery.
The World Congress of Endoscopic Surgery provides a scientific forum in which to debate and exchange scientific experiences in the field of Minimally Invasive Surgery. While moving toward the next millennium, technologies such as this system will be one of the most significant advancements in endoscopy, helping to redefine minimally invasive surgery as we know it today.
Intuitive is developing a computer-enhanced minimally invasive surgery system that uses proprietary electronics, advanced robotics, and enhanced visualization to greatly improve surgical technique and take surgical precision far beyond what is possible today.
The system is a new surgical technology intended to eliminate the major obstacles to widespread adoption of Minimally Invasive Surgery. It is designed to transform a broad range of open procedures to Minimally Invasive Procedures by making MIS more precise and easier to perform.
Using state-of-the-art computing, sophisticated software and highly-specialized micro-surgical instruments, this system combines the natural hand movements used in traditional open surgery, with the less traumatic approach of Minimally Invasive Surgery – thereby delivering the best of both techniques.
Using this system, surgeons will perform procedures seated at the console while viewing a high-resolution 3-D video image of the surgical field.
The surgeon’s hands rest below the monitor and hold instruments that provide the flexibility of those used in open surgery. Highly-specialized technology simultaneous transfers the surgeon’s exact hand movements made at the console to precise microsurgical movements of the instruments at the operative site.
With this remote control it is nowadays possible to operate with precision and these surgical procedures can be done based on scientific and clinical experience of the application in telesurgery.

ULTRACISION – THE ARMONIC SCALPEL

As we know, electrosurgical units are more often based on monopolar energy sources which transmit the electrical power to the patient by means of a metallic pad placed on the skin. Once the surgeon activates the unit, a flow of electrical energy passes through the patient tissues and, according to the frequency and intensity, cauterisation or cutting is obtained.
Complications from the diffusion of energy to healthy structures or skin burns are frequently reported. Armonic dissection is a totally different approach to obtain sectioning of tissue and simultaneous hemostasis with no risks of inadvertent injury to the surrounding structures.
The Ultracision – Armonic Scalpel is composed by a current generator connected to a piezoelectric transducer which is located inside the handle used by the surgeon. The transducer transforms the electric power into mechanic energy, then transferred to a blade. The blade vibrates linerly for a distance varying between 50 and 100 microns at a frequency of about 55,000 times per second. The blade is incorporated in a mechanism in the shape of scissors. Only tissues incorporated by the surgeons between the two blades undergo the mechanical dissection energy. Low temperature heath is generated, which contributes to vessel coagulation without carbonisation of tissue, a normal effect of most monopolar electrosurgical units.
Therefore, Armonic Dissection and Ultracision guarantee one of the most precise and less invasive dissection methods available today provided by Ethicon Endo-Surgery a Johnson & Johnson Company.

OMED POSTGRADUATE COURSE ORGANIZED
WITHIN THE 6th WORLD CONGRESS OF ENDOSCOPIC SURGERY Rome, JUNE 1998

The Postgraduate Course was organized under the auspices of the OMED, the EAES and the SAGES. The coordinators were J.R. Armengol Mirò, M.D. and M. Crespi, M.D. for OMED, Sir A. Cuschieri, M.D. and J.J. Jakimowicz, M.D. for EAES and J. Ponsky, M.D. and G. Van Stiegman, M.D. for SAGES
This interesting and successful Course was followed by 322 participants for 10 hours a day.
This Postgraduate Course with live interactive demonstrations (16 patients operated in 2 days) with Satellite connection with the Auditoruim of Alitalia where the Nurses’ Seminar took place and with the Hospitals in Milan and Taranto.
The Postgraduate Course was dedicated to "Diagnostic and Interventional Flexible Endoscopy; Interventional Radiology and Endoscopic Surgery: Competing, Complementary, Combined?". The contribution and participation of about 40 specialists in the different minimally invasive methods has brought up the possibility of managing patients through a cooperative efforts. When involved in the management of patients, only the knowledge of the possibilities and limits of each diagnostic and therapeutic approach makes it possible to achieve the best outcome with the lowest morbidity and costs. The Postgraduate Course has been focused mainly on all management options of digestive diseases of surgical interest, including interventional radiology and flexible endoscopy, with updating of all new-coming technologies, from the ultimate imaging technologies to the future role of telerobotics and virtual reality. The technological evolution has been indicated as the path for future wider and wider application of the principles of Minimally Invasive Surgery.

Nonetheless, technology has not been the only commitment of the Course, where special regard has been given to the study and treatment of pre-cancerous lesions, early cancers and other malignancies. Therefore, at the end of the Course, the new profile for the Surgeons of the 3rd millennium has been drawn: an expert in sophisticated technology; good hand skills but also deep cultural roots.

Ethics Committee
Endoscopy and ethics, May 1996

ENDOSCOPY AND ETHICS, MAY 1996

Hippocrate’s Oath has been considered as the physicians’ legal and moral code in the whole world for twenty two centuries.
The Code of Nuremberg defines the conditions in which experiments on human subjects may be authorited. The difterent Ethics Committees, and more recently, Laws about Bio-Ethics attest of the fundamental questions that science and medical technics improvements bring, modifying continuously what gives the worth to life and death to Human being Endoscopy in Gastroenterology, and the permanent development of its diagnostic and therapeutic possibilities, raise new questioning about medical power and medical know how.
Concerning this invasive procedure, Ethics defines collective rules of "logic" and "good practice" that can’t be limited in their dimensions by an individual choice.
These measures allow to establish some rules of conduct we must respect to avoid drifts regarding the patient and the technique.

Even if these basic principles seem obvious and established, to ensure patient’s security ancl cornfolt before, during and after intervention.

ETHICS COMMITTEE REPORT

Among the activities of the Committee, is the publication of the book "Medical Ethics in Gastroenterology and Digestive Endoscopy: changing concepts in a changing world" Editor J. Escourrou, with articles from N Antaki (Syria), Ben Khelifa
- A. Kilani (Tunisie), M.A. Latorzeff - J. Escourrou (France), J. Campos (Colombia), F. Villardell (Spain), M.C. Milano (Argentina), J.H. Solhaug (Norway), B.H. Novis (Israel), C. Francesconi (Brazil) - C. Stanciu (Romania).
The passionate and competent work of Professor Escourrou during his chairmanship of the OMED Ethics Committee has produced a booklet which will be, for several years, a reference text for gastroenterologists and endoscopists. This book is distributed at the World Congress in Vienna and is available through the OMED Secretariat.

In a changing medical world, characterized by an increasing confrontation with administrative rules, budget restrictions, litigations, but also with a decrease of compassion and distorted human relationships, the doctors are confronted too often with difficult and sometimes painful decisions. This publication, which faces these problems from different points of view, will refresh to all of us our duties and obligations and give us the opportunity to stop for a while and ask ourselves: where we are?
We may be proud that Professor Jean Escourrou and his co-authors, under the auspices of OMED, were able to produce such a valuable reference work.

Medical Ethics, Gastroenterology and Digestive Endoscopy : changing concepts in a changing world

Editor Prof. Jean Escourrou, Chairman of the OMED Ethics Committee
An OMED Newsletter Publication
Editor: Prof. Alberto Montori
Co-Editor: Prof. Massimo Crespi
Rome, Italy 1998

The passionate and competent work of Professor Escourrou during his chairmanship of the OMED Ethics Committee has produced the present booklet which will be, for several years, a reference text for gastroenterologists and endoscopists.
In a changing medical world, characterized by an increasing confrontation with administrative rules, budget restrictions, litigations, but also with a decrease of compassion and distorted human relationships, the doctors are confronted too often with difficult and sometimes painful decisions. This publication, which faces these problems from different points of view, will refresh to all of us our duties and obligations and give us the opportunity to stop for a while and ask ourselves: where we are?

I am proud that Professor Jean Escourrou and his co-authors, under the auspices of OMED, were able to produce such a valuable reference work. Thank you Jean, thank you all.

Professor Massimo Crespi President OMED

FOREWORD
Sir Thomas Percival was the first to recognize the necessity of collective thought on the development of new medical procedures back in 1803. The first " Ethical code " concerning research on human beings was developed after the Nuremberg trial, and has since been completed at different meetings.

As Greenberger said, Ethics is a domain of truth or error, where intelligent and sensitive people can sincerely differ. Indeed, countries can have a different conception of Ethics according to the different social values and/or religions in a given society. This concept is constantly questioned due to progress in the fields of biology and medicine. It is not uniform or static, and doesn’t concern medicine alone. Contrary to morals which are based on individual conscience, the notion of ethics is decided on, is arbitrary and must correspond to a collectif consensus ;
In this work, the reader will find the reflections of authors from different countries on existing ethical relationships in numerous fields. Thus, N. Antaki (Allepo, Syria) has analysed particularly well the link between ethics - the goal of which is the common well - being, and morals, which correspond to personal obligations. Habib Ben Khalifa (Tunis) has developed the duties of the gastroenterologist, especially as regards the need to follow the procedure according to the rules, yet respecting the ethical aspect. From this point of view informed consent is the basis of the respect of the patient. The evolution of means of communication and data-processing mean that new problems concerning the respect of the medical secret have arisen. These two aspects have been particularly well analysed by J. Campos (Bogota) and F. Villardell (Barcelona). The limitation of financial means generates a real conflict when it comes to respecting ethics. The same is true for ethics and scientific progress, dealt with by Claudia Milano (Buenos -Aires) and J. Solhaug (Oslo) Numerous practical elements concerning Helicobacter Pylori are illustrated in the chapter by B. Novis (Tel-Aviv). Finally I would like to thank C. Stanciu (Roumania) President of the Ethical Committee of the WGO (World Gastoenterological Organization) together with Carlos Francisconi (Porto Alegre, Brasil) for having dealt with the responsibilities of Ethical Committees when faced with the different problems that transgress this notion. This notion of ethics that requires each thing and every act to be in the right place. This book should enable physicians in general, and gastroenterologists in particular, to exerce their activity whilst respecting restraints and the four basic principles which are the very backbone of Ethics : -the respect of the invidivual, -the respect of knowledge, -the responsability of the researcher and -the refusal of profit.

Jean Escourrou, France

AUTHORS

ANTAKI Nabil MD. President of the endoscopy section of the Syrian Society of Gastroenterology,
PO BOX 6448 Aleppo - SYRIA

BEN KHELIFA Habib MD. Gastroenterology Unit – Hopital Habib Thameur Tunis - TUNISIA

CAMPOS Jaime M.D. Associate Professor, Dean,Faculty of Medicine. National University of Colombia
Bogota - COLOMBIA

ESCOURROU Jean M.D. Professor of Hepatogastroenterology, University Hospital Rangueil
31403 Toulouse - FRANCE

FRANCISCONI Carlos M.D., FACG, Chief, Gastroenterology Division, Hospital de Clínicas de Porto Alegre,
BRAZIL

KILANI A. MD. Gastroenterology Unit – Hopital Habib Thameur, Tunis - TUNISIA

LATORZEFF Marie Ange MD. Hospital LA GRAVE,Toulouse - FRANCE

MILANO Claudia, M.D. Specialist in Gastroenterology.Specialist in Clinical Oncology.
Hospital Nacional Profesor Alejandro Posadas, Buenos Aires - ARGENTINA.

NOVIS B.H. MD. Meir Hospital, Kfar Saba and the Sackler School of Medicine, Tel Aviv University
ISRAEL

SOLHAUG Jan Helge M.D. Dept of Surgery, Diakonhjemmets Sykehus, Oslo - NORWAY

STANCIU Carol, MD. University Hospital " St. Spiridon " Iind Medical Clinic Gastroenterology B-dul Independentei 6600 Iasi - ROMANIA

VILLARDELL Francisco, MD DSc FRCP FACP Postgraduate School of Gastroenterology,
Autonomous University, Hospital Sant Pau Barcelona - SPAIN

CONTENT


ETHICS AND RELIGION
N. Antaki
1
DUTIES OF THE ENDOSCOPIST
Ben Khelifa - A. Kilani
6
DOCTRINE OF INFORMED CONSENT
M.A. Latorzeff - J. Escourrou
18
ETHICS AND MEDIA
Campos
23
ETHICS, ENDOSCOPY AND COMPUTERS
Villardell
29
ETHICS AND MONEY
A view of ethics, money and collective resources.
M.C. Milano
40
ENDOSCOPY AND CLINICAL TRIALS
J.H. Solhaug
47
HELICOBACTER PYLORI DIAGNOSTIC AND THERAPEUTIC
MEASURES : ETHICAL ASPECTS
B.H. Novis
60
BIOETHICS COMMITTEES
C. Francesconi - C. Stanciu
66

ETHICS AND RELIGION

N. ANTAKI

Ethics and Morals have etymologically the same meaning, Ethics stemming from the Greek ethos and morals from the Latin adjective moralis (1). But, in reality, these two words convey two different concepts. For a long time, morals, defining the good and the bad, were used as a reference, as a rule of conduct for science which had to abstain from everything that was morally bad. It can be of religious or philosophical inspiration. Religious morals, taking its roots in faith, doctrine, sacred texts and tradition, can differ according to the different religions; this is why there are several religious morals as opposed to just one. For the catholic religion, for example, moral conscience urges to love, to call upon the good and avoid the bad (2). It prescribes to man the ways and rules of conduct leading to the promised beatitude (3). Morals takes its roots in the faith that man was created as the image of God, and that God made the total gift of himself in Jesus his son; this faith is the basis of catholic moral precepts which respect life and human dignity.
Morals concerns what "should be" as opposed to "what is". It is defined by four essential lines (4-5): inwardness: which calls upon one's own conviction, one's own implication. It is not a simple exterior conformity.
Idealism: Morals is demanding, it suggests an ideal, it leads to a better self. It even demands heroism in certain cases.
Universality: its precepts and authority extend to all men.

Immutability: it is permanent whatever the changes in history. But with the passing of centuries, societies no longer had in common à unanimous religious tradition nor a belief in the universality of moral faith inscribed in the heart of human nature, which replaced it since the age of enlightenment. we cannot assume that we all have the same concept of what is good.

Medical ethics were born because, on the one hand, the world and societies became pluralists and one cannot impose à specific moral to all. We have been lead to tolerate, for moral reasons, what we sometimes ourselves condemn for moral reasons (6); and on the other hand because religious morals have sometimes been unable to face new situations in the biomedical field.
It was attempted to set up the rules of common morals, named ethics, applicable to all, ranging from the texts of the Human Rights to the rules established in Nuremberg and in Helsinki. Then the legislator intervened by voting the bioethic laws.
These ethics are the putting into practice of principles of different origins and place themselves downstream from morals. Instead of being à moral of conviction (religious) it has become a moral of compromise (7). For some, it represents the smallest common denominator acceptable by all. For others, this compromise is meant to bring the different elements of society together on demanding issues (8)

Civil ethics have replaced, in the biomedical field, religious morals. If morals is defined by inwardness, idealism, universality and immutability, bioethics is on the contrary (9): pluralist = aiming to protect diversities.
minimalist = it is realistic. A law which is inapplicable is a bad law
exteriorized - it demands exterior obedience and does not care about personal feelings.
circumstantial = it addresses particular communities at a given time.

Bioethics presents itself as an alternative, although complementary, to indifference or the incapability of morals to establish a dialogue with the sciences of life (10). But it is admitted as evidence that ethical decisions are precarious and in a large measure arbitrary because they are the result of negotiations which can be challenged as new generations of speakers take part in the debate (11).
Religion and ethics meet on many issues. They can nevertheless diverge on important matters such as voluntary interruption of pregnancy, contraception, in vitro fertilization ... In gastroenterology and in digestive endoscopy, ethics and religions have identical positions on many issues.

Ethics and religion in gastroenterology
Many issues in the practice of gastroenterology and digestive endoscopy raise ethical problems such as organ transplants, blood transfusion, medical responsibility, clinical research and experimentation on humans, euthanasia and informed consent. 0n many of these issues, the different religions have a similar approach and a similar attitude. The religious approach considers that issues relating to the respect of the human being, its integrity and life cannot be resolved by simple reference to conscience, be it common or universal, but by reference to Faith, doctrine and sacred texts.
As far as the position of the different religions on gastroenterology ethics is concerned, it varies according to the problems. The different religions are unanimous in allowing clinical research and experimentation on man as long as they do not represent a threat to the life or health of the volunteer, that he has given his free and informed consent and that their aims are therapeutic.

They are unanimous in prohibiting active euthanasia as nobody has the right to take away life even if the person concerned is in a vegetative state of life, because as stipulated in the Jewish Theology, a fraction of infinity stays infinity (12). If there are controversies on passive euthanasia, all religions nevertheless agree not to confuse the maintenance of life and therapeutic relentlessness.
Informed consent and medical responsibility also make unanimity and medical ethics meet the morals of the different religions on these issues. Blood transfusion is acceptable and even desirable for all religions except, for Jehovah’s witnesses (13-16). Even in 1927, well before the perfecting of transfusion techniques, Jehovah’s witnesses explained that according to the Alliance concluded between Jehovah and Humanity, no blood should be consumed in order to respect the sacred character of life. Based on this doctrine they quoted the formal command given by God to Noah: "Everything that moves and has life will be your nourishment. But you will not eat flesh with its soul, that is to say blood. You will be answerable to me for your blood " (GN 9:3 . 5). According to them, this ban was permanent and involved all those wanting to remain faithful to the Alliance. It is for Jehovah’s witnesses a fundamental belief, à conviction with profound implications as it touches their eternal salvation.

During the decades following the declaration of these principles by their religious leaders, the witnesses have remained attached to the belief that one cannot accept blood even in life-threatening situations. They have rejected most of the new techniques refusing not only total blood but also red cells concentrates, plasma, white blood cells and platelets.

However there are a few methods on which their position is not as clear. It is the case of albumin, immunoglobulins, and preparation for hemophiliacs. Laws and jurisprudence are currently clear enough to allow Jehovah’s witnesses to refuse transfusions and to clear hospitals and doctors of their responsibility. The position is clear and without ambiguity: the patient’s will must be respected on condition that it is freely expressed. The discovery of the hepatic virus .B, C and G and the ravages of Aids have given more arguments to those who reprove transfusion against somebody's will, transfusion not being as safe as doctors once thought. Refusal of transfusion can go against the personal morals of the doctor, telling him to do everything to preserve the life and health of his patient, but bioethics bases itself on the immutable principle of respecting the wish of the person who has the right to refuse a treatment even at the cost of his life.

Let us now talk about organ transplants. Religious morals and medical ethics admit that transplants should be a gift, clear, free and anonymous. In addition, most religions have in common (17):
- The respect of the wishes of the deceased.
- The certainty of the irreversible character of death.
- The respect of the appearance of the corpse.
Unanimously a preliminary consent is requested from the donor (free consent and revocable at any time), that the gift is free, based on the principle of the non patrimoniality of the human-body (free, anonymous and non- patentability of the body and its parts) (18). In addition, they proclaim that transplants should only be carried out with the therapeutic aim to save a human life and not to experiment.
On all these points, the Catholic, 0rthodox, Protestant, Muslim, Buddhist and part of Judaism religions agree. 0n the other hand, Hinduism and Shintoism are against transplants, this is why there are virtually no hepatic transplants in Japan except from partial transplants from live donors (19-23). The problem lies with the criteria of the definition of death. For the above mentioned religions and for ethics, the death criteria is cerebral death, which allows the taking of viable organs. 0n the other hand, for Islam, the death criteria is not the cerebral death, but the definitive stopping of the heart (24), therefore making it impracticable to transplant from dead donors. But a progressive tendency (rejected by the strict Islam) accepts, since the Amman Conference of 1986, cerebral death as an alternative to the definitive stopping of theheart in the definition of death.
For strict Judaism, death is defined as the simultaneous abolition, total and irreversible, of the respiratory, cardiac and neurologic functions, making transplants impossible. But the favorable tendency towards transplants has increased thanks to two ideas (25):

- The kidney taken and transplanted is alive again due to the transplant and therefore outside the laws on the respect of the body.
- The transplant aims at saving the life of the receiver and it prevails on all the interdictions of the Torah.

Remains the problem of the consent. If the informed, clear and revocable consent is an essential condition for all religions, two divergent points emerge:

- For Islam, even if a donor has given his consent while still alive, it is the right of his heirs to dispose of his body after his death. They can annul the consent given and refuse the organ donation expressed by the deceased (26). On the other hand, to increase the number of organs to be transplanted, some laws no longer request a clear or active consent and accept a presumed consent, i.e. the non-refusal of transplant by the donor while still alive.
As far as organ transplants from a live donor are concerned (partial liver), religions and ethics accept this as long as there are no other alternatives and if there is no negative impact on the life or health of the donor and if the consent is given freely (quid psychological pressure on a parent donor to his child?).
Finally we are heading for the concept of the death of the Brainstem as opposed to cerebral death.

REFERENCES:

  1. GOLD F,, Ethique, éthique medical, bioéthique. Repères et situation
    éthiques en médecine. Ellipses, 1996. 10-18.
  2. GAUDIUM et SPES, Ch, 16, Concile Vatican II
  3. CATECHISME DE L'EGLISE CATHOLIQUE, Mame/Pl on, 1992;405
  4. CATECHISME DE L'EGLISE CATHOLIQUE, Mame/Plon, 1992;406-407
  5. DURANT G La bioéthique, méthodes et fondement, Les cahiers scientifiques,
    Montréal, ACFAS, 1989; p.87-96
  6. FAGOT.LARGEAULT A., La réflexion philosophique en bioéthique. Les fondements de la bioéthique, De Boeck, Université, 1992, p, 11-26
  7. GOLD F., Ethique, éthique médicale, bioéthique. Repères et situations
    éthiques en médecine. Ellipses, 1996,p,10-18
  8. GOLD F., Idem
  9. DURANT G Ethique, droit et régulation alternative. Les fondements de la
    bioéthique, De Boech Université, 1992, p.63-75
  10. DOUCET H., la contribution du théologien en bioéthique. Les fondements de la
    bioéthique. De Boech Université, 1992, p.49-62
  11. FAGOT.LARGEAULT A., La réflexion philosophique en bioéthique, Les cahiers
    scientifiques, Montréal, ACFAS, 1989, p. 3-16
  12. GUEDJ P; La recherche médicale dans le Judaïsme, la lettre de RAMBAM, Medica Judaica 23:11
  13. DEVINE R., Save the Body-Lose the Soul; Health Progress, June 1989
  14. THOMAS J.M. Meeting the surgical and ethical challenge presented by Jehovah's
    Witnesses, Canadian medical association journal, vol 128 1153-1154, 1983
  15. GARAY A., GONI P., La valeur juridique de l'attestation de refus de
    transfusion sanguine. Les petites Affiches, N 97, p.14-18, 1993
  16. JAMA, vol. 246,2471-2472, 1981
  17. JACOB I., prélèvements d'organes, Revivre, N° 54, 1992
  18. Loi N 94-654 du 29 Juillet 1994, le dictionnaire permanent Bioéthique e
    Biotechnologies, Editions législatives.
  19. KREIS H., Ethique et transplantation, Administration numéro spécial,
    p;37-49, 1997
  20. VERSPIEREN P. Transplantation et catholicisme, Administration numéro spécial p.51-53, 1997
  21. BOUBAKEUR D., l'Islam et la transplantation, Administration numéro spécial,
    p.57-60, 1997
  22. BOTBOL E., Ethique Juive et transplantation d'organes, Administration numéro
    spécial, p.61-64, 1997
  23. ABEL 0., l'éthique protestante, Administration numéro spécial p.65-66, 1997
  24. .ALBOUTI S.R., kadaya fikhiye mouassira, edition Farabi-Damas p.128-131,1994
  25. NAJMAN A., Greffes d'organes, une éthique de la décision, la lettre de RAMBAM, Médica Judaica N° 20, p.11-13
  26. ALBOUTI S.R., kadaya fikhiye mouassira, edition Farabi.Damas p.132, 1994
  27. THOUVENIN D., Les règles juridiques organisant l'activité de transplantation
  28. d'organes, Administration p.29-36, 1997

DUTIES OF THE ENDOSCOPIST
H. BEN KHELIFA, A. KILANI

INTRODUCTION 
PRIMUM NON NOCERE
Gastro intestinal endoscopy (G.I) is neither infallible nor absolutely safe, and thus becomes a subject of medical ethics which rely on 2 principles (1) :
1/Autonomy of the endoscopist,
2/Beneficence, nonmaleficence and justice for the patient.
The endoscopist must always consider the patient’s best interest and keep in mind that diagnostic and therapeutic safety are foremost, and that endoscopy is not solely guiding the endoscope. So, the duties of the endoscopist play in 3 ways :

  1. He must be competent
  2. The endoscopy unit must be properly organized
  3. The examination must be assessed with standards of care and
    quality assurance.

COMPETENCE OF THE ENDOSCOPIST
Competence in endoscopy assumes a combination of technical and cognitive skills, and requires correct interpretation of abnormal findings. In most countries the proper background is considered to be a formal postgraduate training in gastroenterology.

a)Training :The trainee must learn when endoscopy is indicated
(2 , 3 ) , how to reduce the possible danger of a false diagnosis, and of an iatrogenic lesion,  and how to use endoscopically derived informations in clinical practice ( 4 ). An ethical problem arises in teaching endoscopy (8). The welfare of the patient must always be ensured , so that he is never endangered or exposed to excessive discomfort by the teaching process.
b) Maintaining competency in endoscopic skills is mandatory ,and so, the learning process does not stop at the end of the training period, but should be an ongoing educational process (6-7-8). It is imperative that the endoscopist documents his continuing education effort in the rapidly developing field of GI endoscopy. Self training must occur on a background of basic endoscopic skills , and each endoscopist must assess when additional formal training is necessary before undertaking a new kind of endoscopic procedure (6).

THE ENDOSCOPY UNIT
The endoscopy unit should be properly designed and establish guidelines to render the examination efficient and safe (1O) with :

  1. Room, allowing ideally the endoscopic examination of upper gastrointestinal tract separated from the examination of the distal gastrointestinal tract ( 11 ).
  2. Furnishings and fittings : Examination table, storage space for accessories, sufficient endoscopes, electrocautery devices etc...
  3. Cleaning and disinfection area with good standards.
  4. Radiography room, when procedures utilizing radiological equipment are
    performed.
  5. Preparation and recovery room with cardiopulmonary resuscitation
    equipment for emergency cases.
  6. Photodocumentation of pertinent findings.
  7. If endoscopic procedures are performed in the outpatient or office setting, standards similar to those of the hospital endoscopy unit must be maintained. The one described above is an ideal setting and there is today the need to improve the existing services at least to that standard.

PREPROCEDURAL ASSESSMENT

  1. CONSULTATION : is a very important step during which the endoscopist should :
    document information related to the patient’s history, physical
    examination, relevant X-ray and laboratory data.
    evaluate clearly indication of endoscopy : this point is very
    important.
    inquire about the current medications, and drugs allergy of the patient,
    determine risk of the procedure to optimally manage problems related to pre-existing medical condition, and to allow appropriate post procedural care in the event of any adverse reaction.
    This kind of approach has to be tailored to the level of education of the patient and to the standards of medical practice within the individual country. 
  2. INFORMED CONSENT 
    The performance of endoscopy must take into account both the patient’s autonomy and the question of fairness in the patient-doctor relationship (12 ). With respect to autonomy, the patient has always the right to refuse endoscopy . But gastroenterologists have not only an ethical and moral duty to obtain informed consent prior to procedures, but a legal one as well. It is an absolute precondition of therapeutic endoscopy, or endoscopy for research purposes ( 13, 14 ). The endoscopist should be certain to explain the procedure to the patient, including what will occur before, during, and after it is completed. The nature of the procedure should be described, the benefits outlined, the risks and complications must be detailed . All reasonable alternatives to the proposed procedure should be presented. The informed consent gives a good opportunity to communicate with the patient and to develop mutual respect. The endoscopist must be mindful of the fact that informed consent is a process of disclosure and deliberations, not merely the signing of a form.
    Exceptions to informed consent are (13) emergency, incompetence, therapeutic privilege, waiver and legal mandate .
    Consents in offices are as important as those obtained in hospitals. It is best to have consent witnessed.
  3. WRITTEN INFORMATION AND PSYCHOLOGICAL ASPECTS OF G.I
    ENDOSCOPY.
    The use of written information ( 16 ) is a useful supplement to personal instructions and advice given by the doctor or nurse prior to the procedure but is not a substitute for the physician-patient interaction. Patient input is pivotal in designing patient - directed information material.
    Psychological techniques ( 15 ) can also be used to assist patients in coping with the stress of endoscopy by providing a variety of strategies , including the provision of information, relaxation, cognitive-behaviour approaches and modelling. Being treated as a whole person and not just a subject for investigation makes a major contribution to satisfactory procedure.
  1. EXAMINATION STANDARDS OF CARE
    These define the responsibilities that a physician gastroenterologist who performs endoscopy must fulfil in the care of any patient. The level of care required is that which a reasonable and prudent physician should deliver in the management of any patient, including the following :

a) Endoscopic competence of the endoscopist and his staff and appropriate endoscopy suite. These problems were discussed above.
b) Infection control,
c) Sedation and monitoring ,
d) Personal and expanded duty ,
e) Endoscopic complications, claims and risk management ,
f) Quality assurance.

  1. INFECTION CONTROL :
    Infection during the endoscopic procedure is possible in certain situations for the patient or the personnel at risk, and requires that standards of prevention be followed. Infection can be transmitted by means of inadequately cleaned endoscopes, contaminated water bottles and irrigating solutions, improper use of inadequately designed automatic endoscope washing machines, use of substandard disinfectant solutions, and inadequate drying of the endoscope channels prior to overnight storage ( 17,18 ,19).

The endoscopic devices must be considered semi-critical material and should therefore be sterilized or at least receive high level disinfection. Liquid chemical agents are used almost exclusively for disinfection. Several alternative preparations are recommended  : Of these glutaraldehyde at 2 % concentration is the disinfectant most used and recommended as a first choice in various International guidelines (2O). The disinfection of accessories must be of a high level. The re-use of accessories labelled " for single use only " as a potential means to reduce costs has not been carefully evaluated, but should be allowed only if disinfection is effective (22).
A recent study was reported about the use of acidic electrolytic water potency for endoscope disinfection, safety for the tissues of the subject, and low cost (19 ).
As regards the time of contact between the disinfectant and the endoscope, not less than 1O minutes are recommended. Mechanical cleaning is the first and most important step, followed by high-level disinfection .The protection of the personnel is also important. Standards to prevent contact with infectious blood or body fluids must be maintained. Recent document on disinfection has been published on behalf of the ESGE (19).
Prophylactic antibiotics are recommended by ASGE (21) in patients with prothetic valves and surgically constructed systemic pulmonary shunts. For the British Society of Gastroenterology (16), it is also recommended when the patient is at a high risk of endocarditis, or of symptomatic bacteraemia as a consequence of immunosuppression or neutropenia. In most circumstances, parenteral Amoxicillline and Gentamycin are recommended. The addition of Metronidazole is needed in patients with neutropenia. Antibiotics prophlaxis is also recommended for all patients undergoing ERCP with evidence of biliary stasis or pancreatic pseudo-cyst ( 22 ).

  1. ENDOSCOPIC SEDATION AND MONITORING
    The goal of preparation for all endoscopic procedures should be to make a safe, comfortable, accurate and complete examination. A reassuring confident attitude on the part of the examiner and technical assistants and a calm, educated and motivated patient contribute to an optimal examination.

a) Sedation : consists in reducing the level of consciousness induced by medications used to facilitate acceptance of endoscopic procedures and to increase the comfort and safety of the examination (2). Benzodiazepines are the most commonly used agents in endoscopy and the most frequently prescribed drugs are Diazepam and Midozolam. Analgesia is almost associated, induced by the use of medications primarily opiates. Intravenous sedation is certainly worth recommending, especially for therapeutic endoscopic procedures ; however, it has been clearly shown that it carries significant risks ( 26, 33).
b) Monitoring : ( 27,29) is mandatory and prudent, and consists in the continuous assessment of the patient’s status, before, during, and after the administration of sedatives. It improves the outcome, by decreasing the risks of sedation and of the procedure, and should detect early signs of patient distress, before compromise to vital functions occurs. Most endoscopists are currently employing electronic monitoring equipment , but the best monitors of a patient’s safety are the physicians and skilled assistants working as a team. Nothing replaces clinical assessment, and it is important to underline that the ultimate responsibility for protecting patients lies with the endoscopist and cannot be assigned to an assistant or an electronic monitoring device.
However, both may greatly improve the ability to detect patient distress in time , when intervention will prevent an otherwise adverse outcome.
Emergency assistance, as well as transport to local intensive care units should be readily available. Whenever possible and appropriate the cooperation of an anesthesiologist will avoid a lot of problems and reduce the responsibilities of the endoscopist .
c) Standard clinical monitoring should include heart rate, blood pressure and respiratory rate, before sedation, during the procedure and immediately after , as well as before discharge from the recovery area. Oxymetry is useful for detecting decrease in oxygen saturation which usually carries little clinical risk. Continuous electrocardiographic rhythm is also used. Devices are now available to monitor all these parameters.
d) Out patient and sedation :
The standard practice as documented by multiple surveys ( 25, 27) is to carry out digestive endoscopy as a routine on an outpatient basis. It is also important to note that one half of the world regards upper G.I endoscopy without sedation as being the norm , and some authors suggest that endoscopy without sedation should be encouraged for routine examinations ( 32). The safety aspects point strongly to increased use of topical pharyngeal anesthesia and the reduction in the use of sedation ( 24). The use of throat spray for diagnostic endoscopy is quite acceptable to patients in routine diagnostic uppergastrointestinal endoscopy as it improves tolerance and facilitates examination (28, 29).
In fact, the vast majority of endoscopic procedures can be performed without sedation ( 32).

  1. PRACTICE AND DUTIE
  1. PERSONAL DUTIES
    The physician-patient relationship is usually entered into implicitly and consensually. The endoscopist has to be diligent with his patient, and to do the procedure with consciousness, prudence, and in accordance with the endoscopic standards of care. But it is imperative to know when his duty begins and ends and to be clear as to his role in the management of the patient.
  2. EXPANDED DUTY
    The physician endoscopist must be aware that as his role expands, so do his duties and legal responsibilities, because he assumes several roles which may lead to vicarious liability, which is the extension of liability from a party who is negligent to a second party who has had nothing to do with the negligent act ( 34 ). Vicarious liability from the wrongs of others, must be considered, but varies with the physician’s level of involvement in the care of each patient (34) :
    - As a consultant , it is the duty of the endoscopist to define whether he or the referring physician will be responsible for reevaluating the patient at a later date.
    - As a teacher,  he is responsible not only for his own negligent acts, but for those of his trainees.
    - As an employer, he may be liable for the mistakes of his personnel, and he has to demand a definitive level of professional behaviour from his employees.
    - As an administrator, he has duty to the patients who receive care in his unit, and the endoscopic practice must be within reasonable standards of care. This includes not only the level of endoscopic physician practice, but also that of the unit itself.
  3. PATIENT SURVEILLANCE :
    Screening of patients for potential medical problems is the duty of each physician, which will be limited or expanded, dependent upon the physician’s role in each patient’s health care. In the area of gastrointestinal disease, the majority of the guidelines published pertained to cancer detection and follow-up.
    If the physician endoscopist functions as the patient’s primary care physician, it is his duty to initiate early detection of cancer in asymptomatic people, and also to monitor surveillance of premalignant lesions of the upper G.I tract, colonic polyps, and colorectal cancer ( 33, 34 ). It is the duty of the physician to be familiar with the recommendations of the G.I Societies and to discuss these with his patient and document that discussion
  1. ENDOSCOPIC COMPLICATIONS, CLAIMS AND RISK
    MANAGEMENT
  1. COMPLICATIONS and bad results can and do occur in the normal course of endoscopy ( 41, 42, 43) It is acceptable to experience a complication which has nothing to do with the ( worth (  of the endoscopist. Several authors have attempted to establish the definition of complications and negative outcomes based on : life threating and residual disability ( 37 ) or on thresholds and grades ( 38 ).
    The complication rate of upper gastrointestinal endoscopy is about 0,1% , with cardiopulmonary events predominating. The typical complication of colonoscopy ,perforation, is seen in O, 2 %. The relevant ERCP specific complication is acute pancreatitis in about 1 %, followed by acute cholangitis ( 39, 4O ).
  2. ENDOSCOPIC CLAIMS : the risk of malpractice is real and unavoidable.
    Iatrogenic injury resulting from provider error is a common occurrence as the hospital care of medical and surgical patients. The rate is about 1 % : EGD and flexible sigmoidoscopy represent 8O % of the files, colonoscopy and pancreatobiliary procedures 1O % .The most common allegations associated with endoscopy are : improper performance (5O %) diagnostic error (25%), but perforation and post biopsy or post-polypectomy bleeding are the only endoscopic iatrogenic injury.
  3. RISK MANAGEMENT :
    consists in collecting and using data to minimize loss (443)
    Objectives are :

a) Define instances that place the endoscopist at risk
b) Determine the frequency and significance of these instances,
c) Apply risk treatment to individual cases,
d) Develop remedial and preventive measures.

There are several simple and easy risk techniques which can be incorporated into practice routine (47).

  1. Become familiar with the basics of tort law .
  2. Maintain a positive attitude in patient relationship.
  3. Clearly define the role and responsibility of the endoscopist
  4. Discuss fully complications which may or do occur
  5. Obtain written informed consent
  6. Document all aspects of the patient care
  7. Insure that the office staff is well-trained and interacts well with
    the patients.

The occurrence of complications is not malpractice per se, whereas the failure to make a timely diagnosis of the complication, may be. Documentation is the shield against malpractice claims.

  1. QUALITY ASSURANCE
    Designed to objectively and systematically monitor and evaluate the quality and appropriateness of care, pursue opportunities to improve patient care, and resolve identified problems, and must include   a plan that describes the programme’s objectives, organization, scope, and mechanisms for overseeing the effectiveness of monitoring, evaluation, and problem-solving activities.
    The major elements of a programme for quality assurance in G.I endoscopy are :
    Documentation with procedure reports, and endoscopic unit record. This includes the use of an appropriate terminology like the one defined by the OMED, and ESGE (3).
    Procedure review including :
    appropriateness of indications (45, 46 ), and absence of contra-indications. In any case an even wider statement of " reasons for " the procedure is advisable, possible, on precoded format (3).
    technical performance review.
  1. DOCUMENTATION :
  1. PREPROCEDURAL  : is mandatory and the most effective risk management tool available to the endoscopist once a medical malpractice issue arises. It should be complete, concise, and legal as discussed above.
  2. PROCEDURE REPORT : including patient identification, endoscopist, instrument and medications used (site, amount and time of administration) monitoring devices, anatomic extent of examination, tissue or fluid samples taken, findings, results of any therapeutic intervention, photographs or video-recorded if any, complications, diagnostic impression, recommendations, disposition and follow-up. Again it is important to comply with an agreed system, like the one acknowledged by ESGE (3).
  3. POST-PROCEDURE DOCUMENTATION : must record the patient’s vital signs. Follow-up instructions should be given to patient about driving, activity, medications. A contact emergency phone is also strongly advised.
  4. COMPLICATIONS : if one occurs, it should be documented in the record : what happened, how it happened, the patient’s response in terms of symptoms and vital signs, the actions taken by the endoscopist, and any further actions required.
  5. MAINTENANCE OF THE MEDICAL RECORD : confidentiality maintenance is the duty of the physician and his staff.
  1. PROCEDURE REVIEW
  1. INDICATION OF THE ENDOSCOPY :
    Will be discussed. Is endoscopy the best tool for diagnosis and therapy ? Independent judgement of the indication may lead to a decision against performing endoscopy. When the endoscopist hesitates about an indication he has to ask other colleagues and discuss with them the opportunity of the examination. The decision to perform a diagnostic procedure must take into account the probability and net benefit of identifying or discarding significant disease . In contrast the decision not to perform the procedure must evaluate among other elements, the risk of not detecting a significant disease. Ideally, the use of appropriateness criteria should result in improved patient outcomes as measured not only by morbidity and mortality, but also by quality of life, satisfaction, and drug requirements and in enhanced yield of endoscopic lesions ( 48 ).
    The appropriateness criteria such as those proposed by ASGE ( 49, 5O) do not, substantially enhance the yield of significant endoscopic diagnosis. Guidelines prepared for one community are not necessarily applicable to others. Differences in approach apply not just to geography, but to social class, age, ethic background,  medical education , local education, local referral patterns, the sophistication of local endoscopy services, the funds available for endoscopy, and patients expectations (51, 52, 53,). Other factors, such as patient outcome, are likely to become major determinants of medical care.
    The problem is different in developing countries. The informed consent is not always easy to obtain because of the frequently low education level of patients. The major problem is the gap between the small number of endoscopic units and available instruments, and the large number of procedures. On the other hand, it is evident that there also exists a manpower shortage, and endoscopic units are not always available. These problems amount to trying to " square the circle ".
  1. QUALITY OF TECHNICAL PERFORMANCE :

There is no simple definition of quality (1, 51). The purpose of standards and guidelines is to institute a more appropriate use of gastrointestinal endoscopy resulting in improved patient care which is a natural consequence of standards. Quality improvement in endoscopy directs attention to the procedure and the endoscopic unit. Endoscopic practice should be reviewed regularly by a committee of endoscopists. Individual physicians could also be reviewed on the management of cases falling outside  a predetermined " threshold ". Again a comprehensive and standardized documentation would provide information for in-depth evaluation of specific aspects of patient care related to endoscopy.

CONCLUSION
Diagnostic and therapeutic safety in endoscopy is foremost. This implies formal training and maintenance of competence of the endoscopist . The endoscopic unit should have guidelines, and be well organized. The procedure implies good standards of care, including a preprocedural consultation to document all information about patient and disease, to discuss the aim of the procedure, the benefits and the risks, and to obtain an informed consent which is the best risk management tool.
The risk of infection is real, and depends on cleaning and disinfection. Therefore, a high level of disinfection of the endoscopes is needed. The most critical part of cleaning is mechanical. Sedation with monitoring is an important part of the examination . The physicians and skilled assistants are the best monitors of the patient’s safety. The occurrence of complications is not malpractice per-se, whereas the failure to make a timely diagnosis of the complication, may be. Documentation is the shield against malpractice claims.
Evaluation of the examination performance is necessary to maintain, or even improve the quality of care. Testing the appropriateness of indications, and of the use of a specific examination or treatment is an integral part of the quality of medical care. Unfortunately, in the developing countries these problems must be considered in other terms, as related to the great number of examinations, the low number of endoscopes, manpower shortage and also to the absence of specific areas reserved for endoscopy.

BIBLIOGRAPHY

  1. Consensus in Endoscopy. Can J Gastroenterol 1996 ; 4 :237- 42.
  2. Statement on endoscopic training. Gastrointest endosc 1988 ;34 ,12s-13s.
  3. Maratka Z, Crespi M, Armengol Miro  JR: Minimal standard terminology for data bases in Digestive Endoscopy , 9-1O.
    European Society of Gastrointestinal endoscopy : Preliminary Presentation for testing Normed VERLAG Edition.
  4. Principles of training in gastrointestinal endoscopy. Gastrointest endosc 1992 ; 38 : 743 - 6.
  5. Mallinson CN : Specialist Training in Gastroenterology in the European Community : the case for European Boards. Gut 1994 ; 35 : 135-8.
  6. Aabakken L, et al : Hands on endoscopy training : An evaluation of the SADE endoscopy course. Endoscopy 1995 ; 27 : 66 - 9.
  7. A.S.GE :Maintaining competency in endoscopic skills : Gastrointest Endosc 1995 ; 42 :62O-1.
  8. Crespi M et al  : SIGE-AIGO: proposals for assessing continued education and training in gastroenterology. Report of the SIGE-AIGO working group. Italian J. Gastroenterol 1994 ; 26 : 419 - 21.
  9. Gibinski K : Ethics and training in digestive endoscopy. Endoscopy 1989 ; 21 : 231- 3.
  10. Guidelines for establishment of gastrointestinal endoscopy areas. Gastrointest Endosc 1991 ; 37 : 661-2.
  11. Mulder C JJ. Guidelines for designing an endoscopy unit : Report of the Dutch Society of Gastroenterologists. Endoscopy 1997 ; 29 : I, VI.
  12. President’s commission for the study of Ethical problems in Medical and Biomedical and Behaviour Research : Making health care decisions, 1982.
  13. ASGE : Informed Consent for Gastrointestinal Endoscopy. Gastro intest Endosc 1988 ,34 (suppl) 26s-27s.
  14. Plumeri PA : Informed consent. J Clin Gastroenterol 1983, 5: 185-7.
  15. Woloshynowych M , Oakley D.A , Saunders BP: Psychological aspects of gastrointestinal endoscopy : A review. Endoscopy 1996 ; 28 : 763 - 67.
  16. Aabakken L , Baasland. I ; Lygren I , Osnes M , Development and evaluation of written patient information for endoscopic procedures, Endoscopy 1997 ;29 : 23 - 6.
  17. Frank U, Daschner F.D : Disinfection in Gastrointestinal endoscopy : Current Status. Endoscopy 21 : 276 - 9. British Society of Gastroenterology : cleaning and disinfection of equipment for gastrointestinal flexible endoscopy :Interim recommendations of a working party :Gut 1988, 29 : 1134 - 51.
  18. European Society of Gastrointestinal Endoscopy : Working group. Guidelines on cleaning and disinfection in gastrointestinal Endoscopy :Endoscopy 1995,I.II
  19. Bound W W, Ott BJ, Frankee K.A, Mc Craken J.E. Effective use of liquid chemical germicides on medical devices : Instrument design problems : Disinfection, sterilization and preservation 1O97 - 11O6 . Edited by SS Block , Lea Fibiger 1991,
  20. Tsuji S, et al : A novel and inexpensive method for endoscopic disinfection by water electrolysis . Gastrointest Endosc 1997 ; 45 : AB56.
  21. Axon AK, Kruse A, Urgell R et al: European Society of Gastrointestinal endoscopy (ESGE) Guidelines for reprocessing of accessories in digestive endoscopy. Endoscopy 1996, 28 :534-5.
  22. A.S.G.E : Antibiotic prophylaxis for gastrointestinal Endoscopy. GastrointestEndos 1995 ; 42 : 63O-5.
  23. Mani V, et al : Antibiotic prophylaxis in gastrointestinal endoscopy
    A report of a working party for the British Society of Gastroenterology. Endoscopic Committee. Endoscopy 1997;29: 114-9
  24. British Society of Gastroenterology : Recommendations for standards of sedation and patients monitoring during gastrointestinal endoscopy, Gut 1991 ; 32 : 823 - 7.
  25. Quine MA, Colin, Jones D.G . Gastrointestinal endoscopy : to sedate or not to sedate ? Endoscopy : 1996, 28 : 3O6 - 7.
  26. ASGE : Sedation and monitoring of patients undergoing gastrointestinal
    Endoscopic procedures . Gastrointest Endosc 1995 ; 42 : 626-9.
  27. Lazzadoni M, Bianchi Porro G : Preparation , premedication, and surveillance. Endoscopy 1996 ; 28 : 6 - 12.
  28. Keefe EB, O’Connor Kw 1989, ASGE Survey of endoscopic. Sedation and Monitoring practice, Gastrointest. Endosc 199O ; 36 : S 13 - S18.
  29. Tan CC, Freeman J.G. : Throat Spray for upper gastrointestinal endoscopy is quite acceptable to patients : Endoscopy 1996 ; 28 : 277-82.
  30. Campo R, Brullet E, Montserrat A, Calvet X, Rivero E, Brotons C. : Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy : A randomised double - blind study. Endoscopy 1995 ; 29 : 659 - 64.
  31. Rey JF : sedation for upper gastrointestinal endoscopy : As much as
    possible, or without ?. Endoscopy 1996 ; 28 : 3O8. 9.
  32. Quine MA, Bell G.D, Charlton JE et al: A prospective audit of upper gastrointestinal endoscopy in two regions of England : Safety staffing, and sedation methods. Gut 1995 ; 36 : 462-7.
  33. Reuter S : Vicarious liability, legal aspects. Med Pract 15, 6 : 1987.
  34. The role of endoscopy in the surveillance of premalignant conditions
    of the upper gastrointestinal tract. Gastrointest Endosc 1988, 34 :
    18s - 2Os.
  35. British Society of Gastroenterology :cleaning and disinfection of equipment for gastrointestinal flexible endoscopy :Interim recommendations of a working party :Gut 1988, 29 : 1134 - 51.
  36. Summary of current guidelines for the cancer-related check-up : Recommendations. Professional education publication. American Cancer Society 1988.
  37. Fleisher D.E : Better definitions of endoscopic complications and other negative outcomes : Gastrointest Endosc 1994 ; 4O 511-3.
  38. Cotton PB : Outcomes of endoscopic procedures : Struggling towards definition. Gastrointest Endosc 1994 ; 4O : 514-8.
  39. Hart R, Classen M. Complications of diagnostic gastrointestinal endoscopy. Endoscopy ; 199O ; 22 : 229-33.
  40. Escourrou J, Cordova JA, Lazorthes F et al : Early and late complications after endoscopic sphincterotomy for biliary lithiasis, with and without the gall bladder " in situ " Gut 1984, 25 : 598-6O2.
  41. Keefe EB : Complications of Gastrointestinal Disease . 5th Edition Sleissenger MH and Fortan JS, Eds W.B Saunders . Philadelphia 1993 :3O1-8.
  42. Vallera R, Baillie J,  : Complications of endoscopy. Endoscopy 1996. 28 : 187-2O4.
  43. Siegel JH, Kasmin EF, Cohen SA, Health Hazards and endoscopy : The known and newly experienced : A personal report. Endoscopy 1994 ; 26 : 545 - 8.
  44. Molock L, Lindgren OH, Mills DH. Malpractice, clinical risk management and quality assessment. Goldfield N , Nash DB, eds. Providing quality care. Philadelphia : American College of physicians 1989.
  45. Appropriate use of Gastrointestinal endoscopy. A consensus statement from the American Society for Gastrointestinal Endoscopy, Manchester, Ma, June 1986.
  46. Standards of practice of gastrointestinal endoscopy. Gastrointest Endosc 1988 ; 34 : 8s.
  47. Jacolisen P, Medical Malpractice and the tort system : JAMA 1989 ; 262 : 332O-27.
  48. Froehlich F, Burnand B, Vader JP, Gonvers JJ. Endoscopies : Too many or not enough ? Endoscopy 997 ; 29 : 652-4.
  49. American Society for Gastrointestinal endoscopy. Guidelines for clinical applications. Gastrointest Endosc 1988 ; 34 (suppl 4) : 25s
  50. Kahn KL, Roth CP, Kosecoff J. et al : Indications for selected medical and surgical procedures : a literature review and matings of appropriateness. Diagnostic upper gastrointestinal endoscopy. Santa Monica. The Rand Corporation 1986. Rand Publication : R 32O4/4 - CWP/HCFA/PM
  51. Convers JJ et al : Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy unit. Endoscopy 1996 ; 28 : 661-6.
  52. Axon A : Which patients should be referred for open endoscopy ? Endoscopy 1996 ; 28 : 722-3
  53. Quine MA, Bell G.D, Mc-Cloy RF, et al : Appropriate use of upper gastrointestinal endoscopy. A prospective audit . Gut 1994 ; 35 : 12O9-14
  54. Colin-Jones DG : Improving the standards of endoscopy. Gut 1991, 32 : 725-6.

DOCTRINE OF INFORMED CONSENT
M.A. LATORZEFF - J. ESCOURROU

INTRODUCTION
Advanced medicine; biomedical research, scientific development and strategies, have caused a proliferation of choices in medical therapies.
More efficient, medicine has also become more harmful; more daring techniques, more active therapies are associated with increased and perhaps unknowable risks.
If surgical or medical therapeutic imprudences are sanctionnable, taking risks is also a factor of progress that allows us to give patients additional chances, on condition that:
- risks are identified
- assessed by the physician,
- proportional to the seriousness of the illness
- honestly explained to the patient , in order that he could take share the decision.

DEFINITION
Informed consent is the name for the general principle of law which states that a physician in a non-emergency situation has an obligation to inform a patient of "those risks, benefits and alternatives" which a reasonably prudent patient would have considered material to his decision whether or not to undergo a proposed treatment.(3)
The physician has to give the person he is going to care for information :
- loyal, clear and comprehensible
- appropriate to his condition
- adapted to his personality.(1)
Informed consent is a two outcome process:
- on the one hand, information of the person on the nature, objectives, constraints, and known risks of the proposed treatment, - on the other hand, the free decision of this person to undergo a surgical or medical treatment or to accept to take part in a research procedure.
Thus defined this information enables the patient to give his consent to the decision that his condition seems to impose.

JUDICIAL ASPECT
The concept of informed consent and the choice of the patient has gained strength in both the legal and ethical arenas.
The person must know the risks, he or she must assume these risks voluntarily, but it must not be against public policy to assume them.
Various laws regulate the physician /patient relationship such as:

  • Nuremberg Code (1947)
  • Recommendations guiding physicians in biomedical research involving human subjects adopted by :
    - 18th World Medical Assembly, Helsinki (Finland), June 1954 and amended by the 29th World Medical Assembly Tokyo(Japan), October 1975,
    - 35th World Medical Assembly, Venice(Italy), October1983,
    - 41st World Medical Assembly, Hong Kong, September 1989...

"In any research on human beings, each potential subject must be adequately informed of the aims ,methods, anticipated benefits and potential hazards of the study and the discomfort it may entail. He or she is at liberty to abstain from participation in the study and that he or she is free to withdraw his or her consent to participation at any time. The physician should then obtain the subject's freely-given informed consent preferably in writing." (2)

  • Laws related to:
    - donation and utilization elements and products of the human body.
    - medical assistance to procreation and to prenatal diagnosis that requires an informed authorization and express consent.(1)
  • French rule (Huriet-Séruclat) , 20th December 1988, on persons' protection, insists particularly on getting free and informed consent of persons who involve themselves in biomedical researches.(1)
  • The law related to the nominal data processing for research in the area of health to demands informed and express consent of concerned persons, 1st July 1994.(1)
  • W.H.O declaration about patients' rights has anticipated this situation ( article 3.9, regional European office) - " patient's informed consent is necessary for all participation in medical teaching". (1)

ETHICAL CONSIDERATIONS
(International Ethic Code)
The concept of patient choice is primarily based on the respect of the ethical principle of autonomy.(4)
Autonomy does not, however, grant patients a right of access to medical treatment simply because they desire, or choose such treatment.(4)
The most difficult informed consent problems are those that arise from competently performed but medically unnecessary procedures; the extreme cases are those that involve vanity procedures, such as face-lifts, liposucion, and breast enhancements. They set an informed consent dilemma.(7)
From this perspective, a physician should be allowed to require a patient to assume all the risks.
But a more moralistic perspective is that it is improper for physicians to use their skills and position of respect to perform purely commercial treatment. So Jurists tend toward the moralistic view and tend to rule against the physician even if the consent has not any ambiguities.
Besides, obligations, as a physician, can't only be limited to respect legal or judicial dispositions;
A physician has to exercise his mission in the respect for human life, persons and their dignity.(1)
In the process of discussing the risks, benefits and potential alternative to a given treatment by a continuing dialogue the physician and the patient have an opportunity to ensure that there are no misunderstandings about the patient's complaint and the physician's proposals.
The patient/physician dialogue has necessarily to lead to an adequation between "what the physician wants to disclose and what the patient can understand" .
Particular cases

ALTERNATIVE THERAPY
If an alternative therapy exists, the patient may have a personal preference, or may let the physician decide. He may as well accept to be included in a protocol of research intended to compare the terms of alternatives.
Voluntariness becomes a legal issue, if the physician coerces the patient into accepting a treatment for which there are acceptable alternatives.(7)
Alternatives require qualified judgements, critical analysis , a clear basic choice, colleagues' advice, all the more that a margin of dubiousness always remains, as regards disease complications and treatment results.

THE PATIENT'S REFUSAL
Every person's body is considered inviolable, and consequently every competent adult, for personal reasons, has the right to be free from unwanted medical or surgical treatment nevertheless logical or obvious.
The patient might not reasonably reject all treatments but may justifiably argue he might have chosen a different treatment.
The fact that serious risks or consequences may result from refusal of treatment does not make faulty or defective the right of self determination.(5)
In this case, the physician has to try to convince the patient to change his mind, without exerting on him or on his family excessive pressure.
If a patient persists in his resolution, the physician has to respect his refusal after having told him of all the consequences .
Operating against patient's consent constitutes a professional misconduct that exposes the physician to a disciplinary punishment and commits his civil liability.(1)

THE PATIENT UNABLE TO EXPRESS HIS WISH
If the patient is prevented from expressing his wish, under age children, patients in a coma, serious mental illness ..., the physician cannot operate or give treatment without his close relations' agreement except in emergency and impossibility cases.(1)

WRITTEN INFORMATION AND CONSENT
It's often recommended to get written consent concerning an important decision.
But except when required by law, this written consent has no absolute judicial value.(1)
Nevertheless this written information can testify that the patient has been actually informed; it has the merit of leaving a trace.(1)
It represents a source which the concerned patient and his family can refer to.
Listing the advantages and the risks of a treatment, by specialities, pointing out necessary but non alarming information, allows the patient to take time to think about it , to get further information, before he adheres to the decision.
Written information, and consent are particularly essential in a hospital environment.
The patient comes into contact with a medical team, and healthcare providers have to see that the patient receives necessary explanations about treatment and investigations that are proposed and non imposed .
Hospitalization is often decided for serious , complicated or/and urgent cases. The patient finds himself obliged to give his consent because he cannot see any other alternative.
But a detailed consent form, listing all the risks of the treatment is unnecessary if a patient can prove that a treatment is unnecessary, inappropriate or contra-indicated, then consent to the risks of the treatment becomes ineffective.(7)

CONCLUSION
Informed consent undermines the theory that the patient has accepted that the undifferentiated risks of therapy outweigh the risks of this condition.
Although the physician must tell the patient of the known risk of treatment, this is not a guarantee that other problems cannot occur. Medicine is not a perfect science.
The patient may assume these unknown risks if three conditions are met:
- the risk is unknown or of such a low probability, that it is not known to be related to the procedure.
- the patient is informed that the disclosed risks are not the only possible risks.
- the medical arguments for the treatment are sound.
The historical focus on physician and patient ought not to neglect the influence of other parties on patients' rights. Society, other medical institutions, and increasingly, healthcare insurers and organisations have interposed substantial barriers to the right of the patient to be informed and to consent to the way they receive medical care.
Patients' autonomy can be eroded in many different ways, by many elements of the system.(6)

REFERENCES:

  1. Commentaires du Code de Déontologie médicale -
    Articles 2 - 15 - 35 - 36
  2. World medical association, declaration of Helsinki - 9 .
  3. Orthopedics Today Speciality Forums 12 April 1996
  4. Dworkin G. Autonomy and informed consent . IN: Making health care decisions, vol.3. Washington DC: US Government Printing Office,1982.
  5. Bioethic Bulletin 6.2 Patient choice and privatization, Timothy Caulfield, B. Sc., LL.B, LL.M. Research Director, Health Law Institute.
  6. The New England Journal of Medicine February 22, 1996- 334, 8.
  7. Berkeley Technology Law Journal Abstract . Issue 5:2- Fall 1990

Moore v. The Regents of the University of California: Balancing the need for biotechnology innovation against the right of informed consent, Maureen S. Dorney.

ETHICS AND MEDIA
JAIME CAMPOS

"You have to dream of the whole world, but never lose sight of the tiny villages". Rubén Darío.

Introduction
As we approach the millennium, our world has come to be typified by an extraordinary mobility of information, but at the same time there is a spectacular compulsion for wanting everything immediately, and this means that constraints are put on the time available for research and reflection, those essential requirements for making an ethical decision.
The invasion of privacy and the favouring of the individual, with the consequent devaluation of the collective fabric and social experience, are resulting in our system of life becoming standardised, and at the same time autochthonous values are being relegated and their consequences are not being evaluated.
The information society that gave rise to so many hopes has not proved capable of generating either growth or employment. Let us not forget that equal opportunities, respect for humanistic values, the dignity that work and social protection bring, and a deep-rooted attachment to one's country are essential and fundamental elements that give life a sense and meaning.
The risks involved in entering the new time-space relationship will have to be reduced, with technological innovation being brought into line with the above-mentioned needs.
Western man is thus losing track of the ideals of liberty and equality when he tries to ignore the contradiction that exists between market interests and the interests of objective, serene and reflective information, when he replaces ethics by a dangerous alliance between profit and knowledge, thereby accentuating what Jean Bernard has called "the discordance between progress in science and progress in learning".
The culture of the post-modern era, in the name of a false respect for differences, is really, in the words of María Cristina Reigadas, "neutralising and nullifying them, since everything is equal and nothing really matters".
Decision-making centres have moved from the national level to planetary level, and from the public sphere to a number of private financial institutions whose sole aim is to earn a quick profit for their coffers. In a competitive environment where fighting to death is the name of the game, it is the weak who necessarily lose out in the end.

Information
Information to a large extent consolidates the production of news, with journalistic technique being converted into advertising skill, where the logic of power and strength makes all information equal instead of establishing that longed-for diversification. By investing in the domain of genetic transformation, advertising monopolies have given rise to a "Biolobby", where there is a danger of speculation appearing in biotechnology. Those who hold the power to produce information and communications have won immense political power for themselves, with the consequent explosion in telecommunications. A communications monopoly in the hands of experts has converted what is a right held by everyone into the profession of just a few.

Communication
This relates to the possibility of going back, of exchanges between human beings, between poles with the same communicability coefficient. According to Althusser, the communications media are one of the ideological instruments that uphold a state of affairs aimed at supporting the interests of those who dominate society. For the financial world, the computer is a fantastic instrument for concentrating power and management of the immaterial. Telecommunications have transferred the financial marketplace to financial space, and the immaterial has inverted the logic of former systems, although leaders have not assumed that to govern is to foresee, to plan.
Anyway, we have to accept not only that the media are here to stay but also that they will inexorably increase and expand their presence in coming years, and although they are already an important part of our lives, we cannot and should not stand by and stop criticising. Accumulated experience has shown us other ways of looking at the media and getting involved; fortunately, receivers are becoming critical receivers, capable of rejecting material or discovering meanings in it that were never envisaged by the broadcaster; it can therefore be accepted that the media are offering more than they are denying, as the possibility exists of a critical receiver communicating, and this makes us reflect more when we read about social events.
It is also recommended that the communications media should look on themselves as instruments that belong to the population, for transmitting its sentiments, feelings, thoughts and position with relation to power, thus preserving its integrity and independence. It is essential that bridges are built between the private and social spheres, as these will encourage true integration and thereby permit a thoughtful rationalisation of everything that goes to make up public opinion.

Reflections on Communication
A proposal should be put forward on communication whereby it is essentially looked on as a revaluation of pluralism, a rescuing of the value of public opinion in bringing words and dialogue together for development. Societies should not lose the ability to express doubt, and hence dissidence, as this will prevent the irrational exuberance of the markets becoming the only destiny we are allowed. Alvin Toffer recommends activating all communication systems, to support the enrichment of education and information, and favours public debate through networks between groups and nations.

T.V.
If nothing in the human being is simple, even less so is his relationship with TV, where advertising and publicity, which have erroneously taken on a connotation of value, confuse and mislead opinion without hindrance. The fact that people use TV to isolate themselves from others should lead to the conclusion that something worth investigating is going on in the environment.
With TV, the audio-visual predominates over the written and over logical reasoning; sentiment and passion are linked to the trivial, which prevails first and foremost. During this century we have passed from the confessional to psycho-analysis, and from this latter to superfluous entertainment and leisure programmes, and the result has been behaviour like that of a docile flock of sheep, as imposed consumerism has become linked to showbusiness and not to active involvement for social transformation.
Despite this, however, we should not underrate the value of sensory-emotional material, as against what is rational and intellectual, in merging serious rationality with ludic pleasure and sensitivity. Paul Ricoeur suggests we acknowledge what each human being has in the field of culture-communication relationships.

REFLECTIONS
We have to acknowledge that the media have made marvellous contributions. We intellectuals and teachers have a commitment to see the other side of the coin and at the same time understand other ways of looking at things. The increased range on offer means that sources can be compared and other versions and perceptions looked at, although we should always take cultural space into consideration in relationships with the media, as proposed by Jesús Martín Barbero.
We should now pass from a technological viewpoint to a pedagogical one, in order to try and incorporate the media into an attempt at dialogue. Introducing TV as a learning tool means understanding the rules of the game and thus attempting to make the most of narrative resources so that programmes can be used as a triggering device for reflections and group work that is useful to the community. In other words, the aim should be to encourage a dynamic way of dealing with information that will not only enable but also induce the audience to handle various interpretations and readings of situations and the main characters involved in these. The myth that it is the vertical and absolute word-law which underlies and nurtures the visual language that is the educational axis of the viewer can also be broken.
This means that all communication resources that education can benefit from should be taken over, so as to promote the development of dialogue methodologies where teacher and student work hand in hand to build not only the knowledge but also the coexistence that will transform the word-law culture that for so many years has led us to look approvingly on silence as the exemplary axis around which the educational environment revolves, without any objections or questions.

Ethics
Occasionally, a doctor does not know how to use technology without physically or psychologically hurting the human being; so-called "mirror-ethics" have therefore been promoted, channelled by the scientific world either consciously or unconsciously to ensure that the process does not get slowed down; also, scientific declarations are frequently handled in an exaggerated or incomplete way for countless numbers of sick people, as largely-incomprehensible medical terminology can only with very great difficulty be transferred to everyday language when it comes to informing society on health matters. Thus it is that the hopes both the healthy and the sick population have of understanding and dealing with medical information that is of vital importance to decisions that have to be made on the individual and collective quality of life generally meet with frustration.
Our obligation is therefore to work in search of a new and more humane order, a morality of doubt, even if only provisional, since in ethics as in other values the absolute does not exist, and as Rousseau stated, "What do we learn in Phedra and Oedipus if not that man is not free, and that heaven punishes him for the crimes it makes him commit?"
McLuhan claims that a society is defined and typified by the communication technologies it has available to it, and this communication society seems to be orientated towards fantasizing on the world. Reality gets transformed at a speed that is greater than the intellectual capacity to explain it. Multi-dimensional thought is necessary if this is to be faced up to, where the complexity of human realities is respected. Science needs a non-scientific substratum: cultural decisions, a love of knowledge, and metaphysical obsessions. A subject has to be recognised as having ambiguities if an open, interdisciplinary rationality is to be found that nurtures the dialectic between a humanist culture and a scientific culture, between science and philosophy, human sciences and natural sciences, knowledge and ethics, theory and policy. Only then will we be able to enter an era where we can think of complexity and live in harmony with our myths.
Let us seek the ethics of an organised society that includes political ethics. Ethics that do not aspire to regulate private life, that touch on the public sphere of harmony in the search for a society that needs no fear or force if it is to achieve its goals, and which makes alternatives possible for a pattern of communication norms that is richer and more complex at international-exchange level.

Communication ethics require communicators to go beyond their role of intermediary and take on that of a mediator, and therefore make communication a strategic space in the struggle to abolish frontiers and exclusions and make it possible for the right to live and think differently to be recognised. Edgar Morin suggests on this point that "there is a dialectic between order, disorder and organisation, and through this the universe is built, develops, gets destroyed, and evolves".
The international community should finance social, educational and cultural research into telecommunications and promote exchanges between groups that create communication processes in the fields of science, education and culture. In this way, flexible strategies can be drawn up that are in line with the interests and needs of each community.

How can we reconcile the demands of this new philosophy with the preservation of geographical, ethnic and cultural roots?
Victor Hugo provides us with part of the answer in Les Miserables, when he writes "Do not take the flame where there is enough light!", and suggests that prudence and common sense should be our prime guides. A more humane order needs to be sought, even if this is only provisional, a morality of doubt, where the weight of the word is used, as proposed by Etchegoyen, the coherence between thought and action and the generosity that is implied by pardon, courage and tolerance.
Neither science nor technology are innocent or ingenuous products, as they too are influenced by market logic and the logic of personal interest; communication should therefore make us more careful and respectful of difference, that essential feature for achieving true pluralism. Tolerance should be exercised at all times if we are to achieve a connection between identity and innovation, between what we are and what we would like to be.

BIBLIOGRAPHY

  1. T.W. Adorno y M. Horkheimer. Dialéctica del Iluminismo, Sur Buenos Aires, 1971.
  2. G. Alba G. La mediología. Signo y Pensamiento, No. 24, 1994, pp. 79-82.
  3. R. M. Alfaro. Participación ... ¿para qué?. Un enfoque político de la participación en la comunicación popular. Diálogos de la comunicación. No. 22, 1988, pp.59-101.
  4. Del periódico al parlante, en materiales para la comunicación popular, No. 1, Lima, 1983.
  5. La palabra como Conquista de la capital, Mimeo, Lima, 1985.
  6. J. I. Austin. Cómo hacer cosas con palabras. Paidos, Buenos Aires, 1982.
  7. W. Benjamín. Iluminaciones I: Imaginación y Sociedad, Taurus, Madrid, 1980.
  8. J. Campos. La ética hacia el futuro. Medicina, 1993, 33:29-30.
  9. C. Cortés S. Comunicación y desarrollo. Fernando Vásquez R. Soñar el mundo sin perder la aldea. Signo y Pensamiento, No. 24, 1994, pp. 151-161.
  10. J. Díaz Bordenave. La comunicación latinoamericana -comienzos del tercer milenio-. Signo y Pensamiento, No. 24, 1994, pp. 123-134.
  11. J. Habermas. Teoría de la Acción Comunicativa I. Taurus, Buenos Aires, 1989.
  12. O. Landi. Crisis y Lenguajes Políticos., Cedes, Buenos Aires. 1983.
  13. E. Marín. Etica del periodistes o ètica dels mitjans. III Converses a la Pedrera. Etica i Communicació Social. 1993, pp. 53-54.
  14. J. Martín Barbero. Desafíos a la ética de la comunicación. III Converses a la Pedrera. Etica i Communicació Social. 1993, pp. 57-58.
  15. De los medios a las mediaciones. Calypso, S.A., 1987. 203-247.
  16. G. J. Pérez, S.J. Etica y televisión. Cuestionamientos, reflexiones y propuestas. Signo y Pensamiento,No.24,1994,pp.9-
  17. D. Prieto Castillo. Discurso antiautoritario y Comunicación Alternativa, Edicol, México, 1981.
  18. La televisión en el fin del milenio. Signo y Pensamiento, No. 24, 1994, pp. 103-122.
  19. L. A. Restrepo. ¿Es posible una "Etica Civil "?. Colombia una casa para todos. Ediciones Antropos Ltda. 1991, pp. 87-120.
  20. M. Restrepo J. Telecomunicaciones: mutación del espacio y del tiempo. Signo y Pensamiento, No. 24, 1994, pp. 135-142.
  21. J. M. Ricaurte. Reflexiones sobre tres puntos éticos. III Converses a la Pedrera. Etica i Communicació Social. 1993, pp. 79-80.
  22. O. G. Rincón. La televisión: forma y sensibilidad de nuestro tiempo. signo y Pensamiento, No. 24, 1994, pp. 57-78.
  23. M. Riviere. Etica y comunicación social: notas para una visión dentro del periodismo. III Converses a la Pedrera. Etica i Communicació Social. 1993, pp. 65-68.
  24. G. Thomson. Problemas y dilemas éticos. Ideas y Valores. Revista Colombiana de Filosofía, 1997, 103:21-31.
  25. UNESCO/U. PEDAGOGICA. Democratización y uso social de las telecomunicaciones -seminario-. Signo y Pensamiento, No. 24, 1994, pp. 143-150.

ETHICS, ENDOSCOPY AND COMPUTERS
F. VILLARDELL

INTRODUCTION
The irreversible trend towards the dependence on computers for the gathering, storage and further treatment of clinical information, represents a most important progress in the management of health care. However, the use of advanced information technology has made many people aware of the associated pitfalls that threaten to undermine its benefits. The most serious threat is that to the patient's right to privacy (1). There is widespread concern about what kind of data are registered, their accuracy, the use that will be made and the kind of control necessary to prevent undesirable access to them. Another issue is the extent to which patients may have the opportunity to verify their personal records. A particular problem relates to the storage and retrieval of "objective" information, such as endoscopic images and reports (2). There is an increasing flow of information between hospitals and public or private management systems that will become more so with the widespread use of Internet. Concerns about potential misuse of computer data were voiced as early as 1968 (3).

ENDOSCOPY AND THE COMPUTER
Endoscopy is the most important diagnostic tool available to the gastroenterologist and endoscopic reports are essential components of the patients' history, and probably the first documents that a specialist may consult in search of an objective diagnosis. The continuous growth of endoscopic examinations and the easy possibility of storing and transmitting images and reports to interested third parties raises anxiety about their possible misuse. Computerized records may be used for purposes unrelated to the clinical management of the patients, such as research, retrospective studies of data, and increasingly, for auditing, cost-benefit analysis, efficiency studies and for administrative purposes.

BENEFICENCE, MALEFICENCE AND THE COMPUTER
Computer ethics has been defined as being "the study of the way in which computers present new versions of standard moral problems and dilemmas, causing existing standard moral norms to be used in new and novel ways in attempt to resolve these issues" (4). I would like to review the different ethical problems posed by computers as an aid to endoscopists. It may be useful for this discussion to use the traditional ethical analysis based in such standard concepts as beneficence, maleficence, autonomy and justice (5).
Beneficence: There are many ways in which the patient's management may benefit from the computer. Various software programmes may be used to obtain a comprehensive history of the patient, including accurate life-style parameters (6). Several diagnostic programmes have been used in gastroenterology although the rates of success have been inconstant (7,8). This is mostly due to the fact that although significant progress has been made in modelling and simulating diagnoses (9), there are inherent difficulties in quantifying qualitative data, such as those provided by endoscopic images. It is conceivable that electronic devices may be used in the future for the analysis of endoscopic images that may be transmitted to other centers for consultation and diagnostic decision making. However, computer diagnosis will not result in widespread acceptability unless it exceeds the average physician diagnostic ability, it is cost effective and transferable to other institutions and possesses adequate privacy safeguards (10). This is not yet the case.
Computerized programmes (COMET) have also been used as an aid for obtaining a meaningful patient's consent for given procedures (11).
The Internet facilities have been used to solve difficult diagnostic problems by way of multiple consultations (12). Endoscopy information on-line is available from several organizations, such as ASGE and ESGE and guidelines for endoscopic practice and teaching modules are being provided by both organizations. Information on teaching and training is also available. The Bowman-Gray school of Medicine offers an excellent site "Virtual endoscopy center" and the Université Libre de Bruxelles also has a web site (13).
Maleficence: Organizations are increasingly computerizing the processing of personal information. Advances in computer technology have led to the growth of databases holding personal and other sensitive information in multiple formats, including text, pictures and sound. This may occur without the knowledge of the individuals affected. Obviously, the use of the computer should not bring harm to patients. The computer has no concept of error and cannot quantify harm done by its mistakes (7). Inaccurate information may be difficult to correct once it has been propagated in different files.

A negative duty, such as "do not harm" (maleficence) is more binding than the duty of beneficence, (14). Harm may be produced by such diverse things as assaulting privacy of patients by including their names in teaching slides or in Internet documents or even by the harmful consequences associated with excessive reliance on computer diagnosis which may result in an impaired ability of the physician to make clinical judgements (10).
However the most significant cause of maleficence is the erosion of the individual's privacy and confidentiality (1). Confidential information may be leaked by insiders or may become public by way of careless bureaucratic propagation (15).
Lack of legislation allows for a proliferation of private sector computer data-bases and data exchanges without regulation. There is so far no statutory guidance for persons wronged by abuse of data. Cases have been reported of bankers calling loans to patients with cancer, of companies that admit using medical records in hiring decisions under the excuse of managing the costs of health care (4). A Harris poll of the general public in 1993 disclosed that a quarter of all respondents had experienced improper disclosure of their medical information. (16).

MALICE
Maleficence in the use of computers should be distinguished from plain malice. Continuous inspection of computer systems is necessary to avoid the numerous examples of malicious actions by computer hackers that have been reported, such as blocking the Internet access, altering inputs or appropriating them, using pirated or stolen software, gaining access to data and disclosing and selling unauthorized data to third parties, or even introducing viruses in order to destroy information. There are quite a few examples of data being sold to unscrupulous vendors or to malpractice attorneys (17).

AUTONOMY
Of the four basic ethical principles as they may be applied to information and computer ethics, the most important one is that of autonomy which includes the essential issues of confidentiality and privacy.
Confidentiality : Confidentiality has been defined as " a rule or duty requiring one entrusted with private or secret matters to refrain from divulging them, unless it is in conflict with equal or stronger duties". The harm may be physical but more often moral. The most common justification for breaking confidentiality is preventing harm to society. (18). Essentially, medical confidentiality is the respecting of other people's secrets in the sense of information they do not wish to have further disclosed without their permission (19). It is the necessary ground of the doctor/patient relationship (6).
"The patient has the right of confidentiality. The physician should not reveal confidential communications or information without the consent of the patient, unless provided for by law or by the need to protect the well fare of the individual or the public interest" (20).
Privacy : The concept of privacy is more difficult to define: it is based on the principle of respect for persons and includes several elements such as solitude, intimacy and anonymity (21). The most important aspects of privacy are the right to be free from observation, the wish to avoid identification in a public setting or revealing intimate aspects of his self to others. The right of autonomy includes the right to privacy ; it was already present in the Hippocratic Oath.

Ingham (22) argues that privacy fulfils four important psychological needs: 1. Personal autonomy 2. emotional release 3. self-evaluation (after any personal crisis) 4. to allow limited and protected communication. The patient has the right to have the privacy of this information respected by the confidentiality afforded to it (23).

INFRINGING CONFIDENTIALITY
The increasing involvement of several other health related professions in medical care as well as the changing patterns in inter-professional relationships offer many opportunities to breach confidentiality. It has been calculated that as many as 25 professionals may look at a patient's record in the hospital! (20).
Conflicts arising from individual interests may come into collision with those of groups or institutions whether public or private.Medical audits trespassing autonomy are not uncommon, especially as security measures in hospitals are usually insufficient. Disclosures may occur to private or public insurers, for health evaluation, planning and research, for medical audits, even for purposes totally unrelated to medical care (20). Since the Hippocratic Oath, all codes of medical ethics affirm the importance of confidentiality, although usually exceptions are made if the law requires to do so. Confidentiality is eroded today by legal actions and by changes in the climate of public opinion concerning the patient's rights to information (20). This increasingly diluted confidentiality is fostered by the current systematic quest for effective diagnostic and therapeutic procedures and more rational decisions (24) such as cost-efficiency and cost-benefit analyses (25,26).

Physicians’ opinions on confidentiality are divided: for some of them confidentiality is a prima facie duty (27), while for others, confidentiality is a "decrepit" concept" (28).

EXCEPTIONS TO CONFIDENTIALITY
Legitimate exceptions to confidentiality according to the U.K. General Medical Council (29) are:
a) when the patient gives consent
b) when other doctors participate in care. c) when a doctor believes that a close relative should know and it is medically undesirable to ask the patients' consent. d) exceptionally when the doctor believes that disclosing to a third party will be in the best interests of the patient. e) if there are statutory or legal requirements to disclose. h) medical research approved by a Committee. There is reasonable agreement in Western countries that individuals have intellectual property rights regarding software, but this is not so in the Far East where the predominant philosophy tends to treat intellectual property as communal property.(30). In some instances, "whistleblowing", such as during the conduct of clinical trials, is certainly permissible particularly if the threat of harm is imminent and serious (31).

RIGHT TO PRIVACY
Privacy is a problem with a dilemma: on the one hand, there is a responsibility to share information in an effort to advance knowledge and because legal and social obligations that may require disclosure of data, but on the other, there is an individual right to confidentiality, to be left alone, to be autonomous.
Velu (32) has identified five major aspects of the right to privacy under the European Convention:
1) protection of an individual, physical and mental inviolability and his moral and intellectual freedom
2) protection against attacks to individual honour and reputation
3) protection of an individual's name, identity and likeness against unauthorized use.
4) protection of individuals against being spied, watched or harassed
5) protection against disclosure of information covered by the duty of professional secrecy

DATA PROTECTION
The likelihood that information will be improperly disclosed depends on two things: its value and the number of individuals who have access to it (33).
Instances have been described of thefts of computers and subsequent blackmail attempts, of abuses of prescription systems by drug companies etc. The main threats come more from insiders than from outsiders and they are exacerbated by data aggregation which web computer systems encourage.
Several national and international agencies have drafted resolutions concerning medical confidentiality and data protection, among them the 27th World Medical Assembly (34), which requested members of WMA "to reject all attempts having as a goal legislation authorising any procedures to electronic data processing which could endanger or undermine the right of a patient to secrecy", expressing "the strong opinion that medical data banks should be available only to the medical profession and not linked to other central data banks".
The BMA representative body already in 1978 urged the British Government "to introduce adequate legislative safeguards before the implementation of any computer system" (29). The BMA stressed that "in all medical records, information should be regarded as held for the specific purpose of the continuing care of the patient and should not be used without appropriate authorization by the responsible clinician". The report went on, stressing that access to identifiable information should be restricted to the person clinically responsible and that access to others should be allowed, when practicable, with the consent of the patient. Furthermore an individual should not be identifiable from data supplied for statistical or research purposes.

The Secretary of Health and Welfare of the United States (35) recently made the recommendation that " providers and payers and those receiving information under the provisions of the legislation without the patient's authorization be required to maintain "reasonable and appropriate" administrative, technical and physical safeguards". Although in his report, the Secretary recognized that no legislation could effectively specify how to do this, he stated that Federal legislation is needed because:

  1. current protections are inadequate,
  2. The health care information system is increasingly interstate and because
  3. problems are urgent. Among the recommendations that he has made are that providers be permitted to deny inspection if information is used solely for internal management purposes and not for treatment or administrative determinations about the patient. Also that providers and those receiving information for health oversight be permitted to disclose information without the patient's authorization only if such disclosure is authorized by other laws: he goes on and recommends that " those who misuse personal record information should be punished and those harmed should have legal recourse"and that "Individual's claim to privacy should be balanced by their public responsibility to contribute to the common good, through use of their information for important, socially useful purposes."

Very similar recommendations have been made by the Committee of Ministers of the Council of Europe to member states on the protection of medical data on 13 February 1997, requiring that the patient's authorization to disclose information should have to meet specific requirements (36).

PRINCIPLES OF DATA SECURITY
Threats to data privacy and confidentiality may range widely from the accidental release of information to criminal violations of a health record bank system. It is obvious that regardless of the level of safeguards, no system can provide 100% security.
Controlling input into the system and prevention to unauthorized
access to the data system, should be the primary safeguards. Risks increase with the growth of the number of data and that of users. The greatest threats may emerge from information technology which is not managed properly; many fear that this might happen with the emergence of profit managed care.
Nine principles of data security have been drafted by Anderson on behalf of the British Medical Association (37):
access control: list naming the people who may read the data and append more data to it.
record opening by clinician and the patient on the access control list.
control: one of the clinicians on the access control list must be marked as being responsible.
consent and notification: The responsible clinician should notify the patient of the names of his record access control list and subsequent additions or deletions.
persistence:. No one should have the ability to delete clinical information until the appropriate time is expired
attribution: All accesses to the records should be marked with the name of the person accessing the record, data and time.
information flow: Information derived from record A may be appended to record B if and only B'saccess control list is contained in A's.
aggregation control: Patients should receive special notification if any person whom it is proposed to add to their access control list already has access to personal health information on a large number of people.
trusted computing base: computers that handle personal health information shall have a subsystem that enforces the above principles in an effective way. Its effectiveness should be evaluated by independent experts.

COMPUTERIZED DATA AND INFORMED CONSENT
Many publications comment on the difficulty in obtaining a meaningful patient's consent to release information from computerized data. (38-43).
An important drawback is that many of investigations of data are retrospective in nature such as epidemiological studies, cost-benefit analysis, auditing reports, etc. It has been impossible to devise informed consent practices that satisfy, in full, the competing moral imperatives of respect for autonomy on the one hand, and the concern for the value of health information for the common good of society. The same conflict applies to Internet. Informed consent cannot be entirely achieved at the beginning of any study even if it is the intent of the researcher to do so, because the circumstances of the research are constantly shifting and often the investigator and his associates are not sure about what is being consented to (43).
In these instances, we should probably discuss atypical forms of consent, such as "implied consent" or "alienated consent" (the patient lets the doctor decide), as described by Jonsen (44).

PROTECTING PRIVACY WITH "SMART CARDS"
Plastic cards may store plenty of information (45,46). These are the so-called "smart cards" (in opposition to "dumb" cards, i.e. credit cards that can carry only 200 characters). Cards may be equipped with a tiny integrated circuit memory chip that holds about 8 kilobytes (about four pages of double space typewritten text). They can carry about 8000 characters secured against being read unless the person has an enabling code (typically a PIN held by the card owner and an authorised reader system). In fact, a miniature computer. Data can be added and updated after the card is issued. The card software is installed at the time of manufacture and cannot be altered thereafter.
Smart cards have two important properties: they can carry a substantial quantity of data in a computer readable form and can do it securely.
Ideally patients should be able to get access to their data, and an electronic signature of the patient may be stored to guarantee his approval of the release of his data. The memory of a smart card may be divided into several zones each with a different level of security and requirement for gaining access. A secret zone that no one can read can be set aside for the storage of passwords and cryptographic keys. Different users, such as a first aid team, an administrator, a surgeon, or an endoscopist, may have access to different data.
The data use WORM (write/once/read/many) which cannot be rewritten or erased. More recent cards use softstrip technology, allowing the storage of 32 kylobytes of data (16 pages of double
spaced type-written text). They are immune from destruction by magnetic fields and more resistant to scratches and dirt. Models of this type have been tried, such as Exeter Care Card pilot, or Panacea or the Quebec health card. Another system of this kind is being used widely in France (45).
If we are planning to move health data around Internet and that seems inevitable, it is clear that we must consider issues of security given the essentially open nature of Internet, as the doctor may receive clinical details, x-rays, endoscopic images etc.) (47-49). Smart cards may be of help because they may allow the removal of personal identifiers when necessary.
Obviously privacy will not be absolute, as a data base must be stored in case of loss of card or other accidents (47).

JUSTICE
Justice is here discussed in the judicial context, not as an ethical concern for equity. The problems of liability are not easily solved. Although some agencies recommend that infractors of the above recommendations be punished, one has doubts that this will be implemented at the international level. In spite of some discussions at the Council of Europe, "International ethics" seems to be a very distant goal (50).

CONCLUSIONS
The increasing tendency to use computer systems for the storage, treatment and communication of medical data will very probably have a great impact in the next few years on the management of endoscopic activities. It is conceivable that large amounts of information, including endoscopic reports and images, will be openly and widely transmitted through Internet and other devices. The advantages of computerized systems in the clinical settings, including diagnostic programs, simulation for teaching purposes and research, cannot be overemphasized. However, there is general concern for the protection of privacy in computer stored data and in Internet. Although many directives and recommendations by several national and international bodies are trying to implement valid safeguards including the use of personal cards, ( 35-37, 47,51-54), we are still far from providing adequate protection to the patient's privacy. Adequate legislation is needed at national as well as international levels.

REFERENCES

  1. Rogerson S. Computer and information ethics. Encyclopedia of Applied Ethics, vol.1, San Diego, Academic Press, 1998:563-570.

  2. Hiller MD, Beyda V. Computers, Medical records and the right to privacy in Hiller M.D., Medical Ethics and the Law. Implications for Public Policy.Cambridge, Mass, Ballinger Publishing Co, 1981:153-181.
  3. Parker D. Rules of ethics for information processing. Communications of the ACM 1968;11:198-201.
  4. Johnson DG, Nissenbaum H (eds.). Computer Ethics and Social Values. Engelwood Cliffs, N.J. Prentice Hall, 1995.
  5. Gillon R. Philosophical Medical Ethics,Chichester, John Wiley, 1986:106-112
  6. Holt S, Guram M, Smith M, Skinner HA. Computer assessment of life-style in a gastroenterology clinic. Dig Dis Sci 1992;37:993-996
  7. De Dombal FT. Ethical considerations concerning computers in medicine in the 1980s. J Med Ethics 1987; 13:179-184.
  8. Adams AI, Chan M, Clifford PC et al. Computer-aided diagnosis of acute abdominal pain; a multi-centre study. Br Med J 1986; 293:300-301.
  9. Pellegrino E. Value desiderata in the logical structuring of computer diagnosis. in The Ethics of Diagnosis, JL Peset, D.Gracia (eds) Dordrecht, Kluwer, 1992:173-195
  10. Schaffner KF. Problems in computer diagnosis. in The Ethics of Diagnosis, JL Peset, D.Gracia (eds) Dordrecht, Kluwer, 1992:197-241.
  11. Sieghart P, Dawson J. Computer-aided medical ethics. J Med Ethics 1987; 13:185-188.
  12. Balas EA, Jaffrey F, Kuperman GJ et al. Electronic communication with patients. Evaluation of distance medicine technology. JAMA 1997;278:152-159.
  13. Krabshuis J. Endoscopy information on-line: can endoscopists close the gap between what is known and what they do?. Endoscopy 1997;29:871-882
  14. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Second edition. New York, Oxford University Press 1983:228-237.
  15. Andreae M. Confidentiality in medical telecommunication. Lancet 1996;347:487-488
  16. Spafford EH. Computer Security. Encyclopedia of Applied Ethics, Volume 1 San Diego, Academic Press 571-577, 1998
  17. Spinello, RA. Ethical aspects of information technology. New York, Prentice Hall, 1995.
  18. Armstrong MB. General issues of confidentiality Encyclopedia of applied ethics, vol.1 San Diego, Academic Press 579-582, 1998.
  19. Emson HE. Confidentiality: a modified value. J Med Ethics 1988;14:87-90
  20. McConnell T. Confidentiality and the law. J Med Ethics 1994;20:47-49
  21. Francis HWS. Of gossips, eavesdroppers and peeping toms. J Med Ethics 1982;8:134-143
  22. Ingham R. Privacy and psychology. in Young JB (ed) Privacy ,Chichester, John Wiley, 1978:44-46.
  23. Thompson IE. the nature of confidentiality. J Med Ethics 1979;5:57-64.
  24. Sackett DL, Scott Richardson W, Rosenberg W, Haynes RB Evidence-based medicine. New York, Churchill Livingstone 1997
  25. Chervenak FA, McCullough LB. The threat of the new managed practice of medicine to patient's autonomy. J Clin Ethics 1995;6:320-323
  26. Korrow MH. Medical confidentiality: an intransigent and absolute obligation. J Med Ethics 1986;12:117-122
  27. Hawkins RS. Medical information systems and their importance in managed care. Gastroenterol Clin North Am. 1997;26:823-844
  28. Siegler M. Confidentiality in medicine: a decrepit concept N Engl J Med 1982;307:1518-1521
  29. BMA The Handbook of Medical Ethics London, British Medical Association,1981.
  30. Parker DB, Swope S and Baker BN (eds). Ethical conflicts in information and computer science Wellesley, QED Information Sciences, 1990.
  31. Bok, Sissela. Secrets: on the ethics of concealment and revelation. New York, Pantheon Books, 1982.
  32. Velu J. The European Convention on Human Rights and the right to respect for private life, the home and communications. in Robertson AH (ed) Privacy and Human Rights Manchester, Manchester University Press 1973:12-95.
  33. Anderson R. NHS-wide networking and patient confidentiality. Br Med J 1995;311:5-6
  34. World Medical Association. Resolution on Computers at the 27th World Medical Assembly.
  35. Secretary of Health and Human Services. Confidentiality of individual-identifiable health information. Recommendations pursuant to section 264 of the Health Insurance Portability and Accountability Act of 1996. September 11, 1997.
  36. Council of Europe. Committee of Ministers. Recommendations No R(97)5 On the protection of medical data. 1997.
  37. Anderson R. Clinical systems security: interim guidelines. BMJ 1996;312:109-111
  38. Silverman WA. The myth of informed consent in daily practice and in clinical trials. J Med Ethics 1989;15:6-11
  39. Report of the Council on Ethical and Judicial Affairs. Fundamental elements of the patient-physicians relationship. JAMA 1990;264:3133
  40. Caplan A. On privacy and confidentiality in social science research. in Beauchamp TL (ed) Ethical issues in social science research. Baltimore, Johns Hopkins University Press 1982;312-325.
  41. Pheby FDH. Changing practice on confidentiality; a cause for concern. J Med Ethics 1982;8:12-18.
  42. Tamm JM. Computerized medicine and questions of ethics. Medicine and Law 2,2:1983.
  43. Butler D. Data network threatens patients privacy. Nature 1997; 386: (6620) 6.
  44. Jonsen, AR. The New Medicine and Old Ethics. Cambridge,Mass, Harvard University Press, 1990:101
  45. Skolnick AA. Protecting privacy of computerized patient. information may lie in the cards. JAMA 1994;272:187-189
  46. US Congressional Office of Technology Assessment (OTA) : Protecting privacy in computerized medical information Washington DC :US Government printing office; September 1993.
  47. Neame R. Smart-cards-the key to trustworthy health information systems. BMJ 1997;314:573-577
  48. Craft N. No touch technique BMJ. 1996;312:318-319
  49. Barrows RC, Clayton PD. Privacy, confidentiality and electronic medical records. JAMIA 1996;3:139-148.
  50. Cullinan T. International medical ethics: is it possible?. J Med Ethics 1994;20:55
  51. Horner S. Confidentiality of information on NHS network must be addressed. BMJ 1996;312,579.
  52. Conseil de l'Europe. Rapport explicatif à la Convention pour la Protection des Droits de l'Homme et de la Dignité de l'Etre Humain a l'egard des applications de la biologie et de la medicine: Cconvention sur les Droits de l'Homme et la Biomedicine. DIrection des Affaires Juridiques, Strasbourg, janvier, 1997. Article 10/63
  53. Directive 95/46 CE du Parlement Européen du 24.10.1995.  Protection des personnes physiques pour le traitement des données personnelles et la libre circulation de ces données.
  54. Projet de Convention pour la protection des droits de l'Homme et de la dignité de l'être humain à l'égard des applications de la biologie et de la médecine: Convention sur les droits de l´Homme et la biomédecine. Direction des Affaires Juridiques. Conseil de l'Europe, Strasbourg juin 1996 DIR/JUR (96)7.

ETHICS AND MONEY
A view of ethics, money and collective resources
M.C. MILANO

When Jean Escourrou suggested that I write this chapter on Ethics and Money I felt that I had to do it from my own Land and from Argentina’s own history, intertwined with the reality of a Latin America, torn and impoverished.
This social reality is intimately bound to a model that is both economic and political.
How, then, are we to deal with the subject of money from within a society crushed by neo liberalism, still ailing from a post war and that must, as every society, defend the stars of social welfare ?
These stars ~ Food, Health Care, Education, Housing and Old Age Retirement ~ are placed in the heart of a Public Health system that should be equitable, distributive and ethical. (1)
Perhaps History was not the same in Europe as in Latin America. What happened here, in the South, then, in the era of neo liberalism ?
In a poor Latin America several countries increased exports, thus allowing some nations to experience an annual growth rate of 5% between 1950 and 1975. Figures showed that each Latin American increased his/her income by 3.2% (a rise that would anyway prove insufficient correlated with demographic growth), though this increase was not distributed evenly and was in fact absorbed by the higher layers of society.
‘’Airs of welfare’’ spread, both from the UK with a promising National Health Service, from the US proclaiming equity principles and from within Latin America itself through a State generator of development. This Latin America failed to see that such privileges would be temporary, as wealth was not being re applied as a resource. Later did we realize that hard times would come only too soon. (1)
These patterns of a ‘’happy dream’’ conformed a society based on consumption and oblivious of the means to support it, in a frame of political authoritarianism and a ‘’practically liberal’’ market that was beneficial to very few, made many suffer and planned little for the future. So that Fair Play was neither play nor fair.
The state budget absorbed, and squandered, most of the public spending, actually leaving social spending far behind. Concern was laid on the struggle against ‘’communist contamination’’, while ‘’other’’ contamination disseminated ~ that of poverty and socioeconomic and infectious diseases such as cholera in Peru in the late 80’s, and from there southwards. Money was spent on new aeroplanes, though we lacked tap water in extensive areas of our countries. And the custody of the system was heightened and good business rolled on, paying no heed to ‘’the unprotected of Latin America’’. Eventually the storm reached the South.
The oil crisis along with progressive development of technology lowered prices in the North making the South a low price provider. This allowed creditors to ‘’tighten the rope’’ to a point that made true that statement of the United Nations Program for the Development the more they pay, the more they owe.

In Argentina, in particular, to the ‘’change’’ operated in the early 70’s added the military coup of 76. The economic crisis eroded the meager hopes of a promised day once hoped for, the country ‘s open veins bled secretly echoed by the chants of the world football cup of ‘78, and painful suppression and economic stagnation followed. The external debt grew larger and eternal.
The 90’s found a country fighting with recession, as the rest of Latin America, with a democracy hounded by increasing debt and adjustment, and paying , in turn, with a lack of education, poverty, misery and hopelessness.
A deeper, more painful debt had been contracted. And it was that with the country’s own citizens. (2)
In the years l982~l989 Latin America transferred to its creditors the sum of U$S 203.000 millions. In 1992 the debt had increased to U$S 101.000 millions.(3)
This is the beginning of the North ~ South conflict. A fact that is not merely economic and political. It sets also a cultural difference, principally in terms of health attention.

‘’The Third World’’, a conception that was used to identify the poor countries, especially from the 70’s, actually means ‘’the poverty world’’ and was already present in the northern countries. This notion has now changed and might be more accurately described as the world of ‘’the two thirds’’ as defined by Xavier Gorostiaga. (4)
The 20% richer segment of the world’s population has an income that is 150 times higher than the poorer 20%. (2)
In this frame of neo liberal markets the concept of ‘’democracy’’ is a difficult one to keep, as it is the largest part of the population who will inevitably receive the impact of adjustment.
The ordinary citizen became gradually aware that health and education were no longer equitable and free of charge, that they had to pay for medical attention, in part or totally, that the Public Hospital was a patient in the Intensive Care Unit and the money was gone and still there were sick people to cure and children to educate.
And now who shall we turn to ? Shall we see whether our popular saying that ‘’God is Argentine’’ actually turns true ?
When the hour comes to figure out, to define distribution of resources, to answer the demands of the World Bank, to choose between a net of ordinary tap water and computed tomography, then either God’s telephone line happens to be busy, or He is expecting someone else’s call. Now Society cannot wait any longer.

And so we walk on stage at the present Latin America, as health care workers.
This introduction is simply meant as a general background of the hard social reality we are confronted with in our daily lives and work and with which we have to interact in our effort to integrate the results of international multicentric trials with the lack of means, the ambition to publish and be included in foreign research with the absence of a National Health Budget. And so...we come round to Ethics and Money, a current dilemma of how to deal with such essential needs as primary attention, which, without due care, have only given way to diseases that we wrongly thought eradicated ~ as is the case of Cholera, Tuberculosis, Leper and Malnutrition.
Now if we come back to ‘’The Stars of Social Welfare’’ and take Food, for instance, who can say that ‘’Food’’ shines brighter than, let’s say, Old Age Retirement or Housing? However bright these stars may shine on their own, all are needed ablaze to light a country’s way.
As defined by J.C. Escudero, ‘Food Security’ means the possibility for all human beings to get the food they need to meet the demands of their genetic message or physical activity, whereas ‘Food Insecurity’ happens when food intake stays below the needed requirements, sometimes for natural causes but more often for social reasons or the social processing of natural facts, eventually leading to impaired or retarded growth, sickness or death.(5)

In 1991 ‘’The Hunger Report’’ stated that 20% of the world’s total population (approximately 1.000 million people) do not receive adequate nutritional energy to meet the minimal requirements, 24 million children (16% ) present low weight at birth and 204 million children have low weight gain during their first five years of life. According to the same report around 10.000 people, mostly children under the age of six, die of malnutrition yearly. (The highest rates belong to Asian, African and Latin American countries).
Which is then, our reality, within Latin America, within that "two thirds" of the world, confronted with a distribution of resources that is insufficient, inequitable and immensely selfish ?
Which is the role of a full time physician working in a public hospital as a health care provider of a citizen that lacks health coverage, left to the "State’s mercy" ?
Which decision making policy should then prove ethically sound when we have to decide whether or not to accept high cost procedures ~ as is the case of Bone Marrow Transplant (BMT) ~ that will be paid entirely by an impoverished State ?
The last issue of Clinical Oncology (6) lists detailed indications for BMT; these are rather extended in our milieu. Is this ethical ?

In terms of cost alone, BMT rounds up to U$S 70.000; not including transplant failure and subsequent expenses derived from chronic diseases in the recipient, secondary endocrinology disorders, new tumors and, especially in children, impaired growth and neurological disorders with the accompanying psycho social sequels.
If we think in terms of "Food Security", for a while, we have in our country 13.000.000 children and adolescents (30% of the country’s total population), one third of which live in poverty (UNICEF available data), are consequently malnourished and will never develop their full intellectual potential.(7).
The Argentine State provides schools and day care centers with a "glass of milk" (milk plus basic foods) at a cost of 0.80 cents (1 peso = 1 dollar/day). Now, with a given stipend of U$S 70.000 the State could offer 87.000 rations to 239 poor children during one year, a basic nourishment they will not get otherwise.
Is it ethically sound for an impoverished state to dream of expensive treatments, moderately cost ~ effective, in between socioeconomic crisis and an agonizing public health ?

According to the latest World Bank Report, the cost of health in Argentina goes up to almost U$S 20.000 millions yearly. A sum equivalent to 7% of the country’s annual gross national product (GNP) or to U$S 600 per year per inhabitant. This percentage is high compared with the rest of Latin America, but low compared with 9.9% (Canada) and 14% (USA). It is financed by the State and the users. The State supplies public hospitals with U$S 4.000 millions yearly.(8)
But then again, if we put to one side for a moment the crisis in the sector and the distribution of resources, there is still the ethical question of "how to say NO"(9) to patients, physicians and pharmaceutical industries; a concern involving not only the southern countries, but now also present in the North. In The Lancet, in 1997, (10) (11) evidence is given of how the industry exerted pressure on independent researchers, terminated trials and manipulated patients advocacy via the media.

The Social Welfare Reform Law passed in the U.S. as recently as August 1996 stated that the federal budget will be reduced in U$S 55.000 millions. This will bring about poverty for more than 2.6 million people. Will the North, then, be able to go on spending ?
What about equity then ? What about first class and second class citizens ?
And if we turn to central Europe now, recent demonstrations in Amsterdam (June 1997) claimed for the Unemployed (18 millions) and the Poor (50 millions). After the change of the French Government, the German Economics Minister stated that Germany "will not invest any more money in European Social Projects" (12). What has changed, then, since that declaration of European Unity signed on the ruins of the post war, (Shuman Declaration, May 9, 1950) where Germany proposed joint efforts under a common administration? Are we witnessing the fall of out and out neo liberalism?

BMT, an example of "high tech" procedure, is now discussed amongst Americans as a negative factor on the health budget for primary attention and prevention. Far from the skepticism of the British, some Americans themselves have criticized their own "laissez faire" in faced with the "tragic choices"; and they question themselves on topics such as the high cost attention for the Elderly. In terms of cost alone, the largest health care expenses are those of old age. To avoid "over treating" and the use of expensive high tech at the end of their lives the elderly patients may be offered to sign "advance directives", thus resigning beforehand "heroic" manoeuvers (13). Is this not an example of a covert rationing to hold down state health costs? Are these patients actually being offered a safeguard ? Or subtly pushed to give way to feelings of anxiety and guilt and the fear to become a burden to their families ?

On the one hand, the ethics of palliative care and the right to a dignified death "humanizes" a life’s end allowing patients to meet again their loved ones, hampers Euthanasia (active, passive, direct, indirect, voluntary, involuntary ) and also protects the patient from being "overpowered by overzealous physicians or institutions" (13 ). But on the other hand, we must have the courage to admit that we might also be pleasing a market that claims for shorter hospital admissions, cost reduction of public expenses, and less money for the attention of the terminal or the elderly.
We are then dealing with a hierarchy of values. Coming round to the "Stars of Social Welfare" we might need to make it a priority, for instance, to build a tap water network before buying a computed tomographer and to start with "assisted birth" to reach, eventually, "assisted death".

In the past century philosophers and scholars were busy thinking of "birth control", while the turn of this century finds us worried about "death control". When thinking of the expenses at the end of a person’s life, we might as well look at those of the beginning of life. In the world of the "two thirds", more than 60 % of births do not have medical assistance.(14). In Bolivia, for instance, maternal mortality rate during labour is 400/100.00 (100 times higher than in Japan). We might as well turn our attention to "the Stars" of Food Security, Housing and Education; all of them essential for a person’s dignified life. A country that cannot afford to have medical attention at birth, that comes from malnourished mothers, that lacks proper housing and schooling is bound to underdevelopment and will obviously have no retirement benefits in old age.

In this frame of unattended needs the question is less to deny a medical indication than rather to set a priority and be able to tell the "very urgent" form the "important". G.Berlinger’s view of "Bio ethics of Justification" may throw light on this matter when he speaks of the "dubois" tendency to think that what is technically possible can actually be done, it is fair that it be done and be considered legally right, for which it is illegitimate to prevent it. (15)
BMT is an example of the pressure exerted on physicians to indicate expensive therapeutic measures. There are reasons at the same time economic, social and ethical. First we have to admit that it is a profitable practice, mainly for the so called "tertiary" hospitals with the necessary infrastructure, trained staff and specialised laboratories. Then ( which, in part, can set their minds to rest) the cost could be reimbursed by third parties, as is the case with developed countries. Social reasons are more subtle; the urge to meet "cutting edge research" (not to mention the hard sell machinery of the pharmaceutical industry ) may push physicians and hospitals to overpower the patient, added to the prevailing attitude in our culture to build on the fast and new. Then again nothing should interfere with the ethical imperative of doing all for the "patient". But... Is there always a reason, on ethical grounds, for expensive indications ? Why do we more often indicate BMT in a child with acute leukaemia than a liver transplant in a cirrhotic adult ? (16)

We might argue that both have equal rights to have access to a transplant, but, is it really so ? Do we all have identical rights ? Are these rights respected ? Are all patients equal before the State ? And before the physician ? Are they all equally treated ? Is a hospital patient equal to a private one ? Are the rich and the poor the same ? The ordinary and the interesting ? The easy and the difficult ? The contagious and the terminal ? The old and the young ?
An article in the Journal of Clinical Oncology (17) mentions discriminative factors for accessibility, such as race (patients were divided in white, black and "others"), age and, notably, social coverage (private, uninsured and underinsured).
Italian Democracy has established the so called "Tribunal for the patient’s rights". In some cities, Toscana for instance, people collected signatures and a letter was written demanding that a sick person be treated with dignity and understanding by all health care workers, and his or her right to a global assistance be respected, physically and psychosocially.(18)

There have been similar reactions in Latin America. In Brazil, with the "Encontros Nacionais de Medicina Comunitaria", since 1978. And from catholic progressive groups that understood health as a God’s law directed to us all (so we all deserve it ). There is a reversal of the feeling of guilt for being sick; disease results from a lacking situation, does not emanate from the person. There were similar movements organized by workers in Sao Paulo, Brazil, after this initiative.
It is widely accepted that a person’s rights and obligations are closely correlated. (19). As far as Health is concerned, the State has the obligation to provide all citizens alike with the "Stars of Social Welfare" and all citizens alike are endowed the right to get them, live with dignity, achieve fulfilment and be happy~ for the Greeks, one’s ultimate end as a person.
Either from a religious perspective (as in Brazil’s example) or from the popular belief, Ethics must defend the people’s basic needs ~ the powerful shining of the "Stars of Social Welfare", all that dignifies Man, and hence, a Country.
From the very first of these lines I wondered at the question made by Jean Escourrou: Ethics and Money; or actually Ethics or Money ?

REFERENCES:

Neri, A., Sur, Penuria y Después, Emece Editores, Bs.As., 1995, p14-p22-34.

Rebellato, José Luis. La Encrucijada de la Ética. Neoliberalismo. Conflicto Norte~Sur. Liberación Editorial. Nordan~Comunidad. Montevideo, Junio 1995. p. 55-65.

Borón, Atilio. Estado, Capitalismo y Democracia en América Latina. Imago Mundi 1992, Bs. As. p. 2l6-9

Gorostiaga, Xavier. La Mediación de las ciencias sociales y los cambios internacionales, Neoliberalismo y Pobres. El debate continental por la justicia. Corre~Gonzalez~Mora (eds.) Santa Fé de Bogota Cinep,1993, p. 563-587.

Escudero, J.C.,Notas sobre Seguridad Alimentaria, Salud, Problema y Debate, N 11, Invierno 1994, Bs. As.,p 5-16.

De Vita JC,Hellman VS,Rosemberg S.Cancer Principles and Practice of Oncology.5th edition,vol 2. 1997,Lippincot Raven (publishers).Philadelphia New York, p2206-2207.

Héctor Pavon, "Clarín" Newspaper, Bs As, August 3, 1997.

Bermúdez Ismael, "Clarín" Newspaper, Bs..As, February 2, 1997.

Daniels N., Why saying "no" to patients in United States is so hard. NEJM, vol. 314, n. 21, 1986, p. 1380 ~ 1383.

The Lancet. Good manners for the pharmaceutical industry, vol. 349, n. 9066, June 1997, p 1635.

The Lancet.A curious stopping rule from Hoescht Marion Roussel, vol. 350, n 9072, p155,June 1997.

Viceconte Araceli, "Clarin" Newspaper, Bs.As, June 15, 1997.

Callahan D.Controlling the Cost of Health. Care for the Elderly -Fair Means and Foul, NEngJ.Med,Sept 5,1996, p. 744.

Dr. José Portillo, personal communication, Latin American Congress of Social Medicine, Bs. As, March 1997.

Berlinger, G. Bioética: reglas y culturas. Salud ,Problema y Debate, primavera 96.,p 18.

Durbin Meg MD., BMT Transplantation; Economic, Ethical and Social Issues, Pediatrics, Vol. 82, n 5, November 1988.,p 774-782.

Mitchell, J. M, Meehan, K.R., et al. Access to Bone Marrow Transplantation for Leukaemia and Lymphoma: the role of socio- demographic factors. J Clin Onc 15: 1997, 2644-265

Berlinger, G., La Enfermedad, Lugar Editorial, Marzo 1994,p 124-125.

Jacques Maritain, Preliminary Notions of Moral Philosophy, Artes Graficas, Bs. As., 1966, p177.

ENDOSCOPY AND CLINICAL TRIALS
J.H. SOLHAUG

"In research on man the interest of science and society should never take presedence over considerations related to the well-being of the subject" (Declaration of Helsinki,1964)
Endoscopy has been one of the most expanding fields within clinical medicine during the last 20-30 years. An Ovid Medline search of the literature with the text words,- endoscopy and clinical trial, revealed an enormous increase in reported trials from 1966 to 1998,

1966-74 87 publications
1975-79 150 "
1980-84 237 "
1985-89 615 "
1990-94 1340 "
1995-97 1432 "

The rapid development and general adoption into common practice of these new and expensive techniques creates several dilemmas,- How to learn? How to teach? How to interpret the images? Which equipment? Which procedure? Need for randomized studies? Cost and efficacy assessment, etc........ Any new procedure must be compared with existing procedures or against untreated patients. Potential benefits and risks of the new procedure must be carefully evaluated. Failure to do this is unethical.
Introduction of a new technical procedure is a form of research and should be assessed in clinical trials like any new diagnostic or therapeutic procedure. It is covered by the Declaration of Helsinki and should be approved by an Ethics Committee. The evolution of new techniques implies research in patients. Developments in clinical practice often contain elements of clinical research. The distinction between clinical practice and clinical research may be unclear. Sometimes this lack on clarity may be used to avoid the ethical review process which always should precede the introduction of new technologies. Research on patients should always be submitted to the scrutiny of an ethics committee.
The continuing growth in use of endoscopy for diagnosis and treatment of patients urged the need for reliable and solid data with respect to the application of endoscopic methods to clinical problems. Any new discovery or any technical improvement runs the risk of its overuse or being used in non-appropriate applications. This certainly applies also to diagnostic and therapeutic endoscopical procedures. Before these new methods can be compared with existing modalities they must first be tested in a small number of well monitored patients to see if they have any diagnostic or therapeutic advantages. The techniques of modern clinical medicine are the results of an accumulated corpus of observation, recording, reflection, discussion and publishing (1).

When comparing the outcome of different endoscopy procedures the main problem is to avoid subjectivity. The results presented by different endoscopists must have the patient population and their lesion clearly defined. Detailed and understandable outcome measures are required. A major problem is that most results are reported by the people who have performed the procedure with an inherent risk of bias in collection and interpretation of the data. Conclusions are often drawn in order to show the superiority and to promote the technique possessed by the author(s) whose main supportive recommendations are prestige and passion of the experts. Diagnostic endoscopies and endoscopic applied therapy have been pioneered by enthusiasts and often adopted by consensus without scientific proof by conventional clinical trials. In some cases, the extended use of endoscopy has even continued in spite of negative trial results (2). However, there has been significant improvement in the quality of endoscopy reporting and documentation.

The question of the "best" therapy is most appropriately answered by randomized trials comparing the different endoscopic modalities. Since all these therapies seem to be highly effective, studies comparing them have to be large in order to reach enough power to detect any differences. Many studies can therefore be done only on a multicenter basis.
Thus, a common problem with research projects involving new technology is the fact that researchers have insufficient time to study samples large enough to produce results that are statistically reliable. The demand from patients, media and the industry may force the researcher to publish and draw conclusions before an adequate evaluation is performed. Otherwise, the method may be adopted by others and the new technique become established routine - at which point proper evaluation becomes impossible. Thus, the resolution of clinical problems must often be based on analyses of events and observations that occur in non-experimental circumstances. By using adequate methods for collecting and analyzing data, such observational data may, however, become of great clinical importance.

Any investigation or study in man designed to develop or contribute to increased medical knowledge raises ethical issues and should be subject to ethical reviews. Patient’s participation should be based on a full and understandable explanation of the procedure including both benefits and hazards. Voluntary consent of the patient is absolutely essential. It is the doctor’s duty to inform the patient sufficiently to enable him to make up his own mind. The first sentence of the Nurenberg code strongly underlines the consent requirement in research using human subjects. The purpose of a procedure may be diagnostic, therapeutic or for research including the development and assessment of new techniques. The patient should be fully informed of which of these is applicable in his case. It is the obvious right of the patient to refuse participation.
Introduction of new gastroenterological techniques are expensive and economic concerns must influence the decision whether it is right for a community to bear the costs of the new technology. If it is introduced at the expense of limited funds in a limited economy, more essential medical care can be jeopardised. Then, fundamental ethical questions will be raised.

We must also recognize the problems that introduction of new, sophisticated and expensive technology brings to the developing countries. Medical priorities and financial resources of a society must be taken into account and will govern the size and the scope of the endoscopical facilities. Thus, what might be ethical to introduce into one society might not be ethical in another, due to different cultural and socio-economic differences.
Not all new technologies and clinical procedures can or should undergo a formal randomized comparative assessment (3). Randomized trials are unfeasible for studying minor changes in therapy or modifications due to rapid technological improvements in available diagnostic or therapeutic procedures. Thus, despite the scientific superiority of the controlled randomized clinical trial, observations occurring in the every-day care of patients require also major attention. Long-term randomized trials will be frustrating in circumstances where the available technique or treatment frequently changes and new powerful regimens occur (4).
A major problem in assessing technical procedures is that the results often depend more on the endoscopist than on the technical facilities. Thus, the problem of varying expertise may play a major role in evaluating technical procedures. On the other hand, careful registration and documentation of patients and patient outcome is necessary if any judgement should be possible without randomized trials. End points of the study, relevant protocol and unbiased assessment of the outcome must be clarified before the study starts.

Healthy volunteers present an obvious ethical challenge. Clearly the kind of procedures they are asked to undergo is restricted. Diagnostic procedures with minimal risks may be used while invasive procedures including biopsies are questionable and endoscopic therapeutic procedures impermissible.
In clinical, technological research there is a close partnership between the industry and the medical profession. In this cooperation the clinician must, of course, have the freedom to conduct the study according to sound scientific principles, freedom to publish the results and be aware of the ethical issues that may occur.
Looking back on the history of medicine the risk that a new technique will be introduced and accepted without adequate evaluation is obvious. It soon becomes "established". At this point prospective, controlled studies or proper evaluation becomes impossible. It is difficult, also ethically, to do a trial once the treatment has been generally accepted.

Evaluation of diagnostic technology.
The diagnostic yield in upper and lower endoscopies has been documented in numerous reports and are well established clinical methods. There are, also, several prominent issues that have been studied in randomized trials in evaluating endoscopic technology. Sedation, cleaning regimens and endoscopic haemostasis are issues studied in well-designed prospective trials (5,6,7,8). In endoscopic comparative pharmacological trials, blinded, double-dummy study design is suitable (9).

Bile and pancreatic ducts. A large number of laboratory tests, radiological methods and endoscopic techniques are available for the evaluation of the jaundiced patient. The challenge is to select, on an individual basis the most efficient and cost-effective method as well as the therapeutic option with the lowest mortality and morbidity rates and the best short- and long-term results. Endoscopic retrograde cholangiopancreatography (ERCP) is a combined endoscopic and radiological technique requiring good cooperation between endoscopists and radiologists to achieve optimal results. It is well established in the diagnosis of biliary and pancreatic diseases, duct stones, inflammation and malignancies.

Morphological changes indicating biliary or pancreatic tumors should be proven by tissue diagnosis. Retrograde brush cytology through the duodenoscope is an effective method with a reasonable sensitivity and high specificity (10). Spinchter of Oddi manometry is still controversial and under investigation needing further documentation before introduction into general clinical work (11,12).

Enteroscopy. Several reports have been published dealing with intubation technique and clinical results in small-bowel endoscopy. This, often cumbersome and difficult method seems most useful in the investigation of occult gastro-intestinal bleeding (13,14) and in patients with uncertain diagnosis after pathological laboratory or radiological findings (15). Peroperative small-bowel enteroscopy in patients with occult intestinal bleeding undergoing diagnostic laparotomy seems effective in revealing the cause of bleeding (16).

Population screening. Extensive surveillance and screening programs in polyp and cancer detection have been advocated to reduce cancer mortality by removing precancerous mucosal changes and detecting malignancies at an early and curable stage. Clinical studies have provided evidence that screening programs have an impact on disease detection and mortality, specially in high-risk groups (17,18,19). Universal screening programs are clearly not possible and a better definition of sub-groups with patients at risk is necessary to optimalize the use of the available resources. Surveillance colonoscopy studies has demonstrated a yield in revealing later neoplasis (20,21,22). In the last years, the benefit and role of endoscopic surveillance in patients with inflammatory bowel disease and following colo-rectal surgery has been questioned (23,24). Further cost- benefit studies are awaited. The ethical dilemma of randomizing people to a control arm in surveillance or screening studies is obvious. One main difficulty of assessing the different screening and surveillance programs is the lack of controlled studies.
The total cost of repeated colonoscopic investigations will increase due to the fact that people become older and the number of patients needing follow-up will increase.It is impossible, within the budgetary situation in most countries today to afford general population screening and, therefore, it is important that surveillance and mass follow-up programs are really scientifically based and correctly carried out in the right population.

Future methods. A large number of papers have confirmed the accuracy of endoscopic ultrasonography (EUS) in preoperative locoregional staging of malignant tumors and in locating endocrine pancreatic tumors (25,26). It is superior to CT or MRI in oesophageal (27) and pancreatic tumor staging (28). In a recent study magnetic resonance imaging (MRI) compared favourably with EUS in the staging of rectal cancer (29). The practical use of MRI in staging and detecting recurrences must be further studied and evaluated in comparable studies. Thus, while some indications are established on the basis of accumulated data, further prospective outcome studies using EUS are desirable. EUS has not yet, reached general use and is still concentrated to a limited number of hospitals. It is important to realize that unwillingness and an extended "wait and see" attitude in introducing new and effective technology may also give rise to serious ethical considerations.
The development of genetic and biological markers may replace future endoscopies, allowing more optimal allocation of endoscopic resources for treatment and surveillance (30).
The advent of virtual endoscopy is gaining growing interest but must be tested against available methods before being introduced into general practice. It may in the future replace some of the diagnostic, endoscopic techniques but it is time-consuming and carries the risk of additional radiation burden to the patient.
The advent of magnetic resonance cholangiopancreaticography (MRCP) is non-invasive and will probably replace diagnostic ERCP’s leaving mainly the therapeutic role to ERCP. Comparable studies are planned and awaited.

Evaluation of endoscopic treatment
Since its advent about two decades ago, therapeutic endoscopy has steadily grown and proved to have an important impact in several clinical situations. Continuing improvements in the endoscopes and accessories together with increased clinical competence are still widening the use of endoscopic treatment modalities.

Esophagogastric varices. The traditional method of sclerotherapy has been studied in randomized studies with respect to injection technique and sclerosants. It has been challenged by new endoscopic modalitites, such as cyanoacrylate injection (31) and variceal rubber band ligation (32). Prophylactic sclerotherapy is still a controversial issue. While prophylactic sclerotherapy had a good effect on the bleeding incidence, the impact on survival was more uncertain in two prospective trials (33,34). In a multicenter, randomized study from Vienna, sclerotherapy did not show any significant effect on either bleeding or survival (35). However, meta- analysis of fourteen randomized studies has shown a significant benefit in Child B and C patients (36).
Endoscopic variceal ligation has been compared to sclerotherapy in several studies (37,38). Ligation is effective in stopping the bleeding with less risk of rebleeding and complications. A meta-analysis of randomized trials confirmed the reduced risk of rebleeding, the efficacy in eradicating the varices and reducing local complications (39). Multi- band ligator devices permitting up to six ligations with a single scope insertion without the need of an overtube have recently been introduced and are gaining increasing popularity.

Upper gastro-intestinal non-variceal bleeding. A peptic ulcer is still the most frequent cause of upper intestinal bleeding. Endoscopic injection therapy is well established as a first hand treatment. Adding a sclerosant to epinephrine injection does not seem to improve the results but increases the complication rate (40). Histoacryl showed no benefit over epinephrine injection (41). In prospective studies the outcome of epinephrine injection or sclerotherapy compared to laser treatment was similar (42). The costs, however, are highly different!!!
In a prospective study from Taiwan a distilled water injection was as effective as epinephrine injection in controlling ulcer bleeding (43). Fibrin sealants (a combination of thrombin and fibrinogen) as an injection therapy are expensive and difficult to use and do not offer any clinical advantages. Coagulation therapy using a heater or bipolar electrocoagulation probe has no advantages compared to injection therapy (44).

Percutaenous endoscopic gastrostomy (PEG). The main interest has been focused on nutrition (45) and decompression in malignant intestinal obstruction (46). With the refinement of the technique and equipment the complication rate is reduced.

Therapeutic Biliary endoscopy. The management of biliary stones was revolutionized with the introduction of endoscopic sphincterotomy (ES). It has, since then, replaced surgery in the treatment of bileduct stones in elderly, high risk patients. The benefits are less obvious in younger patients with less operative risks. ES and removal of the duct stones before open cholecystectomy showed no advantages compared with surgery alone in a randomized study (47). The treatment of obstructive common bile duct stones complicated with acute cholangitis or pancreatitis in desperately ill patients is an emergency situation calling for decompression. Endocopists have long been convinced that urgent ERCP and ES with stone extraction or alternatively stenting would be the method of choice (48,49). In randomized studies the advantage of endoscopic decompression compared to surgical decompression has been demonstrated (50).
Endoscopic ballon dilatation of the biliary sphincter is an alternative for the removal of bile duct stones. The main advantage of the balloon method is avoiding cutting the sphincter with a decreased risk of perforation and bleeding complications. An Increased risk of pancreatitis or difficulties in the removal of the stones have been the theoretical disadvantages. In a randomized study Bergman et al. (51) compared the two methods. The success and complication rates were similar while the risk of acute cholecystitis in the follow-up period was reduced in the balloon dilated group indicating that preservation of the sphincter function may prevent long-term complications. This excellent study clearly demonstrates that it is possible to perform scientifically high standard studies even within the field of endoscopical treatment.
A variety of lithotripsy techniques and dissolution therapies have been used in managing big and difficult stones (52). Methods of stone extraction have been evaluated in prospective studies (53).In follow-up studies after successful sphincterotomy and stone extraction an expectant attitude with respect to surgical removal of the gallbladder is appropriate(54,55).
In prospective, randomized studies different types of stents have been compared in patients with malignant biliary obstruction (56,57).

Therapeutic pancreatic endoscopy. Endoscopic therapy has been increasingly used in pancreatic disorders. Lack of prospective studies and long-term results contribute to the uncertainty and controversies. In gallstone pancreatitis, however, ES has been shown to reduce late pancreatic complications or recurrences even in patients with the gallbladder "in situ" (58,59). These findings indicate that sphincterotomy alone without surgery of the gallbladder is safe and further surgery could be avoided in high risk patients. Randomized studies are lacking.
Early papillotomy has been advocated in patients with gallstone pancreatitis (60). In the first randomized study reporting urgent ERCP with ES compared with conservative treatment in patients with acute pancreatitis,- mortality and morbidity rates were reduced in the ES group (61). Recently the significance of emergency ERCP has been questioned and elective ERCP seems adequate even when remaining bile duct stones are assumed (62).
Pancreatic duct stenting seems to be beneficial in patients with pancreas divisum or idiopathic recurrent pancreatitis (63). There is growing evidence in the literature that endoscopic therapy is beneficial in the management of pancreatic duct stones and pseudocysts (64,65,66).

Colonic tumors. Colon cancer screening and the removal of neoplastic tumors are considered to be the major factors in the improvement of survival rates in patients with colo-rectal neoplasies. Malignant polyps can be endoscopically removed. If the polyp is completely excised with no evidence of lymphovascular invasion further surgery seems unnecessary (67).

Malignant obstructions. The effect of endoscopic treatment of malignant obstructive diseases has been assessed, prospectively in several studies. Endoscopic therapy of tumorous obstruction has been dominated by laser treatment or expandable stents (68). These techniques are safe and technically feasible and indicated in selective patients for palliation.

Future methods. Photodynamic therapy has been tested in the treatment of papillary tumors (69), in colosigmoid villous adenomas and polyps of the colon (70), in oesophagogastric tumors (71) and in potentially malignant mucosal changes (72).
The advent of laparoscopic biliary surgery has increased the demand for ERCP and endoscopic therapeutic procedures being the methods of choice to confirm and treat the majority of patients with bile duct injuries and residual stones following laparoscopic cholecystectomy.

Concluding remarks. The need for cost reduction is the driving force in most health systems at the moment. In the shrinking health care budgets, a proper evaluation of new technologies and clinical strategies is mandatory to secure optimal patient care and optimize cost-benefit outcome. The overall cost and quality of life assessment in endoscopic research has been limited and must be improved. Introduction of poorly assessed and poorly evaluated technology may be harmful both to the individual and to the society.
The patient should be protected from unnecessary endoscopy and from an endoscopist without adequate experience or competence. Without peer review the rate of unjustified or inappropriate endoscopies reach 20-25%, representing hundreds of million of dollars spent unnecessarily every year (73,74). New studies that better evaluate the value and cost- effectiveness of endoscopic therapy or palliation and define subgroups that benefit the most, are currently being conducted. These studies will have an important impact in future evaluation and treatment of these patients. Further comparable studies concerning diagnostic and therapeutic yield are desirable. Whether this will be constrained by economic and other factors in the future, remains an open question.
In a survey of the literature it is obvious and encouraging to observe that the scientific basis of new endoscopic technology before introduction into general use has improved. The quality of documentation and endoscopic studies has markedly improved and ethical review is now accepted as an integral part of serious endoscopic research.

REFERENCES:

  1. Evans D, Evans M. A decent proposal. Ethical review of clinical research. Chicester. John Wiley and Sons. 1996; p 54.
  2. Cotton PB. Therapeutic gastrointestinal endoscopy. Problems in proving efficacy. New Engl J Med 1992; 326: 1626-1628.
  3. Bouchard S, Barkun AN, Barkun JS, Lawrence J. Technology assessment in laparoscopic general surgery and gastrointestinal endoscopy: Science or convenience? Gastroenterology 1996; 110: 915-925.
  4. Feinstein A R, An additional basic science for clinical medicine. The limitations of randomized trials Ann Int Med 1983; 99: 544-550
  5. Martin JP, Arlett PA, Holdstock G. Development of a sedation policy for upper GI endoscopy based on an audit of patients’ perception of the procedure Eur J Gastroent Hepat 1997; 8: 355-357.
  6. Sharma VK, Chockalingham S, Clark V et al. Randomized, controlled comparison of two forms of preparation for screening flexible sigmoidoscopy. Am J Gastroent 1997; 92: 809-811.
  7. Dronfield MW, Ferguson R, Mcillimurray MB, Atkinson M,Langman MJS. A prospective , randomized study of endoscopy and radiology in acute upper gastro-intestinal bleeding.
    Lancet 1977; 1: 1167-69.
  8. Peterson WL, Barnett BS, Smith HJ. et al. Routine early endoscopy in upper gastro-intestinal tract bleeding: a randomized, controlled trial. N Engl J Med. 1981; 304: 925-29.
  9. Biabchi Porro G, Lazzaroni M, Petrillo M. Double-blind, double dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatoid arthritis. Am J Gastroent 1997; 92: 663-667.
  10. Osnes M, Serck-Hansen A, Myhren J. Endoscopic retrograde brush cytology of the biliary and pancreatic ducts. Scand J Gastroent 1975; 10: 829-831.
  11. Vestergard H, Kruse A, Rokkjaer M, et al. Endoscopic manometry of the sphincter of Oddi and the pancreatic and biliary ducts in patients with chronic pancreatitis. Scand J Gastroent 1994; 29: 188-192.
  12. Evans PR, Dowsett JF, Bak YT. Abnormal sphincter of Oddi response to cholecystokinin in postcholecysectomy syndrome patients with irritable bowel syndrome. Dig Dis Sci 1995; 40: 1149-1156.
  13. Van Gossum A, Schmit A, Gay F et al. Results of enteroscopy in patients presenting occult digestive bleeding with or without melena. Gastroenterology 1995; 108: A 335.
  14. Berner JS, Mauer K, Lewis BS. Push and sonde enteroscopy for the diagnosis of gastointestinal bleeding. AM J Gastroent 1995; 89: 2139-2142.
  15. Chong J, Tagle M, Barkin JS, Reiner DK. Small bowel push-type fiberoptic enteroscopy for patients with occult gastrointestinal bleeding or suspected small-bowell pathology. Am J Gastroent 1995; 89; 2143-2146.
  16. Lewis MPN, Khoo DE, Spencer J. Value of laparotomy in the diagnosis of obscure gastrointestinal haemorrhage. Gut 1995; 37: 187-190.
  17. Jonsson B, Åhsgren L, Andersson LO et al. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994; 81: 689-691.
  18. Hoff G, Sauar J, Vatn MH et al. Polypectomy in the prevention of colorectal cancer. 10 years follow up of the Telemark Polyp Study. A prospective controlled population study. Scnad J Gastroent 1996; 31: 1006-1010.
  19. Hofstad B, Vatn MH, Andersen SN et al. Growth of colorectal polyps: recovery and evaluation of unresected polyps for a period of 3 years. Gut 1990; 39: 449-456.
  20. Nakagoe T, Fukuda Y, Ishikawa H et al. Significance of follow-up total colonoscopy after resection for colorectal cancer 1994; 6: 7-16.
  21. Lautenbach E, Forde KA, Neugut AI. Benefits of colonoscopic surveillance after curative resection of colo-rectal cancer. Ann Surg 1994; 220: 206-211.
  22. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981.
  23. Ekbom A. Chronic ulcerative colitis and Crohn’s disease as precancerous conditions: what are the role of colonoscopy? Endoscopy 1995; 27: 50-53.
  24. Kronborg O. Optimal follow-up in colorectal cancer patients tests and how often? Semin Surg Oncol 1994; 10: 217-224.
  25. Røsch T. Endoscopic ultrasonography. Endoscopy 1994; 26: 148-168
  26. Hildebrandt U, Feifel G. Importance of ultrasonography staging for treatment of rectal cancer. Gastrointest Endosc Clin Am 1995; 5: 843-849.
  27. Koch J, Halvorsen RA. Staging oesophageal cancer: computed tomography, magnetic resonance imaging and endoscopic ultrasound. Semin Roentgen 1994; 29: 364-372.
  28. Muller MF, Meyenberger C, Bertschinger P et al. Pancreatic tumors: evaluation with endoscopic US, CT and MRT imaging. Radiology 1994; 190: 745-751.
  29. Meyenberg C, Huch Boni RA, Bertschinger P et al. Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995; 27: 469-479.
  30. Mizuno M, Nakagawa M, Uesu T et al. Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer. Gastroenterology 1995; 109: 826-831
  31. Feretis C, Dimopoulus C, Benakis P et al. Histoacryl plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding oesophageal varices: a randomized prospective study. Endoscopy 1995; 27: 355-357.
  32. Stiegman GV, Goff JS, Michaletz OP et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding oesophageal varices. N Engl J Med 1992; 326: 1527-1532.
  33. Paquet KJ, Kalk JF, Klein CP, Gad HA. Prophylactic sclerotherapy for oesophageal varices in high-risk cirrhotic patients selected by endoscopic and haemodynamic criteria; a randomized single-center controlled trial. Endoscopy 1994; 26: 734-740.
  34. Koch H, Binmoeller KF, Grimm H et al. Prophylactic sclerotherapy for oesophageal varices: long-term results of a prospective study. Endoscopy 1994; 26: 729-733.
  35. Pøtzi R, Bauer P, Schofl R. et al. Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis: long-term follow-up and final rresults of a multicenter prospective controlled randomized study in Vienna. Endoscopy 1993; 25: 287-289.
  36. Fardy JM, Laupacis A. A meta-analysis of endoscopic prophylactic endoscopic sclerotherapy for oesophageal varices. Am J Gastroent 1994; 89: 1938-1948.
  37. Gimson A, Ramage JK, Panos MZ et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 1993; 342: 391-394.
  38. Hashizume M, Ohta M, ueno K. et al. Endoscopic ligation of oesophageal varices compared with injection therapy: a prospective randomized trial. Gastrointest. Endoscop 1993; 39: 123-126.
  39. Laine L, Cook D. Endoscopic ligation vs. sclerotherapy for oesophageal varices: a meta-analysis. Gastroint Endosc 1994; 40: P77.
  40. Choudari CP, Palmer KR. Endoscopic injection therapy for bleeding peptic ulcer: a comparison of adrenaline alone with adrenaline plus ethonalamine oleate. Gut 1994; 35: 608-610.
  41. Choudari CP, Palmer KR. Bleeding peptic ulcer: injection of adrenaline or tissue adhesive (Histoacryl). Gastroenterology 1995; 108: A72.
  42. Carter R, Andersson R. Randomized trial of adrenaline injection and laser photocoagulation in the control of hemorrhage from bleeding ulcer. Br J Surg 1994; 81: 869-871.
  43. Lai KH, Peng SN, Guo WS et al. Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy 1994: 26; 338-341.
  44. Llach J, Bordas JM, Salmeron JM et al. A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhages. Gastrointest Endosc 1996; 43: 117-120.
  45. Senft M, Fietkau R, Iro H et al. The influence of supportive nutritional therapy via a percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Cancer Care 1993; 1: 272-275.
  46. Annizzaro R, Bortoluzzi F, Valentini M et al. Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis. Endoscopy 1995; 27: 317-320.
  47. Neoptolemos JP, Carr-Locke DL, Fossard DP. Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. BMJ 1987; 294: 470-4.
  48. Cotton PB. Endoscopic drainage for suppurative cholangitis. Lancet 1989; 2: 213.
  49. Solhaug JH, Rosseland A. Endoscopic papillotomy in patients with acute cholangitis. Surg Gastroent 1984; 3: 3-7.
  50. Lai ECS, Mok FPT,Tan ESY et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992; 326: 1582-1586.
  51. Bergman JJGHM, Rauws EAJ, Fockens P, et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomi for removal of bileduct stones. Lancet 1997; 349: 1124-1129.
  52. Graham SM, Flowers JL, Zucker KA. Endoscopic management of the difficult common bile duct stones. Surg Lap End 1993; 3: 54-59.
  53. Lauri A, Horton RC, Davidsson BR et al. Endoscopic extraction of bile duct stones: management related to stone size. Gut 1993; 34: 1718-1721.
  54. Solhaug JH, Fokstuen O, Rosseland AR, Rydberg B. Endoscopic papillotomy in patients with gallbladder in situ. Acta chir Scand 1984; 150: 475-478.
  55. Escourrou J, Cordova JA, Lazorthes F et al. Early and late complications after endoscopic sphincterotomy for biliary lithiasis with and without the gallbladder "in situ". Gut 1984; 25: 598-602.
  56. Davids PHP, Groen AK, Rauws EA et al. Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492.
  57. Knyrim K, Wagner HJ, Pausch J, Vakil N. A prsopective randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993; 25: 207-212.
  58. Siegel JH, Verappan A, Cohen SA, Kasmin FE. Endoscopic sphincterotomy for biliary pancreatitis: an alternative to cholecystectomy in high-risk patients. Gastrointest Endosc 1994; 40: 573-575.
  59. Welbourn CRB, Beckly DE, Eyer-brook IA. Endoscopic sphincterotomy without cholecystectomy for gallstone pancreatitis. Gut 1995; 37: 119-120.
  60. Rosseland A, Solhaug JH. Early papillotomy in patients with acute pancreatitis. Ann Surg 1984; 9: 165-167.
  61. Neoptolemos JP, Carr-Locke DL, London NL et al. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988; 2: 979-83.
  62. Folsch UR, Nitsche R, Ludtke R. et al. Controlled randomized multicenter trial of urgent endoscopic papillotomy for acute biliary pancreatitis. Gastroent 1995; 108: A 353.
  63. Lans JI, Geenen JE, Johansson JF et al. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc 1992; 38: 430-434.
  64. Kozarek RA, Ball TJ, Patterson DJ et al. Endoscopic pancreatic duct sphincterotomy: indications, technique and analysis of results. Gastrointest Endosc 1994; 40: 592-598.
  65. Smits MF, Rauws EAJ, Tytgat GNJ et al. Results of endoscopic treatment of pancreatic stones. Gastrointest Endosc 1995; 41: 429 A.
  66. Catalano MF, Geenen JE, Schmalz MJ et al. Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointestn Endosc 1994; 42: 214-218.
  67. Cooper SL, Deppisch LM, Gourley WK et al. Endoscopically removed malignant colorectal polyps: clinicopathological correlations. Gastroenterology 1995; 108: 1657-1667.
  68. Haddad NG, Fleischer DE. Endoscopic laser therapy for esophageal cancer. Gastroint Endo Clin North Am 1994; 4: 863-874.
  69. Abulafi AM, Allandice JT, Williams NS et al. Photodynamic therapy for malignant tumors ot the ampulla of Vater. Gut 1995; 36: 853-856.
  70. Loh CS, Bliss P, Brown SG et al. Photodynamic therapy for villous adenomas of the colon and rectum. Endoscopy 1995; 26: 243-246.
  71. Jin M, Yang B, Zhang W, Wang Y. Phoptodynamic therapy for upper gastrointestinal tumors over the past 10 years. Semin Surg Oncol 1994; 10: 111-113.
  72. Overholt BF, Pan Jehpour M, DeNovo RC, Petersen MG. Photodynamic therapy destroys dysplasia in Barrett’s oesofagus. Am J Gastroenent 1995; 90: 1566 - 1569.
  73. Froehlich F, Burnand B, Pache I et al. Overuse of upper gastrointestinal endoscopy in a country with open-access endoscopy: a prospective study in primary care. Gastrointest Endosc 1997; 45: 13-19.
  74. Minoli G, Prada A. Comments on appropriateness and diagnostic yield of upper gastrointestinal endoscopy. Endoscopy 1997; 29: 430-431.

HELICOBACTER PYLORI DIAGNOSTIC AND THERAPEUTIC MEASURES:
ETHICAL ASPECTS

A. H. NOVIS
Although great scientific strides have been made over the past decade in the Helicobacter pylori saga, less attention has been given to the ethical questions involved in diagnosing and treating the condition. One of the weightiest ethical conundrums is whether the H. pylori infection should be treated under all circumstances.
This paper will not try to resolve such controversies, but rather try and indicate the ethical positions gastroenterologists and other medical practitioners should consider when dealing with their patients. The hope is to avoid the misuse of various breath tests and serology in otherwise healthy population groups, thus avoiding much anxiety, while at the same time, helping patients benefit from the tremendous depth of knowledge that has emerged in the last decade and a half since Helicobacter pylori was rediscovered by Warren and Marshall.
H. pylori infection is a very common condition. Epidemiological studies have shown that perhaps half of the world’s population is infected with H. pylori and that most infections begin in childhood.
In terms of the harm it does, infection with H. pylori has been identified as a definite etiological factor in patients with peptic ulcer disease, low grade gastric MALT lymphoma and gastritis. In addition, it has been identified as a risk factor for gastric adeno-carcinoma of the antrum and corpus.
Pathogenic mechanisms by which H. pylori induces gastric injury are now fairly well explained, but though there is an inverse relationship between socio-economic status and the prevalence of infection, the exact mode of transmission remains a mystery. Nevertheless, controversies surround the methods of diagnosing and treating dyspeptic patients without ulcers and even those with suspected but unproven peptic ulcers. In addition, controversy exists as to whether all H. pylori are intrinsically "bad" and potentially dangerous, and thus should be eradicated, or whether some H. pylori are "good" and therefore should be left alone.
In answering such ethical questions, the first factor to consider is the nature of the patient-physician relationship. Not only is this of paramount importance, but attitudes to this relationship have been undergoing profound change in recent times.
Once, a paternalistic attitude was the norm, based on the belief that "scientific objectivity" was the dominant value in diagnosing and treating a patient, and in the interests of scientific objectivity, the physician was best qualified to make decisions without much reference to the patient. A non-paternalistic approach, on the other hand, assumes that the patient has the right to full information about techniques and research progress involved in his condition and its treatment.
Medical theorist Robert Veatch suggests in "The Patient-Physician Relation" (1) a partnership model in which the principles of autonomy and justice take precedence over beneficence, with the physician being obliged to create an atmosphere inducive to questioning by the patient about, for example, H Pylori and the need or not for testing and treatment.
The controversy about an active versus a passive patient involvement model is complicated by the fact that so much is still not known about the condition.
Gastroenterologists have been and still are divided among those who believe that "the only good Helicobacter is a dead one" and those who believe that possible "good" Helicobacter should be protected.
This controversy is exemplified by two recent articles. On one hand, a recent editorial in the British Medical Journal by Anthony Axon and David Forman (2), "Helicobacter gastroduodenitis: a serious infectious disease" concluded that it is timely to consider H pylori gastroduodenitis as a disease in its own right, with peptic ulcer and gastric cancer as important complications. About 85% of infected individuals, they note, "will not develop complications but until a reliable means can be found to identify the 15% who will become seriously ill, all those with the disease must be considered at a high risk of a potential fatal outcome."
On the other hand, an article by Martin Blaser (3) in the Lancet, "Not all Helicobacter pylori strains are created equal; should all be eliminated?" suggested a conceivable benefit to some infected people, and noted that at present, we are too ignorant of the diversity of H. pylori strains and their interactions with human beings to advocate their total elimination. It is very possible that in addition to the "bad" or the "very bad" H pylori strains, there are also the "good" or "neutral" strains.
In considering the ethical implications, primary consideration must be given to the protection of the patient, since to practice medicine ethically, the physician must apply his knowledge and power only for the benefit of the patient in particular and mankind in general. This consideration also applies to the use of new diagnostic tests which have allowed us in recent times to diagnose conditions in ways that were not possible in the past. Helicobacter induced gastritis is but one example.
Perhaps we as physicians should adapt the words of the prophet Malachi, "What is good and what is required of you but to do justice to your patients, show them love and kindness and always walk humbly..."
The question, of course, is how to apply such exhortations to the ethics of new diagnostic tests. Should we, or should we not, test in the case of H. Pylori? Most people agree that once a positive test is found, then treatment is usually indicated. If positive, it is probably not ethical to leave the patient untreated. Even if serious outcomes are uncommon, it is appropriate at least to explain to the patient the potential effects of treating or not treating.
Who then should we test and treat? If the answer is "everyone", then we have the problem of expense, particularly in the developing countries, though perhaps less in the West. The potential of inducing antibiotics resistance as well as the potential side effects of therapy must also be taken into account. Should treatment be reserved for only the "bad" strains, ie. Cag A positive and Vac A positive (Vacuolating cytotoxin genotype.) (4) which have been associated with peptic ulcer and gastric cancer. Concerning the host’s response to the H pylori, the host immune response, genetic factors and life style habits are all factors of which the importance is not yet clear.
We should be asking ourselves a number of question: Is broad screening for H. Pylori infection indicated? Which method of screening is the most specific and sensitive? Is recognition of the most virulent strains of H. Pylori of importance? Is complete eradication of H. Pylori appropriate? Should we screen and treat all patients with H. Pylori gastritis?
In favor of this, 50% of the world’s populations are infected with H. Pylori, of whom 10% will develop complications and 2% die. These figures could all be reduced and primary cancer prevention may thus be possible. In addition, the pool of infection would be much reduced
Against screening and treating everyone with H. pylori gastritis are : the dubious ethics of treating asymptomatic persons; the unrestrained use of antibiotics that could result in resistant strains; the astronomical costs of such a project to any health fund or government body. How can an undeveloped country afford such a proposal? There is evidence that there has been a natural decline of the prevalence of infection as socio-economic conditions have improved in countries so much that in certain countries, such as New Zealand (5), it has dropped to under 10% of the population. Finally, there is the feeling among the ecologically-minded that we should not "mess with the environment". H. Pylori has probably been around since creation.
W De Boer at the recent International Workshop on Helicobacter pylori held in Lisbon (6) summarized the salient points regarding gastric carcinoma and H pylori as follows. There is evidence that H. Pylori infection increases the risk of gastric cancer two to three fold (7) and that gastric cancer is the second most common cancer in the world and fourth in the developed countries. However, rates are decreasing sharply in the West and the risk/benefit ratio for primary prevention is unknown.
The question is whether preventive efforts should be focused on high risk groups only, such as patients with a family history of gastric cancer or young patients who need long term treatment with a proton pump inhibitor or on the whole population.
David Forman (8) at a recent meeting in Copenhagen reported data from a meta analysis of eight prospective studies involving more than 700 patients with non-cardia gastric cancer and showed the risk to be between 1-12 fold (combined average 2.8) for H. pylori positivity and non-cardia gastric cancer. However, as regards gastric cardia cancer, H. pylori may even have a protective effect, with a risk of between 0.8 - 1.3 (combined average 0.9).
Other studies by Blaser in 1995 (3) and Parsonnet in 1997 (9) have shown a definitive association between gastric cancer and CagA positive serology among H.pylori infected subjects.
John Atherton (4) summarized the association between peptic ulceration and CagA positive serology among H pylori infected subjects. Five studies have shown a significant increase in the percentage of CagA positively in patients with an ulcer (8.2-100%) compared to those with no ulcer (37-64%).
The ethics and advisability of testing and treating patients with non ulcer dyspepsia (NUD) for H. pylori also requires looking at. Peter Malfertheiner in Lisbon (10) stated that the relationship of non ulcer dyspepsia and H. pylori has yet to be confirmed. In fact the prevalence of H. pylori has not been found to be any greater in NUD than in asymptomatic population groups. There is also a lack of convincing evidence from well designed studies that H. Pylori eradication alleviates symptoms in patients with NUD. It may be that there is a subgroup of patients with NUD in whom eradication of H. Pylori will be helpful. There is evidence that treatment of NUD patients simply converts a H. Pylori positive to H. Pylori negative dyspeptic patient.
Therefore the question arises: is it ethical to test for and then eradicate H. Pylori to cure a condition that may not be improved by eradication therapy? The decision to treat a non ulcer dyspepsia should thus be made on a case for case basis and not on a consensus statement.
Concerning the question of the value of some of the tests available to diagnose H. pylori infections, such as the Urea breath tests and serology, the physician should be convinced they are safe, accurate, sufficiently specific and useful as a diagnostic technique and should use them under the correct circumstances only.
The Urea breath tests have been used for a number of years in patients with peptic ulcer disease to diagnose the presence of H. pylori or to assess eradication. They are based on the generation of CO2 in the stomach by the action of urease produced by the H. pylori on ingested labelled urea. Labelled CO2 is absorbed in the blood and eliminated via the lungs in the breath and the proportion of CO2 in the breath before and after the ingestion of labelled urea is an indirect measure of the presence of H. pylori. Once we have decided to do a UBT, the question becomes, is it ethical to do the 14-CUBT or should only the 13-CUBT (11) be used. The non-radioactive 13-C test requires expensive equipment but it can be used in young children (12). The test is easy to perform, does not require special transport conditions but may be fairly expensive. The 14-C test is cheap but radioactive. The radiation exposure is less than one day’s exposure to the sun and one-tenth of that of a chest X-ray. However, there is the problem of environmental contamination with an isotope that has a half-life of 5700 years (13). Both tests are very sensitive (95%) and about 90-95% specific (14). False negative results can occur if done in proximity to PPI(proton pomp inhibitor), bismuth or antibiotic therapy. Tests done less than one month after therapy may give a false indication of eradication.
Laboratory serological tests for H pylori are based on the detection of IgG (occasionally IgA) antibodies specific to H. pylori. Several commercial ELISA kits are available (15) and eight of these have been compared in a multicenter study with satisfactory accuracy. Their main use has been epidemiological studies (16). False negative results may occur in children, the elderly and the immunocompromised. All commercial kits need validation on the population to be studied by testing against a well-defined panel of sera to establish a valid cut-off point. Serological tests are relatively specific, 70-90%, and sensitive , 75-95%, and are inexpensive. Their role in confirming eradication is limited, however. The instant result finger prick tests are less specific and less sensitive than the laboratory based tests. Values range from 63-97% sensitivities and 68-92% specificities (17) (18). On-site serological testing has also been promoted as a "test and treat" strategy in a primary care setting.
Is testing after eradication therapy ethically necessary when we consider the cost involved? Should patients who have had therapy be restested for confirmation of successful eradication? This is also questionable.
Only 33 % of treated patients report symptom resolution after eradication of infection. Triple therapy has an eradication rate of about 90% (19). However when questioned, 90% of the patients who had become asymptomatic, desired confirmatory evidence of H.PYLORI eradication (19).
Getting back to ethics, Pellagrino and Thomasma in their book "A Philosophic Basis of Medical Practice" (20) stress that "treating patients in a technological fashion is not being a true physician. Clinical concerns should go beyond the technical details of biological tests." The choice of what is to be done cannot be the privilege exclusively of the physician or the patient. The decision on what to do must arise somehow from cooperation between the one who is in need, the patient, and the one who attempts to alleviate that need, the physician.
There is often a fine line between advising based on knowledge of a particular case, and telling a patient what to do in a paternalistic way. As gastroenterologists, we are required to provide facts relating to H. pylori as well as an evaluative judgement of our opinion. Such a judgement is formed after consideration of the body of medical evidence, medical values and intuition based on past medical experience. An evaluative medical judgement better equips the patient to decide what is best for his or herself (21).
The principles of the new Italian code of medical practice state that the conduct of the physician should find inspiration in the equilibrium and interplay between science and conscience, a middle ground conducive to responsible medical performance and to the fulfilment of the patient’s interest

SUMMARY
The aim of this paper is not to come to a conclusion on whether we should regard H pylori as sometimes or always a serious infection or perhaps even potentially beneficial, but to discuss some facts which may help us come to an ethical decision on the recommendation of Urea breath tests and/or serology tests to various population groups and on the subsequent need for eradication therapy. At a time when guidelines are constantly changing as a result of new scientific studies and discoveries, it is neither wise nor ethical to be dogmatic on the subject. Rather, we should judge on a case by case basis, in order to avoid the misuse of breath tests and serology tests to diagnose H. pylori infections in otherwise healthy population groups and thus avoid much anxiety about the H. pylori plague. In situations where indications for testing and treatment are not conclusively recommended by consensus statements, patients should be given the facts and the physician and patient should together come to a satisfactory decision about treatment and testing.

REFERENCES:

  1. Veatch RM. The Patient-Physician Relation. Bloomington and Indianapolis: Indiana University Press , 1991
  2. Axon A, Forman D. Helicobacter gastroduodenitis: A serious infectious disease. BMJ 1997; 314: 1430 - 1.
  3. Blaser MJ. Not all Helicobacter pylori strains are created equal: Should all be eliminated? Lancet 1997; 349: 1020 -2.
  4. Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997; 40:701-3.
  5. Barbezat G. - Personal Communication
  6. De Boer W. Symposium on "Universal Eradication of Helicobacter pylori - an Ethical Dilemma" at the 10th International Workshop on Gastroduodenal Pathology and H. pylori". Lisbon September 1997.
  7. Munoz N, Pisani P. Helicobacter pylori and gastric cancer. Eur J. Gastroenterology and Hepatology 1994; 6: 1097 -1103.
  8. Forman D. Helicobacter infection and gastric cancer, the public health context 9th International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Copenhagen October 1997.
  9. Parsonnet J, Freedman GD, Orenstreich N, Vogelman H. Risk of gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
  10. Malfertheiner P. Symposium on "Universal Eradication of Helicobacter pylori - An Ethical Dilemma at the 10th International Workshop on Gastroduodenal Pathology and H. pylori. Lisbon September 1997.
  11. Logan RPH, Polson RJ, Misiewicz JJ et al . Simplified single sample 13C urea breath test for Helicobacter pylori: Comparison with histolology, culture and Elisa serology Gut 1991; 32: 1461 -4.
  12. Rowland M, Lambert I, Gormally S. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children. J. Pediatr 1997; 131: 815-20
  13. Novis BH, Gabay G., Leichtmann G, Peri M, Bernheim J. Pomeranz IS. Two point analysis 15-minute 14C urea breath test for diagnosing Helicobacter pylori infection. Digestion 1991; 50: 16-21.
  14. Cutler AF, Havstad S, Mack et al . Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995; 109: 136-41.
  15. Feldman RA Deeks JJ, Evans SJ. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur JClin Microbiol Infect Dis 1995; 14: 428-33.
  16. Drumin B, Perez-Perez GI, Blaser MJ, Sherman PM. Intra familial clustering of Helicobacter pylori infection . N Eng J Med 1990; 322:359-63.
  17. Peitz U, Labenz J. Tillenburg G, Baumann M, Borsch G. Validity of a new whole blood test for Helicobacter infection (abstract) Gut 1995; 37 (suppl 2): A 85
  18. Breslin NP, Flynn S, Balbirnie E, O’ Morain C. Validation of an "office" serological test for Helicobacter pylori (abstract) Gastroenterology 1996; 110: A68.
  19. Fendrick AM, Fennerty MB, Chey WD. Symptom status and the desire for H. pylori confirmatory testing after eradication treatment (abstract) Gastroenterology 1997; 112 A14.
  20. Pelligrino ED, Thomasa Dc. A Philosophical Basis of Medical Practice. New York and Oxford; Oxford University Press, 1981.
  21. Madder H. Existential autonomy : why patients should make their own choices. J of Medical Ethics, 1997; 23:221-5 .

BIOETHICS COMMITTEES
C. FRANCESCONI - C. STANCIU

A. Definitions
Hospital Bioethics Committees (EC) are multidisciplinary organized bodies of people from different backgrounds who should be able to identify, analyze and help resolve moral problems that arise in the care of individual patients.
Research Ethics Committees (RECs) are multidisciplinary organized bodies of people from different backgrounds who should be able to identify, analyze and help resolve moral problems that arise in both clinical research and non-clinical biomedical research. A REC can develop its action either at an institutional or at a national or regional level.

B. Origin and Composition
In 1803 Sir Thomas Percival in his book Medical Ethics was the first person to recognize the need of an organized body of persons to exchange ideas concerning the development of new medical procedures. In historical perspective this is probably the first time REC is mentioned.
After the Second World War, as a consequence of the atrocities that were inflicted by the Nazis under the excuse of "medical research", the first international research code was developed: the Nuremberg Code which was subsequently improved at different moments (Helsinki 1964, Tokyo 1975, Venice 1983, Hong Kong 1989 and CIOMS 1982 and 1993). All these codes have in common the prescription of measures aimed to protect research subjects against possible abuses. Different countries have national medical research codes according to international rules but in accordance to moral and social values of a given society.
The development of the renal dialyses units in the 1960s, raised a very difficult ethical question to the nephrologists, with a number of patients far exceeding the number of centers where the skills and machinery were available to the patients. At that time, in a medical center a board of lay people selected patients to under go treatment; those patients had a chance of surviving. This committee became known as the "God Committee" for they had the power of life and death. "Social worth" and "productivity" were values that were often taken into consideration to make this choice.
In 1976 Karen Quinlan’s case posed a complex question to a judge who had to decide if the patient’s family had the right to ask to the doctors responsible for her care to interrupt the measures that kept her alive. At this moment she was in a persistent vegetative state with no perspective of clinical improvement. The judge asked the Nursing Home Ethics Committee, where she was maintained alive for help indeciding whether the claim was morally acceptable or not. Than it was realized that the hospitals in the United States did not have this kind of committee and that the people involved in the case, were not aware of the pioneer paper written by Karen Teel, who, the previous year proposed the constitution of multidisciplinary committees. So one was created at Karen’s nursing home to answer the judge’s question. In the following years this kind of committee was organized in a great number of American hospitals and also in countries all over the world (1).

Committees that deal with ethical issues are usually composed of people from different backgrounds. Because EC and REC are organs responsible for the protection of patients and/or research subjects, they have the social obligation to protect the members of the community under its jurisdiction from any ethical infringement from the health professions. For this reason, society must be represented on these committees by people of both genders, different races, representative of the city or country, and sometimes, in special questions, by minorities when issues that are pertinent to them are brought up. It is also essential that different medical specialities be represented in these committees as well as members of other professions such as nurses, social workers, lawyers, church representatives, administrators, ethicists and lay people representing the community (1).

C. Responsibilities
REC and EC have different responsibilities. The former has to deal with the protection of the rights and welfare of all human subjects exposed to scientific experimentation and the latter with the protection of patients in medical institutions. The hospitals and the different health care institutions like hospices, outpatient clinics, homes for orphans, homes for elderly people and mental hospitals very often have moral questions and dilemmas that are raised at the moment that physicians and staff of these institutions mentioned above.
REC members have to review research protocols and in some circumstances to follow them to be sure that, in delicate or risky research situations for the subjects, they are protected by the research team (2). In some countries institutional REC has to report to the national REC for the approval of research of new drugs, vaccines and new technologies. Multicentric studies are evaluated in different ways in different countries; the ethics evaluation can be independently performed by institutional, regional, national or international EC. One important issue raised in the last CIOM’s International Guidelines for Biomedical Research Involving Human Subjects (3) it needs to be mentioned. Externally sponsored investigation of new drugs or any new technology, that has direct implication in third world countries received special attention, as follows: "Externally sponsored research entails two ethical obligations:

An external sponsoring agency should submit the research protocol to ethical and scientific review according to the standards of the country at the sponsoring agency, and the ethical standards applied should be no less exacting than they would be in the case of research carried out in that country.
After scientific and ethical approval in the country of the sponsoring agency, the appropriate authorities of the host country, including a national or local ethical review committee or its equivalent, should satisfy themselves that the proposed research meets their own ethical requirements."
In our personal experience, informed consent has been the most frequent cause of interaction between REC and researchers. Problems related with its formal presentation are the main reasons to return protocol to researchers asking for improvement. We ask for a clear presentation of the topics so they can be perfectly understood by the research subjects as recommended by international guidelines of research (CIOMS and the ICH Harmonized Tripartite Guideline for Good Clinical Practice) (3,4). We think those joint meetings between REC and Scientific Committees are very productive for two reasons: the first is that a scientifically sound protocol is the basic ethical foundation of medical research and second the fact that it decreases the evaluation time of the protocol.
EC  have different responsibilities. First of all it is a consultation committee rather than an executive one like REC. In most medical institutions EC works for:
a) education: its interaction with members of the health and administrative staff, through the discussion of ethical matters related to their work with patients. This is an important way of increasing the sensitivity of these professionals to the ethical aspects of patient care. It has also the role of educating the members of the committee themselves that will represent, at the end, a multiplier effect for the dissemination of ethical issues;
b) policy formulation: EC can work at the request of the institutional administration or its own initiative, when any measure that may improve or protect patients is contemplated. As a consultant body, EC submits drafts for evaluation of the administrative authorities;
c) case consultation, which is done at the option of any person of the health team or even of the patients. Moral issues in the care of terminal patients, allocation of scarce resources, patient’s autonomy, conflicts between beneficence and autonomy, fertilization and the interruption of pregnancy and moral problems in the care of AIDS patients, usually related to confidentiality and privacy are usually submitted to the EC (7).
EC members are expected to have some special skills in order to do their work in a more effective way and, at the same time, to gain the trust of people that ask for their advice. La Puma and Schneidermayer (8) suggest the following skills and roles for ethics consultation members:

  1. Fundamental skills
  1. identify and analyze clinical ethical problems
  2. use and model reasonable clinical judgment
  3. communicate with and educate team patient, and family
  4. negotiate and facilitate negotiations
  5. teach and assist in problem solving
  1. Appropriate roles
  1. professional colleague
  2. patient advocate
  3. case manager
  4. negotiator
  5. educator

It is interesting to observe that these skills and roles as well as the kind of cases that are brought to consultation described by American authors have been observed by one of the authors (CF) to apply in the operation of an EC in a developing country with a Latin culture.
However, there are some difficulties for ethics consultants and the teamwork of an EC. It is difficult to pass enthusiasm and ethical knowledge to each member of the committee in order to make the decision process more coherent and scientific and less based on "gut feelings". It is expected from its member a kind of moral sensitivity and not necessarily solid bioethical foundations. So the selection process of the EC constituents is critical: it should be done neither on political nor on friendship criteria. The feeling that only ethical consultants are experts in ethics, so that the remaining members of the hospital staff and faculty should mention their moral commitment regarding the care of their patients. Moral neutrality must be avoided at any cost.

In order to be efficient and reliable, ethical consultants must promptly attend consultations. As EC members they are usually involved in their basic activities, the availability of time is critical to meet the expectations of the community institution. For this reason it is essential that at least 3 to 5 of its members have similar skills to be able to attend urgent consultations.
Factors involving group dynamics can add some difficulty in the running of an EC. In selection process it is essential to avoid persons with dogmatic, rude, narcissistic or individualistic characteristic personality features or any other characteristic that can harm teamwork in the discussion of delicate moral questions. It is also essential the members be bound to confidentiality and privacy principles. The environment of the meeting, when one brings his or her case to the group must be as friendly as possible to avoid any threatening or intimidating feeling. The EC must also be alert and avoid discussing non-moral issues like personal, deontological/legal and administrative problems.

D. Ethics Committees of National and International Organizations
Almost all national and international societies or organizations related to gastroenterology, hepatology and gastrointestinal endoscopy place an Ethical Committee on their bylaws. It usually has two roles:
a)one, and the most traditional, concerned with deontological questions, like professional incorrect attitudes of their members, financial questions of reimbursement of professional work and so on;
b) the OMGE EC has also been engaged in bioethical education and research in the last years. It has been a very productive activity; for instance, the discussion in several countries of issues of truth telling, using an international research sponsored by the committee (9) as a base for the debate of moral principles like autonomy, beneficence, veracity, fidelity and justice. The cross cultural differences observed in the Pan-American, Brazilian, Rumanian, South-African meetings have been a very rich experience both to the members of the committee who have participated in the events and also to the audience who have praised greatly the open discussion of this matters. It is a very promising fact the effort of OMGE and OMED to join some of their committees, the Ethics Committee being the first one to share members of both organizations.

REFERENCES :
Tealdi JC, Mainetti JÁ: Hospital Ethics Committees in Bioethics Issues and Perspectives; Editors: Connor SS Fuenzalida HL Pan American Health Organization 1990, 24-29.

Capron AM: Human Experimentation in Veatch RM Medical Ethics; Jones and Bartlett Publishers 1989 , 125-172

International Ethical Guidelines for Biomedical Research Involving Human Subjects prepared by the Council for International Organizations of Medical Sciences (CIOMS) in collaboration with World Heath Organization (WHO), 1993

ICH Harmonized Tripartite Guideline for Good Clinical Practice; supplement; Good Clinical Practice Journal;3:4,Sept/Oct 1996

Silverstein F., Larson EB, Rohrmann Jr. C.A.: Diagnostic and Therapeutic Modalities in Gastroenterology; General Considerations, in Textbook of Gastroenterology, Yamada T., Alpers D., Owang C., Powell D., Silverstein F., 2538-2544, JB Lipincott Company, Second Edition, Philadelphia EUA, 1995

Bouchard S., Barkun A.N., Barkun, J.S., Joseph L.: Technology Assesment in Laparoscopie General Surgery and Gastrointestinal Endoscopy: Science or Convenience?; Gastroenterology 110: 915-925, 1996

Junkerman CL: Manual for Ethics Committee Members Froedtert Memorial Lutheran Hospital& John L Doyne Hospital Joint Ethical Committee Milwaukee, Wisconsin 1994

La Puma J, Schneidermayer DL: Ethics Consultations and Skills, Annals Int. Med. 114, 155-160, 1991

Thomsen O.,Wulff HR, Martin A, Singer P: What do gastroentero- logists in Europe tell cancer patients? Lancet, 341, 473; 1993.

"This publication is supported
by an unrestricted educational grant from
Takeda Italia"


Home | What is OMED   | Governing Council and Activities | OMED Committees
Member National Societies | World Congresses | News from the Member Societies

Statutes | Websites | Meetings of interest | Minimal Standard Terminology
OMED newsletter | Product news | OMED educational videotapes | The Clinical Case


By and with the contribution of Èulogos and UniNet.
Maintained by A. Grassi, M.D. - Email: omed@uni.net